,words,labels,sentence_id,full sentence
430,In,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
431,many,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
432,cases,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
433,",",O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
434,further,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
435,selection,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
436,goals,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
437,such,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
438,as,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
439,milk,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
440,composition,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
441,",",O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
442,udder,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
443,morphology,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
444,",",O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
445,somatic,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
446,cell,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
447,count,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
448,",",O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
449,and,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
450,scrapie,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
451,resistance,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
452,have,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
453,been,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
454,implemented,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
455,.,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
533,At,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
534,the,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
535,moment,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
536,",",O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
537,the,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
538,most,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
539,effective,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
540,strategy,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
541,seems,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
542,to,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
543,be,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
544,the,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
545,strengthening,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
546,of,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
547,research,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
548,projects,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
549,aimed,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
550,at,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
551,finding,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
552,causal,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
553,mutations,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
554,along,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
555,the,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
556,genes,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
557,affecting,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
558,traits,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
559,of,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
560,economic,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
561,importance,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
562,.,O,17.0,"At the moment , the most effective strategy seems to be the strengthening of research projects aimed at finding causal mutations along the genes affecting traits of economic importance ."
680,Short,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
681,-,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
682,term,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
683,consumption,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
684,of,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
685,the,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
686,product,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
687,significantly,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
688,lowered,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
689,24,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
690,-,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
691,h,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
692,urinary,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
693,calcium,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
694,excretion,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
695,by,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
696,approximately,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
697,0.65,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
698,+,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
699,/-,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
700,0.19,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
701,mmol,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
702,/,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
703,d,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
704,(,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
705,means,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
706,+,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
707,/-,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
708,SEM,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
709,",",O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
710,p,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
711,less,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
712,than,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
713,0.001,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
714,),O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
715,.,O,22.0,"Short - term consumption of the product significantly lowered 24 - h urinary calcium excretion by approximately 0.65 + /- 0.19 mmol / d ( means + /- SEM , p less than 0.001 ) ."
739,Elderly,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
740,people,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
741,in,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
742,particular,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
743,might,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
744,benefit,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
745,from,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
746,the,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
747,new,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
748,product,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
749,because,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
750,it,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
751,reduces,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
752,their,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
753,calcium,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
754,loss,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
755,as,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
756,well,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
757,as,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
758,their,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
759,intake,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
760,of,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
761,protein,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
762,",",O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
763,phosphorus,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
764,",",O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
765,energy,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
766,",",O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
767,and,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
768,liquid,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
769,volume,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
770,.,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
1177,Education,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1178,to,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1179,promote,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1180,positive,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1181,choices,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1182,and,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1183,physical,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1184,activity,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1185,and,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1186,resolute,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1187,public,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1188,health,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1189,interventions,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1190,on,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1191,food,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1192,delivery,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1193,are,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1194,requested,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1195,to,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1196,reduce,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1197,the,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1198,burden,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1199,of,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1200,obesity,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1201,-,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1202,related,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1203,cancer,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1204,and,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1205,lighten,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1206,the,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1207,unsustainable,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1208,growing,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1209,expenses,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1210,to,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1211,health,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1212,systems,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1213,.,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
2123,On,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2124,the,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2125,basis,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2126,of,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2127,the,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2128,literature,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2129,review,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2130,",",O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2131,it,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2132,can,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2133,be,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2134,asserted,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2135,that,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2136,some,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2137,kinds,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2138,of,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2139,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2140,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2141,have,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2142,favorable,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2143,effects,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2144,on,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2145,human,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2146,health,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2147,at,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2148,different,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2149,stages,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2150,of,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2151,life,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2152,.,O,66.0,"On the basis of the literature review , it can be asserted that some kinds of cocoa products have favorable effects on human health at different stages of life ."
2303,After,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2304,16,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2305,weeks,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2306,",",O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2307,ginger,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2308,supplementation,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2309,alleviated,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2310,the,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2311,HFD,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2312,-,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2313,induced,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2314,increases,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2315,in,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2316,body,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2317,weight,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2318,",",O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2319,fat,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2320,accumulation,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2321,",",O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2322,and,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2323,levels,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2324,of,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2325,serum,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2326,glucose,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2327,",",O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2328,triglyceride,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2329,and,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2330,cholesterol,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2331,.,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2332,Indirect,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2333,calorimetry,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2334,showed,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2335,that,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2336,ginger,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2337,administration,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2338,significantly,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2339,increased,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2340,the,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2341,respiratory,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2342,exchange,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2343,ratio,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2344,(,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2345,RER,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2346,),O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2347,and,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2348,heat,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2349,production,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2350,in,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2351,both,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2352,diet,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2353,models,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2354,.,O,75.0,Indirect calorimetry showed that ginger administration significantly increased the respiratory exchange ratio ( RER ) and heat production in both diet models .
2514,At,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2515,the,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2516,geographic,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2517,level,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2518,",",O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2519,intake,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2520,maps,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2521,closely,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2522,onto,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2523,the,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2524,distribution,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2525,of,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2526,lactase,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2527,persistence,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2528,(,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2529,LP,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2530,),O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2531,",",O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2532,a,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2533,genetic,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2534,trait,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2535,that,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2536,allows,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2537,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2538,to,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2539,be,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2540,consumed,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2541,beyond,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2542,the,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2543,weaning,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2544,period,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2545,without,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2546,gastrointestinal,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2547,side,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2548,effects,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2549,.,O,82.0,"At the geographic level , intake maps closely onto the distribution of lactase persistence ( LP ) , a genetic trait that allows milk to be consumed beyond the weaning period without gastrointestinal side effects ."
2948,Last,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2949,",",O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2950,speakers,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2951,described,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2952,the,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2953,role,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2954,of,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2955,dairy,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2956,products,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2957,in,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2958,global,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2959,public,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2960,health,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2961,and,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2962,nutrition,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2963,",",O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2964,the,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2965,scientific,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2966,basis,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2967,for,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2968,current,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2969,dairy,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2970,recommendations,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2971,",",O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2972,and,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2973,future,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2974,scientific,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2975,and,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2976,policy,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2977,needs,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2978,related,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2979,to,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2980,dairy,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2981,and,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2982,yogurt,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2983,recommendations,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2984,.,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2985,Breakfast,O,93.0,Breakfast beverages with different nutrient compositions may affect postprandial glycemic control differently .
2986,beverages,O,93.0,Breakfast beverages with different nutrient compositions may affect postprandial glycemic control differently .
2987,with,O,93.0,Breakfast beverages with different nutrient compositions may affect postprandial glycemic control differently .
2988,different,O,93.0,Breakfast beverages with different nutrient compositions may affect postprandial glycemic control differently .
2989,nutrient,O,93.0,Breakfast beverages with different nutrient compositions may affect postprandial glycemic control differently .
2990,compositions,O,93.0,Breakfast beverages with different nutrient compositions may affect postprandial glycemic control differently .
2991,may,O,93.0,Breakfast beverages with different nutrient compositions may affect postprandial glycemic control differently .
2992,affect,O,93.0,Breakfast beverages with different nutrient compositions may affect postprandial glycemic control differently .
2993,postprandial,O,93.0,Breakfast beverages with different nutrient compositions may affect postprandial glycemic control differently .
2994,glycemic,O,93.0,Breakfast beverages with different nutrient compositions may affect postprandial glycemic control differently .
2995,control,O,93.0,Breakfast beverages with different nutrient compositions may affect postprandial glycemic control differently .
2996,differently,O,93.0,Breakfast beverages with different nutrient compositions may affect postprandial glycemic control differently .
2997,.,O,93.0,Breakfast beverages with different nutrient compositions may affect postprandial glycemic control differently .
3471,In,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3472,this,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3473,study,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3474,",",O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3475,intake,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3476,of,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3477,total,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3478,vegetables,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3479,was,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3480,shown,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3481,to,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3482,have,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3483,a,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3484,protective,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3485,effect,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3486,",",O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3487,whereas,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3488,high,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3489,nitrate,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3490,-,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3491,containing,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3492,vegetables,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3493,increased,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3494,the,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3495,risk,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3496,of,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3497,GC,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3498,.,O,109.0,"In this study , intake of total vegetables was shown to have a protective effect , whereas high nitrate - containing vegetables increased the risk of GC ."
3615,In,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3616,a,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3617,second,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3618,study,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3619,",",O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3620,8,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3621,cows,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3622,received,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3623,bST,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3624,or,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3625,vehicle,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3626,7,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3627,d,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3628,before,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3629,bacterial,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3630,challenge,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3631,.,O,114.0,"In a second study , 8 cows received bST or vehicle 7 d before bacterial challenge ."
3912,Canola,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3913,and,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3914,soybean,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3915,oils,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3916,significantly,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3917,lowered,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3918,serum,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3919,HDL,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3920,cholesterol,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3921,concentrations,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3922,relative,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3923,to,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3924,butter,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3925,.,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
4118,We,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4119,describe,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4120,a,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4121,method,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4122,for,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4123,the,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4124,direct,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4125,determination,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4126,of,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4127,stilbenes,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4128,in,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4129,several,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4130,red,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4131,wines,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4132,using,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4133,high,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4134,-,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4135,performance,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4136,liquid,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4137,chromatography,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4138,with,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4139,UV,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4140,detection,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4141,.,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4253,delta,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4254,-,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4255,Viniferin,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4256,contributes,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4257,",",O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4258,as,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4259,well,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4260,as,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4261,cis,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4262,-,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4263,resveratrol,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4264,and,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4265,trans,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4266,-,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4267,piceid,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4268,",",O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4269,to,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4270,a,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4271,significant,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4272,proportion,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4273,of,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4274,stilbenes,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4275,in,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4276,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4277,dietary,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4278,intake,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4279,",",O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4280,particularly,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4281,with,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4282,Merlot,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4283,varieties,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4284,containing,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4285,an,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4286,average,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4287,level,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4288,of,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4289,10,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4290,mg,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4291,/,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4292,L,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4293,for,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4294,delta,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4295,-,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4296,viniferin,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4297,",",O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4298,15,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4299,mg,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4300,/,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4301,L,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4302,for,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4303,cis,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4304,-,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4305,resveratrol,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4306,",",O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4307,and,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4308,13,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4309,mg,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4310,/,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4311,L,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4312,for,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4313,trans,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4314,-,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4315,piceid,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4316,.,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4720,Soft,B-http://purl.bioontology.org/ontology/SNOMEDCT/226465004,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4721,drinks,I-http://purl.bioontology.org/ontology/SNOMEDCT/226465004,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4722,and,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4723,alcoholic,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4724,beverages,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4725,were,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4726,available,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4727,in,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4728,80·7,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4729,and,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4730,42·0,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4731,%,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4732,of,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4733,the,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4734,vending,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4735,sites,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4736,selling,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4737,beverages,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4738,",",O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4739,respectively,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4740,.,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4741,Concluding,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4742,",",O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4743,industrial,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4744,snacks,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4745,and,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4746,home,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4747,-,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4748,made,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4749,pastries,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4750,high,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4751,in,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4752,Na,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4753,and,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4754,unhealthy,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4755,fat,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4756,were,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4757,frequent,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4758,in,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4759,Chişinău,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4760,.,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
5504,The,O,178.0,The overall evidence of an association between fluid intake and bladder cancer is not entirely consistent .
5505,overall,O,178.0,The overall evidence of an association between fluid intake and bladder cancer is not entirely consistent .
5506,evidence,O,178.0,The overall evidence of an association between fluid intake and bladder cancer is not entirely consistent .
5507,of,O,178.0,The overall evidence of an association between fluid intake and bladder cancer is not entirely consistent .
5508,an,O,178.0,The overall evidence of an association between fluid intake and bladder cancer is not entirely consistent .
5509,association,O,178.0,The overall evidence of an association between fluid intake and bladder cancer is not entirely consistent .
5510,between,O,178.0,The overall evidence of an association between fluid intake and bladder cancer is not entirely consistent .
5511,fluid,O,178.0,The overall evidence of an association between fluid intake and bladder cancer is not entirely consistent .
5512,intake,O,178.0,The overall evidence of an association between fluid intake and bladder cancer is not entirely consistent .
5513,and,O,178.0,The overall evidence of an association between fluid intake and bladder cancer is not entirely consistent .
5514,bladder,O,178.0,The overall evidence of an association between fluid intake and bladder cancer is not entirely consistent .
5515,cancer,O,178.0,The overall evidence of an association between fluid intake and bladder cancer is not entirely consistent .
5516,is,O,178.0,The overall evidence of an association between fluid intake and bladder cancer is not entirely consistent .
5517,not,O,178.0,The overall evidence of an association between fluid intake and bladder cancer is not entirely consistent .
5518,entirely,O,178.0,The overall evidence of an association between fluid intake and bladder cancer is not entirely consistent .
5519,consistent,O,178.0,The overall evidence of an association between fluid intake and bladder cancer is not entirely consistent .
5520,.,O,178.0,The overall evidence of an association between fluid intake and bladder cancer is not entirely consistent .
6152,Tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6153,also,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6154,contain,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6155,other,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6156,active,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6157,compounds,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6158,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6159,namely,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6160,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6161,neoxanthin,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6162,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6163,lutein,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6164,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6165,α,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6166,-,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6167,cryptoxanthin,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6168,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6169,α,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6170,-,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6171,carotene,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6172,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6173,β,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6174,-,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6175,carotene,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6176,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6177,cyclolycopene,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6178,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6179,and,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6180,β,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6181,-,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6182,carotene,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6183,5,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6184,",",O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6185,6,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6186,-,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6187,epoxide,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6188,.,O,201.0,"Tomato also contain other active compounds , namely , neoxanthin , lutein , α - cryptoxanthin , α - carotene , β - carotene , cyclolycopene , and β - carotene 5 , 6 - epoxide ."
6942,Calcium,O,227.0,Calcium intake positively affects bone mass and is crucial in childhood and youth for correct bone development .
6943,intake,O,227.0,Calcium intake positively affects bone mass and is crucial in childhood and youth for correct bone development .
6944,positively,O,227.0,Calcium intake positively affects bone mass and is crucial in childhood and youth for correct bone development .
6945,affects,O,227.0,Calcium intake positively affects bone mass and is crucial in childhood and youth for correct bone development .
6946,bone,O,227.0,Calcium intake positively affects bone mass and is crucial in childhood and youth for correct bone development .
6947,mass,O,227.0,Calcium intake positively affects bone mass and is crucial in childhood and youth for correct bone development .
6948,and,O,227.0,Calcium intake positively affects bone mass and is crucial in childhood and youth for correct bone development .
6949,is,O,227.0,Calcium intake positively affects bone mass and is crucial in childhood and youth for correct bone development .
6950,crucial,O,227.0,Calcium intake positively affects bone mass and is crucial in childhood and youth for correct bone development .
6951,in,O,227.0,Calcium intake positively affects bone mass and is crucial in childhood and youth for correct bone development .
6952,childhood,O,227.0,Calcium intake positively affects bone mass and is crucial in childhood and youth for correct bone development .
6953,and,O,227.0,Calcium intake positively affects bone mass and is crucial in childhood and youth for correct bone development .
6954,youth,O,227.0,Calcium intake positively affects bone mass and is crucial in childhood and youth for correct bone development .
6955,for,O,227.0,Calcium intake positively affects bone mass and is crucial in childhood and youth for correct bone development .
6956,correct,O,227.0,Calcium intake positively affects bone mass and is crucial in childhood and youth for correct bone development .
6957,bone,O,227.0,Calcium intake positively affects bone mass and is crucial in childhood and youth for correct bone development .
6958,development,O,227.0,Calcium intake positively affects bone mass and is crucial in childhood and youth for correct bone development .
6959,.,O,227.0,Calcium intake positively affects bone mass and is crucial in childhood and youth for correct bone development .
7444,Of,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7445,our,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7446,patients,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7447,",",O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7448,42.5,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7449,%,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7450,reported,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7451,allergic,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7452,symptoms,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7453,after,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7454,ingestion,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7455,of,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7456,these,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7457,fruits,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7458,and,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7459,a,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7460,total,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7461,of,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7462,112,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7463,intolerance,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7464,reactions,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7465,were,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7466,recorded,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7467,.,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7813,Thus,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7814,",",O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7815,these,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7816,results,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7817,confirm,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7818,the,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7819,previous,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7820,report,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7821,in,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7822,showing,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7823,a,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7824,significant,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7825,effect,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7826,of,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7827,saturated,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7828,fat,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7829,in,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7830,increasing,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7831,risk,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7832,of,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7833,colon,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7834,cancer,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7835,but,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7836,suggest,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7837,a,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7838,contribution,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7839,of,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7840,meats,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7841,to,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7842,risk,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7843,of,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7844,rectal,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7845,cancer,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
7846,.,O,259.0,"Thus , these results confirm the previous report in showing a significant effect of saturated fat in increasing risk of colon cancer but suggest a contribution of meats to risk of rectal cancer ."
8602,No,O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8603,relation,O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8604,was,O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8605,found,O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8606,for,O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8607,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8608,and,O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8609,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8610,",",O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8611,soups,O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8612,",",O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8613,eggs,O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8614,",",O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8615,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8616,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8617,",",O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8618,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8619,",",O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8620,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8621,",",O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8622,pulses,O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8623,",",O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8624,potatoes,O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8625,",",O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8626,fruits,O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8627,",",O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8628,desserts,O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8629,and,O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8630,sugars,O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8631,.,O,284.0,"No relation was found for coffee and tea , soups , eggs , red meat , fish , cheese , pulses , potatoes , fruits , desserts and sugars ."
8930,We,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8931,compared,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8932,the,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8933,effects,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8934,of,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8935,normal,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8936,protein,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8937,(,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8938,control,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8939,),O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8940,diet,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8941,with,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8942,high,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8943,protein,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8944,diets,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8945,containing,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8946,whey,B-http://purl.bioontology.org/ontology/SNOMEDCT/226770007,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8947,",",O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8948,or,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8949,its,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8950,fractions,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8951,lactalbumin,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8952,and,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8953,lactoferrin,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8954,",",O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8955,on,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8956,energy,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8957,balance,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8958,and,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8959,metabolism,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8960,.,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
9016,Notably,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9017,",",O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9018,lactoferrin,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9019,produced,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9020,sustained,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9021,weight,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9022,and,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9023,fat,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9024,loss,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9025,",",O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9026,and,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9027,attenuated,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9028,the,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9029,reduction,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9030,in,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9031,energy,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9032,expenditure,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9033,associated,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9034,with,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9035,calorie,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9036,restriction,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9037,.,O,296.0,"Notably , lactoferrin produced sustained weight and fat loss , and attenuated the reduction in energy expenditure associated with calorie restriction ."
9237,Using,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9238,the,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9239,primary,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9240,data,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9241,",",O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9242,the,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9243,study,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9244,-,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9245,specific,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9246,relative,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9247,risks,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9248,(,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9249,RRs,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9250,),O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9251,were,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9252,calculated,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9253,and,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9254,then,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9255,pooled,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9256,using,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9257,a,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9258,random,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9259,effects,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9260,model,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9261,.,O,305.0,"Using the primary data , the study - specific relative risks ( RRs ) were calculated and then pooled using a random effects model ."
9754,Lingonberry,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9755,and,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9756,blueberry,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9757,plants,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9758,were,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9759,found,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9760,to,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9761,be,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9762,rich,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9763,sources,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9764,of,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9765,phenolic,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9766,compounds,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9767,.,O,324.0,Lingonberry and blueberry plants were found to be rich sources of phenolic compounds .
9794,These,O,326.0,"These results were in correlation with phenolic contents including total flavonoids , anthocyanins , and tannins ."
9795,results,O,326.0,"These results were in correlation with phenolic contents including total flavonoids , anthocyanins , and tannins ."
9796,were,O,326.0,"These results were in correlation with phenolic contents including total flavonoids , anthocyanins , and tannins ."
9797,in,O,326.0,"These results were in correlation with phenolic contents including total flavonoids , anthocyanins , and tannins ."
9798,correlation,O,326.0,"These results were in correlation with phenolic contents including total flavonoids , anthocyanins , and tannins ."
9799,with,O,326.0,"These results were in correlation with phenolic contents including total flavonoids , anthocyanins , and tannins ."
9800,phenolic,O,326.0,"These results were in correlation with phenolic contents including total flavonoids , anthocyanins , and tannins ."
9801,contents,O,326.0,"These results were in correlation with phenolic contents including total flavonoids , anthocyanins , and tannins ."
9802,including,O,326.0,"These results were in correlation with phenolic contents including total flavonoids , anthocyanins , and tannins ."
9803,total,O,326.0,"These results were in correlation with phenolic contents including total flavonoids , anthocyanins , and tannins ."
9804,flavonoids,O,326.0,"These results were in correlation with phenolic contents including total flavonoids , anthocyanins , and tannins ."
9805,",",O,326.0,"These results were in correlation with phenolic contents including total flavonoids , anthocyanins , and tannins ."
9806,anthocyanins,O,326.0,"These results were in correlation with phenolic contents including total flavonoids , anthocyanins , and tannins ."
9807,",",O,326.0,"These results were in correlation with phenolic contents including total flavonoids , anthocyanins , and tannins ."
9808,and,O,326.0,"These results were in correlation with phenolic contents including total flavonoids , anthocyanins , and tannins ."
9809,tannins,O,326.0,"These results were in correlation with phenolic contents including total flavonoids , anthocyanins , and tannins ."
9810,.,O,326.0,"These results were in correlation with phenolic contents including total flavonoids , anthocyanins , and tannins ."
9811,Brain,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9812,-,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9813,derived,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9814,cell,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9815,cultures,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9816,from,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9817,rats,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9818,were,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9819,prepared,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9820,and,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9821,grown,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9822,for,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9823,about,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9824,2,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9825,weeks,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9826,.,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9827,Cell,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9828,cultures,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9829,were,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9830,treated,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9831,with,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9832,glutamate,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9833,(,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9834,100,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9835,μM,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9836,),O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9837,for,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9838,24,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9839,h,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9840,",",O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9841,and,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9842,the,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9843,effect,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9844,of,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9845,extracts,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9846,was,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9847,determined,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9848,on,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9849,cells,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9850,subjected,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9851,to,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9852,this,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9853,excitotoxicity,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9854,.,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9871,Whereas,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9872,lingonberry,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9873,fruit,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9874,extract,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9875,did,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9876,not,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9877,provide,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9878,protection,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9879,from,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9880,glutamate,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9881,toxicity,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9882,",",O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9883,blueberry,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9884,fruit,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9885,extracts,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9886,were,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9887,extremely,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9888,protective,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9889,.,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
10454,For,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10455,horses,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10456,",",O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10457,farm,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10458,and,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10459,companion,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10460,animals,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10461,",",O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10462,no,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10463,risk,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10464,characterisation,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10465,for,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10466,potato,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10467,GAs,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10468,could,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10469,be,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10470,performed,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10471,due,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10472,to,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10473,insufficient,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10474,data,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10475,on,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10476,occurrence,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10477,in,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10478,feed,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10479,and,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10480,on,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10481,potential,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10482,adverse,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10483,effects,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10484,of,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10485,GAs,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10486,in,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10487,these,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10488,species,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10489,.,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10490,Milk,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10491,beverages,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10492,derived,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10493,from,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10494,plant,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10495,-,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10496,based,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10497,protein,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10498,have,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10499,attracted,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10500,the,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10501,interest,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10502,of,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10503,consumers,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10504,and,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10505,researchers,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10506,as,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10507,a,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10508,health,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10509,-,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10510,promoting,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10511,functional,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10512,food,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10513,.,O,354.0,Milk beverages derived from plant - based protein have attracted the interest of consumers and researchers as a health - promoting functional food .
10636,In,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10637,addition,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10638,",",O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10639,it,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10640,also,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10641,provides,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10642,a,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10643,detailed,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10644,review,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10645,of,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10646,the,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10647,general,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10648,characteristics,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10649,and,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10650,functional,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10651,properties,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10652,of,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10653,these,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10654,plant,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10655,sources,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
10656,.,O,359.0,"In addition , it also provides a detailed review of the general characteristics and functional properties of these plant sources ."
11069,A,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11070,high,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11071,consumption,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11072,of,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11073,caloric,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11074,beverages,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11075,",",O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11076,such,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11077,as,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11078,alcoholic,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11079,or,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11080,sweetened,B-http://purl.bioontology.org/ontology/SNOMEDCT/226465004,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11081,drinks,I-http://purl.bioontology.org/ontology/SNOMEDCT/226465004,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11082,",",O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11083,may,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11084,particularly,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11085,contribute,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11086,to,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11087,weight,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11088,gain,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11089,",",O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11090,and,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11091,lower,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11092,satiety,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11093,has,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11094,been,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11095,associated,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11096,with,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11097,the,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11098,intake,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11099,of,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11100,liquid,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11101,instead,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11102,of,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11103,solid,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11104,calories,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11105,.,O,372.0,"A high consumption of caloric beverages , such as alcoholic or sweetened drinks , may particularly contribute to weight gain , and lower satiety has been associated with the intake of liquid instead of solid calories ."
11525,This,O,385.0,This review evaluates the current evidence behind the cardioprotective effects of a Mediterranean dietary pattern .
11526,review,O,385.0,This review evaluates the current evidence behind the cardioprotective effects of a Mediterranean dietary pattern .
11527,evaluates,O,385.0,This review evaluates the current evidence behind the cardioprotective effects of a Mediterranean dietary pattern .
11528,the,O,385.0,This review evaluates the current evidence behind the cardioprotective effects of a Mediterranean dietary pattern .
11529,current,O,385.0,This review evaluates the current evidence behind the cardioprotective effects of a Mediterranean dietary pattern .
11530,evidence,O,385.0,This review evaluates the current evidence behind the cardioprotective effects of a Mediterranean dietary pattern .
11531,behind,O,385.0,This review evaluates the current evidence behind the cardioprotective effects of a Mediterranean dietary pattern .
11532,the,O,385.0,This review evaluates the current evidence behind the cardioprotective effects of a Mediterranean dietary pattern .
11533,cardioprotective,O,385.0,This review evaluates the current evidence behind the cardioprotective effects of a Mediterranean dietary pattern .
11534,effects,O,385.0,This review evaluates the current evidence behind the cardioprotective effects of a Mediterranean dietary pattern .
11535,of,O,385.0,This review evaluates the current evidence behind the cardioprotective effects of a Mediterranean dietary pattern .
11536,a,O,385.0,This review evaluates the current evidence behind the cardioprotective effects of a Mediterranean dietary pattern .
11537,Mediterranean,O,385.0,This review evaluates the current evidence behind the cardioprotective effects of a Mediterranean dietary pattern .
11538,dietary,O,385.0,This review evaluates the current evidence behind the cardioprotective effects of a Mediterranean dietary pattern .
11539,pattern,O,385.0,This review evaluates the current evidence behind the cardioprotective effects of a Mediterranean dietary pattern .
11540,.,O,385.0,This review evaluates the current evidence behind the cardioprotective effects of a Mediterranean dietary pattern .
11948,Heat,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11949,treatment,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11950,in,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11951,some,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11952,cases,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11953,can,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11954,decrease,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11955,this,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11956,off,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11957,-,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11958,flavor,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11959,.,O,402.0,Heat treatment in some cases can decrease this off - flavor .
12619,Our,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12620,aim,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12621,was,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12622,to,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12623,review,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12624,the,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12625,epidemiological,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12626,literature,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12627,on,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12628,possible,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12629,cancer,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12630,-,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12631,preventive,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12632,effects,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12633,of,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12634,the,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12635,consumption,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12636,of,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12637,fruits,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12638,and,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12639,vegetables,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12640,in,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12641,humans,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12642,",",O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12643,to,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12644,quantify,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12645,the,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12646,effect,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12647,of,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12648,high,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12649,versus,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12650,low,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12651,consumption,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12652,of,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12653,fruits,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12654,and,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12655,vegetables,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12656,",",O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12657,and,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12658,to,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12659,give,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12660,an,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12661,overall,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12662,assessment,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12663,of,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12664,the,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12665,existing,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12666,evidence,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12667,.,O,422.0,"Our aim was to review the epidemiological literature on possible cancer - preventive effects of the consumption of fruits and vegetables in humans , to quantify the effect of high versus low consumption of fruits and vegetables , and to give an overall assessment of the existing evidence ."
12885,It,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12886,is,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12887,important,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12888,to,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12889,recognize,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12890,that,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12891,this,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12892,is,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12893,only,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12894,a,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12895,crude,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12896,range,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12897,of,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12898,estimates,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12899,and,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12900,that,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12901,the,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12902,proportion,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12903,of,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12904,cancers,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12905,that,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12906,might,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12907,be,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12908,preventable,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12909,by,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12910,increasing,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12911,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12912,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12913,vegetable,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12914,intake,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12915,may,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12916,vary,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12917,beyond,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12918,this,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12919,range,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12920,for,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12921,specific,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12922,cancer,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12923,sites,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12924,and,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12925,across,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12926,different,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12927,regions,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12928,of,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12929,the,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12930,world,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12931,.,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
13089,Rice,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13090,hypersensitivity,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13091,was,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13092,rare,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13093,in,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13094,both,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13095,Australia,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13096,and,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13097,Asian,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13098,countries,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13099,.,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13299,Postprandial,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13300,serum,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13301,insulin,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13302,concentration,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13303,AUC,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13304,was,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13305,significantly,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13306,higher,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13307,during,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13308,the,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13309,POT,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13310, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13311,+,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13312, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13313,CA,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13314,meal,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13315,compared,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13316,with,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13317,the,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13318,POT,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13319,meal,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13320,(,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13321,P,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13322, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13323,=,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13324, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13325,0·001,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13326,),O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13327,and,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13328,the,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13329,CA,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13330,meal,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13331,(,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13332,P,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13333, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13334,<,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13335, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13336,0·05,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13337,),O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13338,",",O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13339,which,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13340,in,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13341,turn,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13342,was,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13343,significantly,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13344,higher,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13345,than,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13346,the,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13347,POT,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13348,meal,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13349,(,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13350,P,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13351, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13352,<,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13353, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13354,0·05,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13355,),O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13356,.,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13407,Information,O,445.0,Information concerning gluten intake in the general population is scarce .
13408,concerning,O,445.0,Information concerning gluten intake in the general population is scarce .
13409,gluten,O,445.0,Information concerning gluten intake in the general population is scarce .
13410,intake,O,445.0,Information concerning gluten intake in the general population is scarce .
13411,in,O,445.0,Information concerning gluten intake in the general population is scarce .
13412,the,O,445.0,Information concerning gluten intake in the general population is scarce .
13413,general,O,445.0,Information concerning gluten intake in the general population is scarce .
13414,population,O,445.0,Information concerning gluten intake in the general population is scarce .
13415,is,O,445.0,Information concerning gluten intake in the general population is scarce .
13416,scarce,O,445.0,Information concerning gluten intake in the general population is scarce .
13417,.,O,445.0,Information concerning gluten intake in the general population is scarce .
13743,Plant,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13744,lipid,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13745,transfer,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13746,proteins,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13747,",",O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13748,a,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13749,widespread,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13750,family,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13751,of,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13752,proteins,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13753,",",O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13754,have,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13755,been,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13756,recently,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13757,identified,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13758,as,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13759,important,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13760,food,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13761,allergens,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13762,.,O,457.0,"Plant lipid transfer proteins , a widespread family of proteins , have been recently identified as important food allergens ."
13798,This,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13799,has,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13800,been,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13801,demonstrated,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13802,for,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13803,the,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13804,LTP,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13805,allergens,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13806,of,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13807,the,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13808,Prunoideae,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13809,subfamily,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13810,",",O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13811,whose,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13812,similarity,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13813,is,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13814,about,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13815,95,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13816,%,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13817,as,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13818,demonstrated,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13819,for,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13820,the,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13821,purified,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13822,allergens,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13823,of,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13824,peach,B-http://purl.bioontology.org/ontology/SNOMEDCT/735049002,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13825,",",O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13826,apricot,B-http://purl.bioontology.org/ontology/SNOMEDCT/735214002,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13827,",",O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13828,plum,B-http://purl.bioontology.org/ontology/SNOMEDCT/735051003,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13829,and,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13830,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13831,.,O,459.0,"This has been demonstrated for the LTP allergens of the Prunoideae subfamily , whose similarity is about 95 % as demonstrated for the purified allergens of peach , apricot , plum and apple ."
13943,Per,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13944,capita,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13945,consumer,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13946,exposure,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13947,to,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13948,most,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13949,of,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13950,these,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13951,food,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13952,ingredients,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13953,is,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13954,rather,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13955,low,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13956,with,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13957,a,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13958,few,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13959,notable,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13960,exceptions,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13961,such,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13962,as,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13963,sugar,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13964,and,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13965,starch,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13966,.,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
14618,Total,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14619,ethanol,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14620,intake,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14621,and,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14622,consumption,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14623,of,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14624,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14625,and,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14626,distillates,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14627,were,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14628,not,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14629,associated,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14630,with,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14631,the,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14632,risk,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14633,of,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14634,cancer,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14635,of,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14636,the,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14637,colon,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14638,or,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14639,rectum,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14640,",",O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14641,nor,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14642,with,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14643,risk,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14644,of,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14645,polyps,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
14646,.,O,486.0,"Total ethanol intake and consumption of wine and distillates were not associated with the risk of cancer of the colon or rectum , nor with risk of polyps ."
15707,After,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15708,further,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15709,adjusting,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15710,for,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15711,potentially,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15712,anticarcinogenic,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15713,constituents,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15714,of,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15715,these,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15716,foods,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15717,",",O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15718,high,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15719,carotenoid,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15720,vegetables,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15721,",",O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15722,cruciferous,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15723,vegetables,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15724,",",O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15725,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15726,",",O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15727,and,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15728,tofu,B-http://purl.bioontology.org/ontology/SNOMEDCT/227365007,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15729,(,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15730,or,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15731,soybeans,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15732,),O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15733,remained,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15734,inversely,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15735,associated,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15736,with,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15737,polyps,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
15738,.,O,526.0,"After further adjusting for potentially anticarcinogenic constituents of these foods , high carotenoid vegetables , cruciferous vegetables , garlic , and tofu ( or soybeans ) remained inversely associated with polyps ."
16735,Coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16736,contains,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16737,various,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16738,chemical,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16739,compounds,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16740,(,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16741,e.g.,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16742,",",O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16743,caffeine,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16744,",",O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16745,chlorogenic,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16746,acids,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16747,",",O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16748,hydroxyhydroquinone,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16749,",",O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16750,kahweol,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16751,",",O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16752,cafestol,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16753,",",O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16754,and,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16755,complex,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16756,chemical,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16757,mixtures,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16758,),O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16759,.,O,557.0,"Coffee contains various chemical compounds ( e.g. , caffeine , chlorogenic acids , hydroxyhydroquinone , kahweol , cafestol , and complex chemical mixtures ) ."
16812,It,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16813,is,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16814,well,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16815,known,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16816,that,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16817,there,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16818,are,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16819,J,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16820,-,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16821,curve,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16822,-,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16823,type,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16824,or,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16825,U,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16826,-,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16827,curve,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16828,-,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16829,type,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16830,associations,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16831,of,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16832,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16833,consumption,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16834,with,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16835,cardiovascular,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16836,events,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16837,including,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16838,myocardial,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16839,infarction,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16840,and,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16841,stroke,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16842,.,O,560.0,It is well known that there are J - curve - type or U - curve - type associations of coffee consumption with cardiovascular events including myocardial infarction and stroke .
16911,Skin,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16912,sensitivity,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16913,to,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16914,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16915,",",O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16916,carrot,B-http://purl.bioontology.org/ontology/SNOMEDCT/256319004,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16917,and,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16918,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16919,",",O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16920,clinically,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16921,related,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16922,to,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16923,birch,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16924,pollinosis,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16925,was,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16926,investigated,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16927,.,O,564.0,"Skin sensitivity to apple , carrot and potato , clinically related to birch pollinosis was investigated ."
16928,Different,O,565.0,Different skin test techniques using fresh fruit were compared .
16929,skin,O,565.0,Different skin test techniques using fresh fruit were compared .
16930,test,O,565.0,Different skin test techniques using fresh fruit were compared .
16931,techniques,O,565.0,Different skin test techniques using fresh fruit were compared .
16932,using,O,565.0,Different skin test techniques using fresh fruit were compared .
16933,fresh,O,565.0,Different skin test techniques using fresh fruit were compared .
16934,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,565.0,Different skin test techniques using fresh fruit were compared .
16935,were,O,565.0,Different skin test techniques using fresh fruit were compared .
16936,compared,O,565.0,Different skin test techniques using fresh fruit were compared .
16937,.,O,565.0,Different skin test techniques using fresh fruit were compared .
17600,However,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17601,",",O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17602,it,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17603,appears,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17604,that,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17605,this,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17606,hypercholesterolaemic,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17607,effect,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17608,is,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17609,apparent,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17610,only,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17611,when,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17612,the,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17613,background,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17614,diet,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17615,is,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17616,low,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17617,in,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17618,saturated,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17619,fat,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17620,and,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17621,cholesterol,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17622,.,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17680,This,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17681,study,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17682,aims,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17683,to,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17684,investigate,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17685,which,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17686,kinds,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17687,of,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17688,dietary,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17689,fat,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17690,cause,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17691,the,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17692,intestinal,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17693,metaplasia,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17694,onset,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17695,.,O,591.0,This study aims to investigate which kinds of dietary fat cause the intestinal metaplasia onset .
17722,Five,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17723,types,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17724,of,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17725,dietary,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17726,fat,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17727,were,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17728,divided,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17729,according,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17730,to,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17731,their,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17732,observed,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17733,effects,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17734,:,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17735,Obese,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17736,with,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17737,high,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17738,metaplasia,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17739,(,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17740,group,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17741,I,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17742,;,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17743,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17744,tallow,I-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17745,",",O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17746,lard,B-http://purl.bioontology.org/ontology/SNOMEDCT/226899009,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17747,",",O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17748,and,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17749,hydrogenated,B-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17750,coconut,I-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17751,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17752,),O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17753,",",O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17754,non,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17755,-,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17756,obese,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17757,with,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17758,high,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17759,metaplasia,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17760,(,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17761,group,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17762,II,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17763,;,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17764,linseed,B-http://purl.bioontology.org/ontology/SNOMEDCT/41573001;http://purl.bioontology.org/ontology/SNOMEDCT/710178007,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17765,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41573001;http://purl.bioontology.org/ontology/SNOMEDCT/710178007,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17766,),O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17767,",",O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17768,obese,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17769,without,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17770,metaplasia,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17771,(,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17772,group,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17773,III,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17774,;,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17775,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17776,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17777,and,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17778,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17779,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17780,),O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17781,",",O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17782,non,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17783,-,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17784,obese,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17785,without,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17786,metaplasia,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17787,(,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17788,group,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17789,IV,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17790,",",O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17791,soybean,B-http://purl.bioontology.org/ontology/SNOMEDCT/226911007,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17792,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/226911007,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17793,),O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17794,and,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17795,lean,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17796,without,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17797,metaplasia,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17798,(,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17799,group,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17800,V,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17801,;,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17802,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107;http://purl.bioontology.org/ontology/SNOMEDCT/226888007,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17803,butter,I-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107;http://purl.bioontology.org/ontology/SNOMEDCT/226888007,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17804,),O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17805,.,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17897,The,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17898,Mediterranean,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17899,diet,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17900,",",O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17901,one,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17902,of,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17903,the,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17904,most,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17905,widely,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17906,evaluated,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17907,dietary,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17908,patterns,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17909,in,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17910,scientific,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17911,literature,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17912,",",O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17913,includes,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17914,in,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17915,its,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17916,nutrients,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17917,two,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17918,fluid,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17919,foods,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17920,:,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17921,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17922,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17923,",",O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17924,as,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17925,the,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17926,main,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17927,source,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17928,of,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17929,fats,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17930,",",O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17931,and,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17932,a,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17933,low,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17934,-,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17935,to,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17936,-,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17937,moderate,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17938,consumption,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17939,of,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17940,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17941,",",O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17942,mainly,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17943,red,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17944,",",O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17945,particularly,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17946,during,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17947,meals,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
17948,.,O,597.0,"The Mediterranean diet , one of the most widely evaluated dietary patterns in scientific literature , includes in its nutrients two fluid foods : olive oil , as the main source of fats , and a low - to - moderate consumption of wine , mainly red , particularly during meals ."
18147,This,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18148,review,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18149,provides,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18150,an,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18151,overview,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18152,of,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18153,the,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18154,nutritional,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18155,value,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18156,of,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18157,potatoes,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18158,and,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18159,examines,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18160,the,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18161,evidence,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18162,for,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18163,associations,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18164,between,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18165,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18166,consumption,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18167,and,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18168,non,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18169,-,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18170,communicable,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18171,diseases,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18172,.,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18519,Contrasting,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18520,",",O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18521,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18522,for,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18523,dinner,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18524,prevented,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18525,re,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18526,-,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18527,entrainment,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18528,in,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18529,the,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18530,jet,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18531,-,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18532,lag,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18533,condition,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18534,and,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18535,favored,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18536,circadian,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18537,desynchrony,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18538,in,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18539,the,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18540,shift,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18541,-,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18542,work,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18543,models,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
18544,.,O,619.0,"Contrasting , chocolate for dinner prevented re - entrainment in the jet - lag condition and favored circadian desynchrony in the shift - work models ."
19011,We,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19012,observed,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19013,that,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19014,FA,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19015,significantly,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19016,improved,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19017,insulin,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19018,sensitivity,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19019,and,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19020,lipid,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19021,profiles,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19022,",",O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19023,and,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19024,reduced,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19025,elevated,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19026,blood,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19027,pressure,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19028,",",O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19029,compared,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19030,to,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19031,untreated,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19032,controls,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19033,(,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19034,p,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19035,<,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19036,0.05,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19037,),O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19038,.,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19111,Our,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19112,results,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19113,suggest,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19114,that,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19115,supplementation,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19116,of,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19117,FA,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19118,may,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19119,have,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19120,health,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19121,benefits,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19122,by,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19123,minimizing,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19124,the,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19125,cardiovascular,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19126,complications,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19127,of,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19128,MS,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19129,and,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19130,alleviating,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19131,its,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19132,symptoms,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19133,.,O,636.0,Our results suggest that supplementation of FA may have health benefits by minimizing the cardiovascular complications of MS and alleviating its symptoms .
19279,For,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19280,meat,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19281,and,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19282,fish,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19283,",",O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19284,pan,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19285,frying,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19286,was,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19287,associated,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19288,with,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19289,decreased,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19290,risk,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19291,",",O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19292,whereas,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19293,stewing,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19294,or,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19295,broiling,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19296,was,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19297,associated,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19298,with,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19299,increased,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19300,risk,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19301,.,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19630,There,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19631,is,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19632,no,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19633,clear,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19634,indication,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19635,that,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19636,the,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19637,risks,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19638,observed,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19639,in,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19640,this,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19641,Chinese,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19642,population,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19643,are,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19644,substantially,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19645,different,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19646,from,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19647,those,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19648,observed,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19649,in,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19650,Caucasian,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19651,populations,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19652,.,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19666,Uncontrolled,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19667,high,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19668,blood,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19669,pressure,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19670,may,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19671,lead,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19672,to,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19673,a,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19674,shortened,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19675,life,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19676,expectancy,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19677,and,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19678,a,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19679,higher,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19680,morbidity,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19681,due,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19682,to,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19683,a,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19684,high,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19685,risk,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19686,of,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19687,cardiovascular,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19688,complications,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19689,such,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19690,as,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19691,coronary,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19692,heart,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19693,disease,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19694,(,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19695,which,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19696,leads,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19697,to,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19698,heart,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19699,attack,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19700,),O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19701,and,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19702,stroke,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19703,",",O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19704,congestive,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19705,heart,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19706,failure,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19707,",",O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19708,heart,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19709,rhythm,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19710,irregularities,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19711,",",O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19712,and,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19713,kidney,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19714,failure,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19715,etc,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19716,.,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
20796,The,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20797,validated,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20798,food,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20799,-,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20800,frequency,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20801,questionnaire,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20802,included,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20803,79,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20804,questions,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20805,on,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20806,food,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20807,items,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20808,and,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20809,recipes,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20810,",",O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20811,categorised,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20812,into,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20813,16,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20814,food,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20815,groups,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20816,.,O,690.0,"The validated food - frequency questionnaire included 79 questions on food items and recipes , categorised into 16 food groups ."
20925,Consumption,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20926,of,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20927,eggs,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20928,and,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20929,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20930,(,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20931,white,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20932,",",O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20933,red,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20934,or,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20935,processed,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20936,meats,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20937,),O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20938,seemed,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20939,uninfluential,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
20940,.,O,693.0,"Consumption of eggs and meat ( white , red or processed meats ) seemed uninfluential ."
21473,External,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21474,oil,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21475,application,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21476,allowed,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21477,for,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21478,controlled,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21479,study,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21480,of,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21481,thermoregulatory,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21482,stress,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21483,as,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21484,well,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21485,.,O,713.0,External oil application allowed for controlled study of thermoregulatory stress as well .
21566,Cinnamon,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21567,",",O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21568,from,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21569,the,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21570,genus,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21571,Cinnamomum,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21572,and,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21573,Lauraceae,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21574,family,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21575,",",O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21576,has,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21577,been,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21578,used,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21579,as,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21580,a,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21581,popular,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21582,spice,B-http://purl.bioontology.org/ontology/SNOMEDCT/24515005,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21583,for,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21584,thousands,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21585,of,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21586,years,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21587,around,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21588,the,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21589,world,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21590,.,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21818,Biogenic,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21819,amines,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21820,have,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21821,been,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21822,reported,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21823,in,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21824,a,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21825,variety,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21826,of,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21827,foods,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21828,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21829,such,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21830,as,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21831,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21832,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21833,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21834,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21835,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21836,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21837,vegetables,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21838,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21839,and,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21840,wines,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21841,.,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
22199,This,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22200,study,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22201,also,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22202,suggests,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22203,that,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22204,combinations,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22205,of,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22206,diverse,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22207,molecular,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22208,components,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22209,may,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22210,be,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22211,responsible,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22212,for,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22213,cell,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22214,-,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22215,level,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22216,bioactivities,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22217,from,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22218,mango,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22219,fractions,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22220,",",O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22221,and,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22222,that,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22223,purification,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22224,and,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22225,activity,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22226,profiling,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22227,of,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22228,individual,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22229,components,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22230,may,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22231,be,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22232,difficult,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22233,to,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22234,relate,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22235,to,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22236,whole,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22237,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22238,effects,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22239,.,O,743.0,"This study also suggests that combinations of diverse molecular components may be responsible for cell - level bioactivities from mango fractions , and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects ."
22691,Consumers,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22692,look,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22693,for,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22694,products,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22695,that,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22696,contribute,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22697,to,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22698,their,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22699,wellness,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22700,and,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22701,health,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22702,",",O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22703,however,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22704,",",O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22705,even,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22706,health,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22707,-,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22708,conscious,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22709,consumers,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22710,are,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22711,not,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22712,willing,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22713,to,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22714,sacrifice,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22715,organoleptic,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22716,properties,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22717,",",O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22718,and,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22719,intense,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22720,full,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22721,-,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22722,flavor,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22723,snacks,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22724,remain,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22725,an,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22726,important,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22727,trend,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22728,.,O,760.0,"Consumers look for products that contribute to their wellness and health , however , even health - conscious consumers are not willing to sacrifice organoleptic properties , and intense full - flavor snacks remain an important trend ."
22766,Slices,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22767,were,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22768,fried,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22769,using,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22770,equivalent,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22771,thermal,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22772,driving,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22773,forces,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22774,",",O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22775,maintaining,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22776,a,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22777,constant,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22778,difference,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22779,between,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22780,oil,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22781,temperature,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22782,and,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22783,the,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22784,boiling,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22785,point,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22786,of,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22787,water,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22788,at,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22789,the,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22790,working,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22791,pressure,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22792,(,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22793,ΔT,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22794,=,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22795,60,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22796,and,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22797,80,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22798,°,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22799,C,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22800,),O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22801,.,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
23247,The,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23248,Copenhagen,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23249,Prospective,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23250,Population,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23251,Studies,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23252,demonstrated,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23253,in,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23254,the,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23255,year,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23256,2000,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23257,that,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23258,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23259,intake,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23260,may,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23261,have,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23262,a,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23263,beneficial,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23264,effect,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23265,on,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23266,all,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23267,cause,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23268,mortality,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23269,that,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23270,is,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23271,additive,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23272,to,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23273,that,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23274,of,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23275,alcohol,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23276,.,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23646,Yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23647,may,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23648,have,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23649,probiotic,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23650,effects,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23651,that,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23652,could,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23653,modulate,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23654,glucose,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23655,metabolism,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
23656,.,O,793.0,Yogurt may have probiotic effects that could modulate glucose metabolism .
24451,Supplementation,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24452,with,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24453,fortified,B-http://purl.bioontology.org/ontology/SNOMEDCT/414290003;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24454,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/414290003;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24455,and,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24456,dairy,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24457,products,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24458,with,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24459,added,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24460,prebiotics,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24461,",",O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24462,increased,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24463,both,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24464,calcium,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24465,and,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24466,magnesium,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24467,absorption,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24468,and,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24469,caused,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24470,some,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24471,modulation,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24472,of,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24473,gut,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24474,microbiota,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24475,in,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24476,animals,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24477,and,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24478,humans,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24479,.,O,824.0,"Supplementation with fortified milk and dairy products with added prebiotics , increased both calcium and magnesium absorption and caused some modulation of gut microbiota in animals and humans ."
24867,This,O,837.0,This study shows significant associations of salt tea drinking and some related habits with ESCC risk .
24868,study,O,837.0,This study shows significant associations of salt tea drinking and some related habits with ESCC risk .
24869,shows,O,837.0,This study shows significant associations of salt tea drinking and some related habits with ESCC risk .
24870,significant,O,837.0,This study shows significant associations of salt tea drinking and some related habits with ESCC risk .
24871,associations,O,837.0,This study shows significant associations of salt tea drinking and some related habits with ESCC risk .
24872,of,O,837.0,This study shows significant associations of salt tea drinking and some related habits with ESCC risk .
24873,salt,O,837.0,This study shows significant associations of salt tea drinking and some related habits with ESCC risk .
24874,tea,O,837.0,This study shows significant associations of salt tea drinking and some related habits with ESCC risk .
24875,drinking,O,837.0,This study shows significant associations of salt tea drinking and some related habits with ESCC risk .
24876,and,O,837.0,This study shows significant associations of salt tea drinking and some related habits with ESCC risk .
24877,some,O,837.0,This study shows significant associations of salt tea drinking and some related habits with ESCC risk .
24878,related,O,837.0,This study shows significant associations of salt tea drinking and some related habits with ESCC risk .
24879,habits,O,837.0,This study shows significant associations of salt tea drinking and some related habits with ESCC risk .
24880,with,O,837.0,This study shows significant associations of salt tea drinking and some related habits with ESCC risk .
24881,ESCC,O,837.0,This study shows significant associations of salt tea drinking and some related habits with ESCC risk .
24882,risk,O,837.0,This study shows significant associations of salt tea drinking and some related habits with ESCC risk .
24883,.,O,837.0,This study shows significant associations of salt tea drinking and some related habits with ESCC risk .
24996,Processing,O,843.0,Processing generally reduces the content of these nutrients and bioprotective substances .
24997,generally,O,843.0,Processing generally reduces the content of these nutrients and bioprotective substances .
24998,reduces,O,843.0,Processing generally reduces the content of these nutrients and bioprotective substances .
24999,the,O,843.0,Processing generally reduces the content of these nutrients and bioprotective substances .
25000,content,O,843.0,Processing generally reduces the content of these nutrients and bioprotective substances .
25001,of,O,843.0,Processing generally reduces the content of these nutrients and bioprotective substances .
25002,these,O,843.0,Processing generally reduces the content of these nutrients and bioprotective substances .
25003,nutrients,O,843.0,Processing generally reduces the content of these nutrients and bioprotective substances .
25004,and,O,843.0,Processing generally reduces the content of these nutrients and bioprotective substances .
25005,bioprotective,O,843.0,Processing generally reduces the content of these nutrients and bioprotective substances .
25006,substances,O,843.0,Processing generally reduces the content of these nutrients and bioprotective substances .
25007,.,O,843.0,Processing generally reduces the content of these nutrients and bioprotective substances .
25664,Patterns,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25665,of,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25666,changes,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25667,with,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25668,time,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25669,after,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25670,feeding,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25671,were,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25672,observed,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25673,for,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25674,the,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25675,composition,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25676,and,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25677,pH,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25678,of,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25679,duodenal,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25680,digesta,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25681,",",O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25682,recovery,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25683,rates,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25684,of,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25685,fresh,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25686,and,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25687,dry,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25688,matter,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25689,",",O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25690,rates,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25691,of,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25692,abomasum,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25693,emptying,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25694,for,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25695,fresh,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25696,and,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25697,dry,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25698,matter,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25699,",",O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25700,gastric,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25701,proteolysis,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25702,",",O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25703,and,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25704,diarrhea,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25705,.,O,866.0,"Patterns of changes with time after feeding were observed for the composition and pH of duodenal digesta , recovery rates of fresh and dry matter , rates of abomasum emptying for fresh and dry matter , gastric proteolysis , and diarrhea ."
25813,Gastric,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25814,proteolysis,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25815,was,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25816,not,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25817,influenced,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25818,by,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25819,the,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25820,nature,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25821,of,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25822,dietary,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25823,fats,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25824,.,O,872.0,Gastric proteolysis was not influenced by the nature of dietary fats .
25970,Hydroxytyrosol,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25971,and,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25972,oleuropein,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25973,inhibited,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25974,the,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25975,multiple,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25976,stages,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25977,in,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25978,colon,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25979,carcinogenesis,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25980,;,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25981,initiation,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25982,",",O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25983,promotion,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25984,",",O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25985,and,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25986,metastasis,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
25987,.,O,880.0,"Hydroxytyrosol and oleuropein inhibited the multiple stages in colon carcinogenesis ; initiation , promotion , and metastasis ."
27026,This,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27027,study,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27028,investigates,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27029,the,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27030,effect,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27031,of,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27032,lifelong,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27033,intake,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27034,of,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27035,different,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27036,fat,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27037,sources,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27038,rich,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27039,in,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27040,monounsaturated,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27041,(,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27042,virgin,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27043,olive,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27044,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27045,),O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27046,",",O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27047,n6,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27048,polyunsaturated,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27049,(,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27050,sunflower,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27051,oil,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27052,),O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27053,or,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27054,n3,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27055,polyunsaturated,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27056,(,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27057,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27058,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27059,),O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27060,fatty,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27061,acids,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27062,in,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27063,the,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27064,aged,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27065,liver,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27066,.,O,916.0,"This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated ( virgin olive oil ) , n6 polyunsaturated ( sunflower oil ) or n3 polyunsaturated ( fish oil ) fatty acids in the aged liver ."
27168,Gene,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27169,expression,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27170,changes,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27171,associated,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27172,with,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27173,age,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27174,in,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27175,animals,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27176,fed,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27177,virgin,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27178,olive,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27179,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27180,and,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27181,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27182,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27183,were,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27184,related,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27185,mostly,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27186,to,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27187,mitochondrial,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27188,function,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27189,and,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27190,oxidative,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27191,stress,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27192,pathways,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27193,",",O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27194,followed,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27195,by,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27196,cell,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27197,cycle,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27198,and,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27199,telomere,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27200,length,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27201,control,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27202,.,O,923.0,"Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondrial function and oxidative stress pathways , followed by cell cycle and telomere length control ."
27238,Non,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27239,-,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27240,selective,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27241,use,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27242,of,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27243,pesticide,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27244,to,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27245,increase,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27246,productivity,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27247,leaves,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27248,residues,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27249,on,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27250,crops,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27251,.,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27502,The,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27503,objective,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27504,of,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27505,this,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27506,study,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27507,was,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27508,to,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27509,derive,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27510,food,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27511,-,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27512,based,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27513,dietary,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27514,guidelines,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27515,for,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27516,the,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27517,Dutch,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27518,population,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27519,.,O,933.0,The objective of this study was to derive food - based dietary guidelines for the Dutch population .
27957,Except,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27958,the,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27959,residue,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27960,forms,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27961,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27962,the,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27963,main,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27964,forms,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27965,of,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27966,metals,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27967,in,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27968,the,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27969,edible,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27970,parts,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27971,of,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27972,three,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27973,selected,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27974,vegetables,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27975,were,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27976,ethanol-,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27977,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27978,NaCl-,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27979,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27980,and,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27981,HAc,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27982,-,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27983,extractable,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27984,fractions,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27985,for,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27986,As,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27987,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27988,Pb,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27989,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27990,and,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27991,Cd,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27992,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27993,respectively,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27994,;,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27995,however,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27996,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27997,Cu,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27998,was,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27999,mainly,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28000,presented,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28001,as,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28002,NaCl,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28003,-,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28004,extractable,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28005,and,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28006,Zn,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28007,as,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28008,HAc,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28009,-,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28010,extractable,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28011,fractions,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28012,.,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28523,In,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28524,recent,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28525,findings,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28526,on,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28527,food,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28528,science,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28529,research,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28530,gut,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28531,microbiota,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28532,plays,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28533,a,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28534,significant,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28535,role,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28536,and,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28537,vastly,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28538,studied,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28539,for,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28540,its,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28541,intermediate,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28542,role,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28543,in,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28544,regulating,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28545,health,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28546,.,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
29156,The,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29157,literature,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29158,overall,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29159,supports,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29160,an,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29161,inverse,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29162,association,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29163,between,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29164,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29165,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29166,and,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29167,cardiovascular,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29168,disease,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29169,-,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29170,related,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29171,health,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29172,outcomes,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
29173,.,O,987.0,The literature overall supports an inverse association between green tea and cardiovascular disease - related health outcomes .
30089,The,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30090,28,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30091,-,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30092,kDa,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30093,pepper,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30094,allergen,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30095,showed,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30096,homology,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30097,to,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30098,a,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30099,wheat,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30100,germin,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30101,protein,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30102,",",O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30103,and,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30104,the,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30105,23,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30106,-,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30107,kDa,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30108,paprika,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30109,allergen,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30110,was,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30111,identified,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30112,as,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30113,a,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30114,homolog,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30115,of,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30116,a,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30117,osmotin,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30118,-,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30119,like,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30120,or,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30121,pathogenesis,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30122,-,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30123,related,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30124,protein,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30125,in,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30126,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30127,.,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30277,This,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30278,longitudinal,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30279,study,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30280,of,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30281,503,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30282,households,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30283,with,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30284,a,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30285,child,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30286,under,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30287,24,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30288,months,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30289,at,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30290,enrolment,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30291,was,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30292,conducted,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30293,in,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30294,villages,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30295,of,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30296,Manyoni,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30297,District,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30298,",",O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30299,Tanzania,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30300,between,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30301,May,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30302,2014,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30303,",",O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30304,and,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30305,May,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30306,2016,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30307,.,O,1025.0,"This longitudinal study of 503 households with a child under 24 months at enrolment was conducted in villages of Manyoni District , Tanzania between May 2014 , and May 2016 ."
30482,Adolescents,O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30483,',O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30484,poor,O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30485,dietary,O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30486,habits,O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30487,increase,O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30488,their,O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30489,subsequent,O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30490,risk,O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30491,of,O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30492,degenerative,O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30493,diseases,O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30494,such,O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30495,as,O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30496,obesity,O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30497,",",O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30498,diabetes,O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30499,",",O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30500,cardiovascular,O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30501,pathologies,O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30502,",",O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30503,etc,O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
30504,.,O,1031.0,"Adolescents ' poor dietary habits increase their subsequent risk of degenerative diseases such as obesity , diabetes , cardiovascular pathologies , etc ."
31131,One,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31132,of,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31133,the,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31134,reasons,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31135,is,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31136,that,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31137,these,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31138,studies,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31139,have,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31140,often,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31141,been,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31142,conducted,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31143,at,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31144,doses,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31145,or,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31146,concentrations,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31147,far,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31148,beyond,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31149,those,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31150,documented,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31151,in,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31152,humans,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31153,.,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31327,TPL,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31328,and,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31329,TNL,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31330,of,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31331,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31332,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31333,were,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31334,fractionated,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31335,by,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31336,HPLC,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31337,for,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31338,further,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31339,study,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31340,.,O,1059.0,TPL and TNL of olive oil were fractionated by HPLC for further study .
31777,Multivariate,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31778,logistic,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31779,regression,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31780,models,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31781,estimated,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31782,energy,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31783,-,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31784,adjusted,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31785,and,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31786,non,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31787,-,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31788,energy,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31789,adjusted,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31790,odds,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31791,ratios,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31792,(,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31793,OR,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31794,),O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31795,.,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31900,In,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31901,African,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31902,-,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31903,Americans,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31904,",",O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31905,frequent,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31906,intake,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31907,of,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31908,dairy,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31909,foods,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31910,was,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31911,associated,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31912,with,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31913,a,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31914,doubling,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31915,in,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31916,risk,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31917,(,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31918,OR,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31919,=,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31920,1.9,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31921,",",O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31922,95,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31923,%,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31924,CI,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31925,=,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31926,1.1,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31927,-,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31928,3.4,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31929,),O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31930,in,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31931,non,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31932,-,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31933,energy,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31934,-,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31935,adjusted,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31936,models,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31937,",",O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31938,whereas,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31939,frequent,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31940,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31941,consumption,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31942,correlated,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31943,with,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31944,a,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31945,non,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31946,-,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31947,significant,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31948,30,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31949,%,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31950,lower,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31951,risk,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31952,.,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
32213,It,O,1093.0,It has been grown since at least 1000 BC in China .
32214,has,O,1093.0,It has been grown since at least 1000 BC in China .
32215,been,O,1093.0,It has been grown since at least 1000 BC in China .
32216,grown,O,1093.0,It has been grown since at least 1000 BC in China .
32217,since,O,1093.0,It has been grown since at least 1000 BC in China .
32218,at,O,1093.0,It has been grown since at least 1000 BC in China .
32219,least,O,1093.0,It has been grown since at least 1000 BC in China .
32220,1000,O,1093.0,It has been grown since at least 1000 BC in China .
32221,BC,O,1093.0,It has been grown since at least 1000 BC in China .
32222,in,O,1093.0,It has been grown since at least 1000 BC in China .
32223,China,O,1093.0,It has been grown since at least 1000 BC in China .
32224,.,O,1093.0,It has been grown since at least 1000 BC in China .
32506,Methods,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32507,to,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32508,exploit,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32509,buckwheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/226723006,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32510,seeds,I-http://purl.bioontology.org/ontology/SNOMEDCT/226723006,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32511,and,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32512,flour,B-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32513,to,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32514,produce,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32515,highly,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32516,effective,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32517,nutraceuticals,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32518,are,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32519,also,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32520,reviewed,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32521,.,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
33031,Plasma,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33032,carotenoid,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33033,concentrations,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33034,on,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33035,a,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33036,random,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33037,28,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33038,%,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33039,sample,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33040,validated,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33041,self,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33042,-,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33043,reported,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33044,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33045,and,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33046,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33047,intake,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33048,",",O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33049,with,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33050,a,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33051,between,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33052,-,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33053,group,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33054,difference,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33055,of,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33056,66,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33057,%,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33058,at,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33059,1,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33060,y,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33061,and,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33062,over,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33063,40,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33064,%,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33065,at,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33066,4,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33067,y.,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33068,This,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33069,large,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33070,change,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33071,will,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33072,allow,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33073,testing,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33074,of,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33075,hypotheses,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33076,on,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33077,the,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33078,role,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33079,of,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33080,dietary,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33081,change,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33082,in,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33083,preventing,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33084,additional,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33085,breast,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33086,cancer,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33087,events,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33088,.,O,1122.0,"Plasma carotenoid concentrations on a random 28 % sample validated self - reported vegetable and fruit intake , with a between - group difference of 66 % at 1 y and over 40 % at 4 y. This large change will allow testing of hypotheses on the role of dietary change in preventing additional breast cancer events ."
33297,However,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33298,",",O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33299,the,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33300,food,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33301,potential,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33302,of,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33303,Bamboo,B-http://purl.bioontology.org/ontology/SNOMEDCT/710224000,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33304,shoot,I-http://purl.bioontology.org/ontology/SNOMEDCT/710224000,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33305,per,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33306,se,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33307,remains,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33308,unexploited,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33309,.,O,1130.0,"However , the food potential of Bamboo shoot per se remains unexploited ."
33423,Occurrence,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33424,of,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33425,taxiphyllin,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33426,",",O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33427,a,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33428,cyanogenic,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33429,glycoside,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33430,in,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33431,raw,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33432,shoots,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33433,",",O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33434,and,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33435,its,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33436,side,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33437,effect,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33438,on,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33439,human,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33440,health,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33441,calls,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33442,for,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33443,the,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33444,demand,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33445,to,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33446,innovate,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33447,processing,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33448,ways,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33449,using,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33450,scientific,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33451,input,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33452,to,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33453,eliminate,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33454,the,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33455,toxic,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33456,compound,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33457,without,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33458,disturbing,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33459,the,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33460,nutrient,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33461,reserve,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33462,.,O,1138.0,"Occurrence of taxiphyllin , a cyanogenic glycoside in raw shoots , and its side effect on human health calls for the demand to innovate processing ways using scientific input to eliminate the toxic compound without disturbing the nutrient reserve ."
33511,Further,O,1142.0,Further investigation is required by the researchers to make novel nutraceutical products and benefit the society .
33512,investigation,O,1142.0,Further investigation is required by the researchers to make novel nutraceutical products and benefit the society .
33513,is,O,1142.0,Further investigation is required by the researchers to make novel nutraceutical products and benefit the society .
33514,required,O,1142.0,Further investigation is required by the researchers to make novel nutraceutical products and benefit the society .
33515,by,O,1142.0,Further investigation is required by the researchers to make novel nutraceutical products and benefit the society .
33516,the,O,1142.0,Further investigation is required by the researchers to make novel nutraceutical products and benefit the society .
33517,researchers,O,1142.0,Further investigation is required by the researchers to make novel nutraceutical products and benefit the society .
33518,to,O,1142.0,Further investigation is required by the researchers to make novel nutraceutical products and benefit the society .
33519,make,O,1142.0,Further investigation is required by the researchers to make novel nutraceutical products and benefit the society .
33520,novel,O,1142.0,Further investigation is required by the researchers to make novel nutraceutical products and benefit the society .
33521,nutraceutical,O,1142.0,Further investigation is required by the researchers to make novel nutraceutical products and benefit the society .
33522,products,O,1142.0,Further investigation is required by the researchers to make novel nutraceutical products and benefit the society .
33523,and,O,1142.0,Further investigation is required by the researchers to make novel nutraceutical products and benefit the society .
33524,benefit,O,1142.0,Further investigation is required by the researchers to make novel nutraceutical products and benefit the society .
33525,the,O,1142.0,Further investigation is required by the researchers to make novel nutraceutical products and benefit the society .
33526,society,O,1142.0,Further investigation is required by the researchers to make novel nutraceutical products and benefit the society .
33527,.,O,1142.0,Further investigation is required by the researchers to make novel nutraceutical products and benefit the society .
33662,The,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33663,activity,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33664,of,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33665,the,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33666,alpha,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33667,-,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33668,glycerophosphate,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33669,shuttle,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33670,was,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33671,greater,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33672,in,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33673,rats,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33674,fed,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33675,the,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33676,coconut,B-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33677,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33678,diet,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33679,than,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33680,in,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33681,rats,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33682,fed,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33683,the,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33684,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33685,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33686,diet,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
33687,.,O,1149.0,The activity of the alpha - glycerophosphate shuttle was greater in rats fed the coconut oil diet than in rats fed the corn oil diet .
34516,Carbon,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34517,footprints,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34518,found,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34519,greenhouse,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34520,gas,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34521,(,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34522,GHG,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34523,),O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34524,emissions,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34525,averaged,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34526,0.849,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34527,kg,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34528,CO,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34529,Barley,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34530,is,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34531,one,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34532,of,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34533,the,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34534,most,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34535,important,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34536,cereal,B-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34537,crops,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34538,and,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34539,arranged,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34540,globally,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34541,as,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34542,fourth,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34543,after,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34544,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34545,",",O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34546,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34547,",",O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34548,and,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34549,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/412357001,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34550,.,O,1177.0,"Carbon footprints found greenhouse gas ( GHG ) emissions averaged 0.849 kg CO Barley is one of the most important cereal crops and arranged globally as fourth after wheat , rice , and corn ."
34581,These,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34582,effects,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34583,are,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34584,mainly,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34585,attributed,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34586,to,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34587,its,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34588,rich,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34589,dietary,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34590,fibers,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34591,",",O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34592,i.e.,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34593,",",O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34594,β,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34595,-,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34596,glucan,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34597,composition,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34598,.,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34994,All,O,1192.0,All flavored spreads were significantly more acceptable than the plain formulation .
34995,flavored,O,1192.0,All flavored spreads were significantly more acceptable than the plain formulation .
34996,spreads,O,1192.0,All flavored spreads were significantly more acceptable than the plain formulation .
34997,were,O,1192.0,All flavored spreads were significantly more acceptable than the plain formulation .
34998,significantly,O,1192.0,All flavored spreads were significantly more acceptable than the plain formulation .
34999,more,O,1192.0,All flavored spreads were significantly more acceptable than the plain formulation .
35000,acceptable,O,1192.0,All flavored spreads were significantly more acceptable than the plain formulation .
35001,than,O,1192.0,All flavored spreads were significantly more acceptable than the plain formulation .
35002,the,O,1192.0,All flavored spreads were significantly more acceptable than the plain formulation .
35003,plain,O,1192.0,All flavored spreads were significantly more acceptable than the plain formulation .
35004,formulation,O,1192.0,All flavored spreads were significantly more acceptable than the plain formulation .
35005,.,O,1192.0,All flavored spreads were significantly more acceptable than the plain formulation .
35300,This,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35301,walnut,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35302,ELISA,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35303,can,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35304,be,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35305,used,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35306,to,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35307,detect,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35308,undeclared,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35309,walnut,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35310,residues,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35311,in,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35312,foods,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35313,and,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35314,ingredients,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35315,and,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35316,as,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35317,a,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35318,tool,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35319,to,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35320,validate,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35321,the,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35322,effectiveness,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35323,of,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35324,allergen,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35325,control,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35326,programs,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35327,for,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35328,walnuts,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35329,.,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35390, ,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35391,Denmark,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35392,",",O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35393,Sweden,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35394,",",O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35395,and,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35396,Switzerland,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35397,have,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35398,the,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35399,highest,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35400,risk,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35401,of,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35402,ovarian,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35403,cancer,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35404,in,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35405,the,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35406,world,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35407,.,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35781,The,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35782,influence,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35783,of,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35784,mastitis,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35785,on,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35786,milk,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35787,perchlorate,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35788,levels,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35789,",",O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35790,where,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35791,there,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35792,is,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35793,an,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35794,increase,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35795,in,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35796,mammary,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35797,vascular,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35798,permeability,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35799,and,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35800,an,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35801,influx,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35802,of,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35803,blood,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35804,-,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35805,derived,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35806,components,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35807,into,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35808,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35809,",",O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35810,remains,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35811,unknown,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
35812,.,O,1225.0,"The influence of mastitis on milk perchlorate levels , where there is an increase in mammary vascular permeability and an influx of blood - derived components into milk , remains unknown ."
36015,The,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36016,overall,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36017,finding,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36018,that,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36019,mastitis,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36020,results,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36021,in,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36022,lower,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36023,milk,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36024,perchlorate,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36025,concentrations,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36026,suggests,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36027,that,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36028,changes,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36029,in,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36030,udder,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36031,health,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36032,do,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36033,not,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36034,necessitate,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36035,increased,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36036,screening,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36037,of,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36038,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36039,for,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36040,perchlorate,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36041,.,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36133,Short,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36134,-,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36135,chain,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36136,fatty,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36137,acid,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36138,(,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36139,SCFA,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36140,),O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36141,",",O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36142,hydrogen,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36143,(,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36144,H2,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36145,),O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36146,",",O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36147,and,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36148,methane,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36149,(,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36150,CH4,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36151,),O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36152,productions,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36153,and,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36154,neutral,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36155,-,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36156,detergent,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36157,fiber,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36158,(,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36159,NDF,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36160,),O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36161,digestibility,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36162,differed,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36163,significantly,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36164,with,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36165,fiber,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36166,source,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36167,.,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36810,Less,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36811,is,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36812,known,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36813,about,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36814,the,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36815,impact,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36816,of,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36817,nutritional,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36818,interventions,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36819,in,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36820,people,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36821,with,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36822,a,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36823,diagnosis,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36824,of,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36825,cancer,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36826,",",O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36827,but,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36828,nutrition,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36829,including,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36830,adiposity,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36831,and,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36832,physical,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36833,activity,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36834,predict,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36835,breast,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36836,cancer,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36837,outcome,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36838,.,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
37215,Statistical,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37216,dose,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37217,-,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37218,distribution,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37219,models,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37220,(,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37221,log,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37222,-,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37223,normal,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37224,",",O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37225,log,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37226,-,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37227,logistic,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37228,",",O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37229,Weibull,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37230,),O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37231,were,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37232,applied,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37233,to,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37234,the,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37235,individual,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37236,NOAELs,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37237,and,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37238,LOAELs,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37239,for,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37240,each,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37241,allergenic,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37242,food,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37243,.,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37437,The,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37438,basis,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37439,of,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37440,the,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37441,calcium,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37442,requirement,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37443,and,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37444,the,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37445,impact,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37446,of,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37447,vitamin,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37448,D,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37449,",",O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37450,protein,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37451,",",O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37452,phosphorus,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37453,",",O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37454,sodium,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37455,",",O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37456,and,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37457,caffeine,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37458,on,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37459,the,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37460,calcium,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37461,economy,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37462,are,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37463,reviewed,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37464,.,O,1281.0,"The basis of the calcium requirement and the impact of vitamin D , protein , phosphorus , sodium , and caffeine on the calcium economy are reviewed ."
37465,Against,O,1282.0,"Against this background , emerging data on potassium are presented ."
37466,this,O,1282.0,"Against this background , emerging data on potassium are presented ."
37467,background,O,1282.0,"Against this background , emerging data on potassium are presented ."
37468,",",O,1282.0,"Against this background , emerging data on potassium are presented ."
37469,emerging,O,1282.0,"Against this background , emerging data on potassium are presented ."
37470,data,O,1282.0,"Against this background , emerging data on potassium are presented ."
37471,on,O,1282.0,"Against this background , emerging data on potassium are presented ."
37472,potassium,O,1282.0,"Against this background , emerging data on potassium are presented ."
37473,are,O,1282.0,"Against this background , emerging data on potassium are presented ."
37474,presented,O,1282.0,"Against this background , emerging data on potassium are presented ."
37475,.,O,1282.0,"Against this background , emerging data on potassium are presented ."
37528,In,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37529,the,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37530,population,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37531,reported,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37532,on,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37533,here,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37534,",",O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37535,dairy,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37536,",",O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37537,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37538,",",O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37539,and,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37540,cereal,B-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37541,grains,I-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37542,together,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37543,contributed,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37544,56,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37545,%,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37546,",",O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37547,and,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37548,fruits,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37549,and,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37550,vegetables,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37551,44,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37552,%,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37553,",",O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37554,of,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37555,total,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37556,dietary,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37557,potassium,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37558,.,O,1285.0,"In the population reported on here , dairy , meat , and cereal grains together contributed 56 % , and fruits and vegetables 44 % , of total dietary potassium ."
37661,Processed,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37662,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37663,intake,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37664,is,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37665,associated,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37666,with,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37667,increased,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37668,risk,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37669,of,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37670,colorectal,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37671,cancer,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37672,.,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37774,Three,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37775,promotion,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37776,studies,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37777,were,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37778,done,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37779,",",O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37780,each,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37781,in,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37782,5,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37783,groups,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37784,of,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37785,10,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37786,rats,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37787,",",O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37788,whose,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37789,diets,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37790,contained,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37791,7,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37792,%,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37793,",",O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37794,14,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37795,%,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37796,",",O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37797,or,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37798,28,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37799,%,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37800,fat,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37801,.,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
38256,Coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,1314.0,Coffee beans may be viewed as healthy vegetable food and a main supplier of dietary phenolic phytochemicals .
38257,beans,I-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,1314.0,Coffee beans may be viewed as healthy vegetable food and a main supplier of dietary phenolic phytochemicals .
38258,may,O,1314.0,Coffee beans may be viewed as healthy vegetable food and a main supplier of dietary phenolic phytochemicals .
38259,be,O,1314.0,Coffee beans may be viewed as healthy vegetable food and a main supplier of dietary phenolic phytochemicals .
38260,viewed,O,1314.0,Coffee beans may be viewed as healthy vegetable food and a main supplier of dietary phenolic phytochemicals .
38261,as,O,1314.0,Coffee beans may be viewed as healthy vegetable food and a main supplier of dietary phenolic phytochemicals .
38262,healthy,O,1314.0,Coffee beans may be viewed as healthy vegetable food and a main supplier of dietary phenolic phytochemicals .
38263,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1314.0,Coffee beans may be viewed as healthy vegetable food and a main supplier of dietary phenolic phytochemicals .
38264,food,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1314.0,Coffee beans may be viewed as healthy vegetable food and a main supplier of dietary phenolic phytochemicals .
38265,and,O,1314.0,Coffee beans may be viewed as healthy vegetable food and a main supplier of dietary phenolic phytochemicals .
38266,a,O,1314.0,Coffee beans may be viewed as healthy vegetable food and a main supplier of dietary phenolic phytochemicals .
38267,main,O,1314.0,Coffee beans may be viewed as healthy vegetable food and a main supplier of dietary phenolic phytochemicals .
38268,supplier,O,1314.0,Coffee beans may be viewed as healthy vegetable food and a main supplier of dietary phenolic phytochemicals .
38269,of,O,1314.0,Coffee beans may be viewed as healthy vegetable food and a main supplier of dietary phenolic phytochemicals .
38270,dietary,O,1314.0,Coffee beans may be viewed as healthy vegetable food and a main supplier of dietary phenolic phytochemicals .
38271,phenolic,O,1314.0,Coffee beans may be viewed as healthy vegetable food and a main supplier of dietary phenolic phytochemicals .
38272,phytochemicals,O,1314.0,Coffee beans may be viewed as healthy vegetable food and a main supplier of dietary phenolic phytochemicals .
38273,.,O,1314.0,Coffee beans may be viewed as healthy vegetable food and a main supplier of dietary phenolic phytochemicals .
38415,For,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38416,male,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38417,coronary,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38418,heart,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38419,disease,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38420,mortality,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38421,",",O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38422,ethanol,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38423,consumption,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38424,was,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38425,subdivided,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38426,into,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38427,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38428,",",O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38429,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38430,",",O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38431,and,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38432,spirits,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38433,consumption,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38434,.,O,1320.0,"For male coronary heart disease mortality , ethanol consumption was subdivided into beer , wine , and spirits consumption ."
38810,Associations,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38811,by,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38812,type,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38813,of,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38814,alcohol,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38815,consumed,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38816,(,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38817,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38818,",",O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38819,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38820,and,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38821,liquor,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38822,),O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38823,were,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38824,also,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38825,investigated,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
38826,.,O,1336.0,"Associations by type of alcohol consumed ( wine , beer and liquor ) were also investigated ."
39058,Major,O,1343.0,Major pollen allergens were not involved .
39059,pollen,O,1343.0,Major pollen allergens were not involved .
39060,allergens,O,1343.0,Major pollen allergens were not involved .
39061,were,O,1343.0,Major pollen allergens were not involved .
39062,not,O,1343.0,Major pollen allergens were not involved .
39063,involved,O,1343.0,Major pollen allergens were not involved .
39064,.,O,1343.0,Major pollen allergens were not involved .
39065,Structural,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39066,similarities,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39067,were,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39068,also,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39069,noticed,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39070,in,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39071,some,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39072,mugwort,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39073,pollen,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39074,antigens,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39075,and,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39076,antigens,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39077,in,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39078,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39079,",",O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39080,carrot,B-http://purl.bioontology.org/ontology/SNOMEDCT/256319004,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39081,and,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39082,celery,B-http://purl.bioontology.org/ontology/SNOMEDCT/256326004,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39083,",",O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39084,but,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39085,none,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39086,of,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39087,these,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39088,mugwort,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39089,antigens,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39090,acted,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39091,as,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39092,an,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39093,allergen,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39094,.,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39264,Following,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39265,introduction,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39266,of,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39267,minimum,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39268,unit,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39269,pricing,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39270,in,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39271,Scotland,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39272,",",O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39273,alcohol,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39274,sales,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39275,fell,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39276,by,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39277,3,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39278,%,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39279,",",O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39280,with,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39281,the,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39282,greatest,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39283,effect,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39284,on,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39285,heavy,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39286,drinkers,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39287,of,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39288,low,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39289,-,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39290,cost,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39291,alcohol,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39292,products,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39293,.,O,1350.0,"Following introduction of minimum unit pricing in Scotland , alcohol sales fell by 3 % , with the greatest effect on heavy drinkers of low - cost alcohol products ."
39522,The,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39523,Lancet,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39524,Commission,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39525,has,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39526,serious,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39527,doubts,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39528,about,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39529,whether,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39530,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39531,initiatives,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39532,described,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39533,in,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39534,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39535,Prevention,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39536,Green,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39537,Paper,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39538,",",O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39539,with,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39540,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39541,onus,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39542,placed,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39543,on,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39544,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39545,individual,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39546,based,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39547,on,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39548,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39549,use,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39550,of,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39551,information,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39552,technology,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39553,and,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39554,the,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39555,latest,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39556,in,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39557,behavioural,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39558,science,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39559,",",O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39560,will,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39561,be,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39562,effective,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39563,.,O,1358.0,"The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper , with the onus placed on the individual based on the use of information technology and the latest in behavioural science , will be effective ."
39604,Dairy,O,1360.0,Dairy products are important sources of dietary fat in India .
39605,products,O,1360.0,Dairy products are important sources of dietary fat in India .
39606,are,O,1360.0,Dairy products are important sources of dietary fat in India .
39607,important,O,1360.0,Dairy products are important sources of dietary fat in India .
39608,sources,O,1360.0,Dairy products are important sources of dietary fat in India .
39609,of,O,1360.0,Dairy products are important sources of dietary fat in India .
39610,dietary,O,1360.0,Dairy products are important sources of dietary fat in India .
39611,fat,O,1360.0,Dairy products are important sources of dietary fat in India .
39612,in,O,1360.0,Dairy products are important sources of dietary fat in India .
39613,India,O,1360.0,Dairy products are important sources of dietary fat in India .
39614,.,O,1360.0,Dairy products are important sources of dietary fat in India .
39749,When,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39750,ghee,B-http://purl.bioontology.org/ontology/SNOMEDCT/226901000,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39751,was,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39752,included,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39753,as,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39754,a,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39755,sole,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39756,source,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39757,of,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39758,fat,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39759,at,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39760,a,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39761,10,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39762,%,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39763,level,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39764,",",O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39765,polyunsaturated,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39766,fatty,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39767,acids,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39768,in,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39769,the,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39770,serum,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39771,and,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39772,liver,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39773,lipids,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39774,were,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39775,reduced,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39776,significantly,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39777,.,O,1367.0,"When ghee was included as a sole source of fat at a 10 % level , polyunsaturated fatty acids in the serum and liver lipids were reduced significantly ."
39778,Similar,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39779,results,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39780,were,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39781,observed,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39782,when,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39783,ghee,B-http://purl.bioontology.org/ontology/SNOMEDCT/226901000,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39784,was,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39785,subjected,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39786,to,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39787,a,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39788,higher,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39789,temperature,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39790,(,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39791,120,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39792,degrees,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39793,C,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39794,),O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39795,to,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39796,generate,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39797,cholesterol,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39798,oxidation,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39799,products,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39800,and,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39801,fed,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39802,to,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39803,the,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39804,animals,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39805,.,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39980,In,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39981,vitro,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39982,oxidation,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39983,of,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39984,LDL,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39985,was,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39986,assessed,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39987,by,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39988,incubating,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39989,LDL,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39990,with,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39991,hemin,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39992,and,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39993,hydrogen,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39994,peroxide,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39995,",",O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39996,and,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39997,measuring,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39998,the,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39999,time,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40000,required,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40001,for,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40002,the,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40003,reaction,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40004,to,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40005,reach,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40006,maximum,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40007,velocity,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40008,(,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40009,lag,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40010,time,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40011,),O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40012,.,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40199,The,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40200,advantages,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40201,of,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40202,reducing,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40203,the,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40204,saturated,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40205,fat,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40206,content,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40207,of,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40208,the,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40209,diet,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40210,were,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40211,reflected,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40212,in,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40213,lower,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40214,total,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40215,and,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40216,LDL,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40217,cholesterol,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40218,levels,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40219,.,O,1378.0,The advantages of reducing the saturated fat content of the diet were reflected in lower total and LDL cholesterol levels .
40220,Although,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40221,previous,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40222,studies,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40223,have,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40224,shown,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40225,inverse,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40226,associations,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40227,between,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40228,nut,B-http://purl.bioontology.org/ontology/SNOMEDCT/13577000,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40229,consumption,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40230,and,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40231,mortality,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40232,",",O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40233,the,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40234,associations,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40235,between,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40236,nut,B-http://purl.bioontology.org/ontology/SNOMEDCT/13577000,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40237,consumption,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40238,and,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40239,less,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40240,common,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40241,causes,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40242,of,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40243,mortality,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40244,have,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40245,not,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40246,been,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40247,investigated,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40248,.,O,1379.0,"Although previous studies have shown inverse associations between nut consumption and mortality , the associations between nut consumption and less common causes of mortality have not been investigated ."
40279,The,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40280,National,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40281,Institutes,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40282,of,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40283,Health,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40284,-,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40285,AARP,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40286,(,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40287,NIH,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40288,-,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40289,AARP,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40290,),O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40291,Diet,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40292,and,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40293,Health,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40294,Study,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40295,recruited,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40296,"566,398",O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40297,individuals,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40298,aged,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40299,50,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40300,-,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40301,71,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40302,at,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40303,baseline,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40304,in,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40305,1995,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40306,-,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40307,1996,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40308,.,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40432,Height,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40433,",",O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40434,weight,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40435,",",O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40436,and,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40437,triceps,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40438,skinfolds,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40439,were,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40440,measured,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40441,.,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40676,Overweight,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40677,teen,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40678,-,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40679,agers,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40680,appear,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40681,to,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40682,be,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40683,more,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40684,conscious,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40685,of,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40686,their,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40687,food,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40688,intake,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40689,than,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40690,under-,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40691,and,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40692,normal,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40693,-,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40694,weight,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40695,children,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40696,.,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
41392,We,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41393,obtained,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41394,blood,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41395,samples,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41396,at,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41397,baseline,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41398,and,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41399,for,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41400,4,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41401,h,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41402,postprandially,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41403,.,O,1419.0,We obtained blood samples at baseline and for 4 h postprandially .
41471,However,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41472,",",O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41473,the,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41474,serum,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41475,protein,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41476,thiol,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41477,concentration,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41478,increased,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41479,following,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41480,the,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41481,almond,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41482,meal,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41483,(,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41484,15,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41485,+,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41486,/-,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41487,14,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41488,mmol,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41489,/,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41490,L,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41491,),O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41492,",",O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41493,indicating,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41494,less,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41495,oxidative,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41496,protein,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41497,damage,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41498,",",O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41499,and,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41500,decreased,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41501,after,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41502,the,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41503,control,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41504,bread,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41505,",",O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41506,rice,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41507,",",O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41508,and,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41509,potato,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41510,meals,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41511,(,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41512,-10,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41513,+,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41514,/-,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41515,8,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41516,mmol,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41517,/,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41518,L,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41519,),O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41520,",",O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41521,when,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41522,data,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41523,from,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41524,these,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41525,3,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41526,meals,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41527,were,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41528,pooled,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41529,(,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41530,P,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41531,=,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41532,0.021,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41533,),O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41534,.,O,1422.0,"However , the serum protein thiol concentration increased following the almond meal ( 15 + /- 14 mmol / L ) , indicating less oxidative protein damage , and decreased after the control bread , rice , and potato meals ( -10 + /- 8 mmol / L ) , when data from these 3 meals were pooled ( P = 0.021 ) ."
41535,The,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41536,change,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41537,in,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41538,protein,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41539,thiols,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41540,was,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41541,also,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41542,negatively,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41543,related,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41544,to,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41545,the,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41546,postprandial,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41547,incremental,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41548,peak,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41549,glucose,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41550,(,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41551,r,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41552,=,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41553,-0.29,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41554,",",O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41555,n,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41556,=,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41557,60,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41558,observations,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41559,",",O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41560,P,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41561,=,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41562,0.026,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41563,),O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41564,and,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41565,peak,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41566,insulin,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41567,responses,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41568,(,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41569,r,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41570,=,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41571,-0.26,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41572,",",O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41573,n,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41574,=,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41575,60,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41576,observations,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41577,",",O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41578,P,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41579,=,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41580,0.046,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41581,),O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41582,.,O,1423.0,"The change in protein thiols was also negatively related to the postprandial incremental peak glucose ( r = -0.29 , n = 60 observations , P = 0.026 ) and peak insulin responses ( r = -0.26 , n = 60 observations , P = 0.046 ) ."
41701,Self,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41702,-,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41703,reported,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41704,incident,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41705,diabetes,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41706,was,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41707,ascertained,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41708,5,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41709,times,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41710,during,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41711,the,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41712,study,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41713,(,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41714,1987,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41715,",",O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41716,1989,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41717,",",O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41718,1992,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41719,",",O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41720,1997,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41721,",",O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41722,and,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41723,2004,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41724,),O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
41725,.,O,1430.0,"Self - reported incident diabetes was ascertained 5 times during the study ( 1987 , 1989 , 1992 , 1997 , and 2004 ) ."
42000,This,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42001,cross,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42002,-,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42003,sectional,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42004,study,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42005,used,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42006,the,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42007,database,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42008,compiled,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42009,in,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42010,Taiwan,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42011,between,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42012,2001,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42013,to,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42014,2010,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42015,.,O,1440.0,This cross - sectional study used the database compiled in Taiwan between 2001 to 2010 .
42222,Our,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42223,results,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42224,support,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42225,that,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42226,the,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42227,dietary,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42228,pattern,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42229,may,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42230,have,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42231,a,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42232,role,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42233,in,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42234,the,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42235,prevention,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42236,and,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42237,management,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42238,of,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42239,dyslipidemia,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42240,and,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42241,abnormal,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42242,fasting,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42243,plasma,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42244,glucose,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42245,.,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42979,A,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42980,more,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42981,complete,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42982,profile,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42983,of,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42984,phenolic,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42985,distributions,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42986,",",O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42987,including,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42988,both,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42989,free,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42990,and,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42991,bound,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42992,phenolics,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42993,in,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42994,these,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42995,vegetables,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42996,",",O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42997,is,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42998,reported,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42999,here,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43000,using,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43001,new,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43002,and,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43003,modified,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43004,methods,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43005,.,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43721,Research,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43722,using,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43723,urinary,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43724,arsenic,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43725,is,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43726,needed,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43727,to,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43728,assess,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43729,potential,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43730,CVD,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43731,effects,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43732,of,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43733,low,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43734,-,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43735,level,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43736,arsenic,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43737,exposure,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43738,.,O,1502.0,Research using urinary arsenic is needed to assess potential CVD effects of low - level arsenic exposure .
43739,Understanding,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43740,the,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43741,role,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43742,of,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43743,low,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43744,-,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43745,level,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43746,arsenic,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43747,as,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43748,it,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43749,relates,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43750,to,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43751,subclinical,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43752,CVD,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43753,may,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43754,contribute,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43755,to,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43756,CVD,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43757,prevention,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43758,and,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43759,control,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43760,.,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
44193,In,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44194,analyses,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44195,focusing,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44196,on,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44197,nutrients,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44198,",",O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44199,rather,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44200,than,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44201,foods,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44202,",",O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44203,polyunsaturated,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44204,fats,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44205,were,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44206,positively,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44207,and,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44208,vitamin,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44209,E,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44210,inversely,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44211,associated,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44212,with,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44213,prostate,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44214,cancer,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44215,.,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44421,We,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44422,describe,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44423,a,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44424,27,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44425,-,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44426,year,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44427,-,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44428,old,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44429,subject,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44430,who,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44431,developed,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44432,rhinitis,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44433,and,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44434,asthma,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44435,symptoms,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44436,1,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44437,year,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44438,after,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44439,starting,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44440,to,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44441,prepare,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44442,a,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44443,certain,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44444,kind,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44445,of,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44446,sausage,B-http://purl.bioontology.org/ontology/SNOMEDCT/227020009,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44447,.,O,1531.0,We describe a 27 - year - old subject who developed rhinitis and asthma symptoms 1 year after starting to prepare a certain kind of sausage .
44872,Meat,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44873,diets,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44874,contained,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44875,30,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44876,%,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44877,or,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44878,60,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44879,%,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44880,freeze,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44881,-,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44882,dried,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44883,fried,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44884,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
44885,.,O,1549.0,Meat diets contained 30 % or 60 % freeze - dried fried meat .
45190,This,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45191,paper,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45192,proposes,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45193,the,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45194,development,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45195,of,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45196,an,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45197,enriched,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45198,Ca,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45199,reduced,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45200,lactose,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45201,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45202,using,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45203,eggshell,B-http://purl.bioontology.org/ontology/SNOMEDCT/881000161109,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45204,and,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45205,kefir,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45206,.,O,1560.0,This paper proposes the development of an enriched Ca reduced lactose milk using eggshell and kefir .
45223,Ca,O,1562.0,Ca intestinal absorption of untreated milk and milk with kefir was compared .
45224,intestinal,O,1562.0,Ca intestinal absorption of untreated milk and milk with kefir was compared .
45225,absorption,O,1562.0,Ca intestinal absorption of untreated milk and milk with kefir was compared .
45226,of,O,1562.0,Ca intestinal absorption of untreated milk and milk with kefir was compared .
45227,untreated,O,1562.0,Ca intestinal absorption of untreated milk and milk with kefir was compared .
45228,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1562.0,Ca intestinal absorption of untreated milk and milk with kefir was compared .
45229,and,O,1562.0,Ca intestinal absorption of untreated milk and milk with kefir was compared .
45230,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1562.0,Ca intestinal absorption of untreated milk and milk with kefir was compared .
45231,with,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1562.0,Ca intestinal absorption of untreated milk and milk with kefir was compared .
45232,kefir,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1562.0,Ca intestinal absorption of untreated milk and milk with kefir was compared .
45233,was,O,1562.0,Ca intestinal absorption of untreated milk and milk with kefir was compared .
45234,compared,O,1562.0,Ca intestinal absorption of untreated milk and milk with kefir was compared .
45235,.,O,1562.0,Ca intestinal absorption of untreated milk and milk with kefir was compared .
45316,It,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45317,has,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45318,been,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45319,suggested,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45320,that,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45321,diet,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45322,may,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45323,influence,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45324,the,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45325,risk,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45326,of,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45327,melanoma,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45328,",",O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45329,but,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45330,few,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45331,studies,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45332,are,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45333,available,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45334,on,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45335,this,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45336,topic,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45337,.,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45525,Conversely,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45526,",",O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45527,an,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45528,inverse,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45529,association,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45530,with,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45531,disease,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45532,risk,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45533,was,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45534,found,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45535,for,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45536,the,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45537,intake,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45538,of,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45539,legumes,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45540,(,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45541,OR,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45542,=,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45543,0.77,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45544,;,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45545,95,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45546,%,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45547,CI,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45548,0.52,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45549,-,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45550,1.13,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45551,),O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45552,",",O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45553,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45554,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45555,(,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45556,OR,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45557,=,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45558,0.77,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45559,;,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45560,95,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45561,%,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45562,CI,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45563,0.51,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45564,-,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45565,1.16,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45566,),O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45567,",",O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45568,eggs,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45569,(,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45570,OR,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45571,=,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45572,0.58,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45573,;,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45574,95,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45575,%,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45576,CI,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45577,0.41,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45578,-,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45579,0.82,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45580,),O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45581,",",O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45582,and,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45583,onion,B-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45584,and,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45585,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45586,(,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45587,OR,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45588,=,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45589,0.80,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45590,;,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45591,95,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45592,%,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45593,CI,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45594,0.52,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45595,-,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45596,1.14,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45597,),O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45598,.,O,1575.0,"Conversely , an inverse association with disease risk was found for the intake of legumes ( OR = 0.77 ; 95 % CI 0.52 - 1.13 ) , olive oil ( OR = 0.77 ; 95 % CI 0.51 - 1.16 ) , eggs ( OR = 0.58 ; 95 % CI 0.41 - 0.82 ) , and onion and garlic ( OR = 0.80 ; 95 % CI 0.52 - 1.14 ) ."
45727,In,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45728,this,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45729,study,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45730,",",O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45731,eight,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45732,common,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45733,vegetables,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45734,were,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45735,investigated,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45736,in,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45737,terms,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45738,of,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45739,the,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45740,glycolipids,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45741,fraction,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45742,",",O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45743,the,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45744,amounts,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45745,of,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45746,major,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45747,glycolipids,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45748,",",O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45749,mammalian,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45750,DNA,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45751,polymerase,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45752,inhibitory,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45753,activity,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45754,and,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45755,antiproliferative,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45756,activity,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45757,toward,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45758,human,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45759,cancer,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45760,cells,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45761,.,O,1581.0,"In this study , eight common vegetables were investigated in terms of the glycolipids fraction , the amounts of major glycolipids , mammalian DNA polymerase inhibitory activity and antiproliferative activity toward human cancer cells ."
45883,Based,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45884,on,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45885,these,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45886,results,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45887,",",O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45888,the,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45889,glycolipids,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45890,fraction,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45891,from,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45892,spinach,B-http://purl.bioontology.org/ontology/SNOMEDCT/256329006,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45893,is,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45894,potentially,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45895,a,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45896,source,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45897,of,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45898,food,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45899,material,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45900,for,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45901,a,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45902,novel,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45903,anticancer,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45904,activity,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45905,.,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
46070,Regular,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46071,consumption,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46072,of,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46073,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46074,and,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46075,vegetables,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46076,is,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46077,associated,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46078,with,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46079,reduced,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46080,risks,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46081,of,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46082,cancer,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46083,",",O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46084,cardiovascular,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46085,disease,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46086,",",O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46087,stroke,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46088,",",O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46089,Alzheimer,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46090,disease,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46091,",",O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46092,cataracts,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46093,",",O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46094,and,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46095,some,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46096,of,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46097,the,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46098,functional,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46099,declines,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46100,associated,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46101,with,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46102,aging,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46103,.,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46104,Prevention,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46105,is,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46106,a,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46107,more,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46108,effective,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46109,strategy,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46110,than,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46111,is,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46112,treatment,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46113,of,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46114,chronic,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46115,diseases,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46116,.,O,1594.0,Prevention is a more effective strategy than is treatment of chronic diseases .
46687,However,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46688,",",O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46689,in,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46690,order,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46691,to,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46692,increase,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46693,consumption,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46694,of,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46695,these,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46696,foods,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46697,",",O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46698,parallel,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46699,efforts,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46700,should,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46701,be,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46702,implemented,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46703,targeting,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46704,consumer,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46705,knowledge,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46706,and,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46707,incentives,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46708,to,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46709,make,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46710,these,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46711,foods,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46712,more,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46713,affordable,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46714,.,O,1614.0,"However , in order to increase consumption of these foods , parallel efforts should be implemented targeting consumer knowledge and incentives to make these foods more affordable ."
46877,The,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46878,highest,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46879,oxalate,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46880,content,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46881,was,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46882,demonstrated,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46883,for,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46884,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/412533000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/391858005,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46885,bran,I-http://purl.bioontology.org/ontology/SNOMEDCT/412533000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/391858005,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46886,(,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46887,457.4,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46888,mg/100,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46889,g,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46890,),O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46891,.,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46974,Epidemiological,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46975,studies,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46976,suggest,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46977,that,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46978,the,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46979,consumption,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46980,of,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46981,tea,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46982,flavonoids,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46983,may,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46984,be,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46985,associated,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46986,with,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46987,reduced,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46988,risk,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46989,of,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46990,coronary,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46991,heart,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46992,disease,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46993,",",O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46994,stroke,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46995,and,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46996,cancer,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46997,-,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46998,related,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46999,deaths,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
47000,.,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
47599,We,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47600,identified,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47601,three,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47602,interpretable,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47603,dietary,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47604,patterns,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47605,:,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47606,',O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47607,high,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47608,fat,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47609,/,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47610,low,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47611,fibre,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47612,',O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47613,(,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47614,high,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47615,in,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47616,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47617,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47618,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47619,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/227003005;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47620,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/227003005;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47621,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47622,white,B-http://purl.bioontology.org/ontology/SNOMEDCT/226590000;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47623,bread,I-http://purl.bioontology.org/ontology/SNOMEDCT/226590000;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47624,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47625,fried,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47626,potato,I-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47627,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47628,eggs,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47629,),O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47630,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47631,',O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47632,prudent,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47633,',O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47634,(,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47635,high,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47636,in,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47637,poultry,B-http://purl.bioontology.org/ontology/SNOMEDCT/28230009,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47638,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47639,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47640,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47641,fruits,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47642,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47643,vegetables,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47644,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47645,legumes,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47646,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47647,pasta,B-http://purl.bioontology.org/ontology/SNOMEDCT/226740002,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47648,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47649,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47650,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47651,wholemeal,B-http://purl.bioontology.org/ontology/SNOMEDCT/226596006;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47652,bread,I-http://purl.bioontology.org/ontology/SNOMEDCT/226596006;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47653,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47654,eggs,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47655,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47656,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47657,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47658,),O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47659,and,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47660,',O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47661,high,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47662,sugar,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47663,',O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47664,(,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47665,high,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47666,in,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47667,biscuits,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47668,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47669,puddings,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47670,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47671,chocolates,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47672,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47673,sweets,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47674,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47675,sweet,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47676,spreads,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47677,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47678,breakfast,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47679,cereals,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47680,),O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47681,.,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47755,Adherence,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47756,to,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47757,a,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47758,',O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47759,high,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47760,-,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47761,sugar,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47762,',O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47763,diet,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47764,was,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47765,associated,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47766,with,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47767,a,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47768,borderline,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47769,significant,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47770,trend,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47771,for,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47772,an,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47773,increased,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47774,risk,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47775,of,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47776,CVD,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47777,and,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47778,CHD,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47779,events,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47780,.,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47984,The,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47985,simultaneous,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47986,ingestion,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47987,of,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47988,glucose,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47989,with,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47990,cottage,B-http://purl.bioontology.org/ontology/SNOMEDCT/226814003;http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47991,cheese,I-http://purl.bioontology.org/ontology/SNOMEDCT/226814003;http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47992,or,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47993,egg,B-http://purl.bioontology.org/ontology/SNOMEDCT/256443002,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47994,white,I-http://purl.bioontology.org/ontology/SNOMEDCT/256443002,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47995,protein,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47996,decreased,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47997,the,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47998,glucose,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47999,area,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48000,response,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48001,to,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48002,glucose,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48003,by,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48004,11,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48005,%,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48006,and,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48007,20,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48008,%,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48009,",",O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48010,respectively,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48011,.,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48328,The,O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48329,protective,O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48330,effect,O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48331,of,O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48332,citrus,O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48333,and,O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48334,other,O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48335,fresh,O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48336,fruits,O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48337,(,O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48338,vitamin,O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48339,C,O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48340,),O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48341,was,O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48342,confined,O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48343,strictly,O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48344,to,O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48345,heavy,O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48346,drinkers,O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48347,.,O,1671.0,The protective effect of citrus and other fresh fruits ( vitamin C ) was confined strictly to heavy drinkers .
48589,For,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48590,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/227589001;http://purl.bioontology.org/ontology/SNOMEDCT/735053000;http://purl.bioontology.org/ontology/SNOMEDCT/227282006,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48591,chips,I-http://purl.bioontology.org/ontology/SNOMEDCT/227589001;http://purl.bioontology.org/ontology/SNOMEDCT/735053000;http://purl.bioontology.org/ontology/SNOMEDCT/227282006,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48592,",",O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48593,consumers,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48594,liked,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48595,samples,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48596,characterized,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48597,by,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48598,meaty,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48599,aftertaste,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48600,",",O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48601,aroma,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48602,",",O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48603,aroma,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48604,-,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48605,by,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48606,-,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48607,mouth,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48608,",",O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48609,and,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48610,umami,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48611,aftertaste,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
48612,.,O,1679.0,"For potato chips , consumers liked samples characterized by meaty aftertaste , aroma , aroma - by - mouth , and umami aftertaste ."
49048,Diet,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49049,plays,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49050,a,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49051,key,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49052,role,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49053,in,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49054,the,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49055,maintenance,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49056,and,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49057,optimal,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49058,functioning,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49059,of,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49060,immune,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49061,cells,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49062,.,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49488,The,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49489,milk,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49490,prolactin,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49491,level,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49492,in,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49493,early,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49494,lactation,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49495,did,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49496,not,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49497,differ,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49498,between,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49499,NAS,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49500,-,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49501,infected,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49502,and,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49503,noninfected,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49504,quarters,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49505,either,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49506,.,O,1708.0,The milk prolactin level in early lactation did not differ between NAS - infected and noninfected quarters either .
49507,Our,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49508,data,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49509,suggest,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49510,that,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49511,IMI,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49512,with,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49513,NAS,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49514,(,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49515,as,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49516,a,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49517,group,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49518,),O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49519,present,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49520,shortly,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49521,after,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49522,calving,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49523,do,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49524,not,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49525,have,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49526,an,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49527,adverse,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49528,effect,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49529,on,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49530,later,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49531,production,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49532,.,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49614,The,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49615,pulsed,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49616,electric,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49617,field,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49618,(,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49619,PEF,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49620,),O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49621,is,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49622,a,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49623,recently,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49624,studied,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49625,technological,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49626,innovation,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49627,for,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49628,the,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49629,improvement,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49630,of,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49631,olive,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49632,oil,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49633,extraction,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49634,technology,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49635,.,O,1712.0,The pulsed electric field ( PEF ) is a recently studied technological innovation for the improvement of olive oil extraction technology .
49975,Total,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49976,plasma,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49977,cholesterol,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49978,(,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49979,TPC,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49980,),O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49981,",",O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49982,LDL,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49983,-,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49984,C,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49985,",",O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49986,and,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49987,HDL,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49988,-,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49989,C,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49990,distributions,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49991,were,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49992,determined,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49993,by,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49994,high,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49995,-,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49996,performance,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49997,gel,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49998,filtration,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
49999,chromatography,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50000,",",O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50001,while,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50002,aortic,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50003,total,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50004,cholesterol,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50005,(,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50006,TC,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50007,),O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50008,and,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50009,cholesteryl,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50010,ester,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50011,(,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50012,CE,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50013,),O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50014,were,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50015,determined,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50016,by,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50017,gas,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50018,liquid,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50019,chromatography,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50020,.,O,1723.0,"Total plasma cholesterol ( TPC ) , LDL - C , and HDL - C distributions were determined by high - performance gel filtration chromatography , while aortic total cholesterol ( TC ) and cholesteryl ester ( CE ) were determined by gas liquid chromatography ."
50247,In,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50248,addition,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50249,",",O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50250,many,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50251,clinical,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50252,observational,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50253,studies,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50254,have,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50255,demonstrated,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50256,the,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50257,absence,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50258,of,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50259,a,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50260,relationship,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50261,between,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50262,the,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50263,frequency,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50264,of,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50265,miso,B-http://purl.bioontology.org/ontology/SNOMEDCT/227354002;http://purl.bioontology.org/ontology/SNOMEDCT/227566009,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50266,soup,I-http://purl.bioontology.org/ontology/SNOMEDCT/227354002;http://purl.bioontology.org/ontology/SNOMEDCT/227566009,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50267,intake,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50268,and,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50269,blood,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50270,pressure,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50271,levels,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50272,or,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50273,hypertension,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50274,incidence,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50275,.,O,1734.0,"In addition , many clinical observational studies have demonstrated the absence of a relationship between the frequency of miso soup intake and blood pressure levels or hypertension incidence ."
50607,The,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50608,present,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50609,study,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50610,demonstrates,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50611,that,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50612,there,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50613,was,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50614,considerable,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50615,variation,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50616,in,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50617,the,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50618,trends,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50619,in,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50620,reported,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50621,food,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50622,PS,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50623,over,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50624,this,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50625,period,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50626,.,O,1743.0,The present study demonstrates that there was considerable variation in the trends in reported food PS over this period .
50931,Extracts,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50932,from,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50933,broccoli,B-http://purl.bioontology.org/ontology/SNOMEDCT/735123009,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50934,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50935,ratio=3.5,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50936,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50937,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50938,calcot,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50939,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50940,ratio=4.8,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50941,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50942,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50943,cauliflower,B-http://purl.bioontology.org/ontology/SNOMEDCT/735336002,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50944,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50945,ratio=4.2,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50946,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50947,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50948,cabbage,B-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50949,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50950,ratio=2.2,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50951,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50952,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50953,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50954,onion,I-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50955,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50956,ratio=3.2,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50957,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50958,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50959,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/461801000124102;http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50960,cabbage,I-http://purl.bioontology.org/ontology/SNOMEDCT/461801000124102;http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50961,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50962,ratio=3.6,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50963,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50964,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50965,black,B-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50966,cabbage,I-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50967,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50968,ratio=4.5,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50969,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50970,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50971,and,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50972,purple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50973,cabbage,I-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50974,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50975,ratio=3.7,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50976,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50977,were,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50978,confirmed,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50979,to,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50980,contain,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50981,MIs,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50982,in,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50983,the,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50984,AREPE,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50985,cell,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50986,line,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50987,.,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
51590,Thirty,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51591,-,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51592,six,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51593,growing,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51594,boars,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51595,were,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51596,randomly,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51597,allocated,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51598,in,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51599,groups,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51600,of,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51601,six,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51602,to,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51603,six,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51604,diets,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51605,which,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51606,they,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51607,ate,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51608,continuously,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51609,for,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51610,42,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51611,d.,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51612,The,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51613,diets,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51614,fed,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51615,were,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51616,:,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51617,1,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51618,",",O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51619,a,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51620,semi,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51621,-,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51622,purified,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51623,(,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51624,SP,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51625,;,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51626,control,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51627,group,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51628,1,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51629,),O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51630,diet,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51631,;,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51632,2,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51633,",",O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51634,SP,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51635,+,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51636,10,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51637,g,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51638,cholesterol,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51639,/,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51640,kg,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51641,(,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51642,control,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51643,group,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51644,2,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51645,),O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51646,;,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51647,3,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51648,",",O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51649,4,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51650,",",O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51651,5,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51652,",",O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51653,6,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51654,",",O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51655,SP,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51656,+,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51657,cooked,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51658,legumes,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51659,(,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51660,70:30,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51661,",",O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51662,w,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51663,/,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51664,w,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51665,;,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51666,respectively,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51667,baked,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51668,beans,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51669,(,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51670,Phaseolus,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51671,vulgaris,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51672,),O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51673,",",O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51674,peas,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51675,(,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51676,Pisum,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51677,sativum,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51678,),O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51679,",",O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51680,lentils,B-http://purl.bioontology.org/ontology/SNOMEDCT/227350006,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51681,(,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51682,Lens,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51683,culinaris,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51684,Medik,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51685,.,O,1771.0,"Thirty - six growing boars were randomly allocated in groups of six to six diets which they ate continuously for 42 d. The diets fed were : 1 , a semi - purified ( SP ; control group 1 ) diet ; 2 , SP + 10 g cholesterol / kg ( control group 2 ) ; 3 , 4 , 5 , 6 , SP + cooked legumes ( 70:30 , w / w ; respectively baked beans ( Phaseolus vulgaris ) , peas ( Pisum sativum ) , lentils ( Lens culinaris Medik ."
51686,),O,1772.0,") , butter beans ( Phaseolus lunatus ) ) + 10 g cholesterol / kg ."
51687,",",O,1772.0,") , butter beans ( Phaseolus lunatus ) ) + 10 g cholesterol / kg ."
51688,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/227345000;http://purl.bioontology.org/ontology/SNOMEDCT/226888007,1772.0,") , butter beans ( Phaseolus lunatus ) ) + 10 g cholesterol / kg ."
51689,beans,I-http://purl.bioontology.org/ontology/SNOMEDCT/227345000;http://purl.bioontology.org/ontology/SNOMEDCT/226888007,1772.0,") , butter beans ( Phaseolus lunatus ) ) + 10 g cholesterol / kg ."
51690,(,O,1772.0,") , butter beans ( Phaseolus lunatus ) ) + 10 g cholesterol / kg ."
51691,Phaseolus,O,1772.0,") , butter beans ( Phaseolus lunatus ) ) + 10 g cholesterol / kg ."
51692,lunatus,O,1772.0,") , butter beans ( Phaseolus lunatus ) ) + 10 g cholesterol / kg ."
51693,),O,1772.0,") , butter beans ( Phaseolus lunatus ) ) + 10 g cholesterol / kg ."
51694,),O,1772.0,") , butter beans ( Phaseolus lunatus ) ) + 10 g cholesterol / kg ."
51695,+,O,1772.0,") , butter beans ( Phaseolus lunatus ) ) + 10 g cholesterol / kg ."
51696,10,O,1772.0,") , butter beans ( Phaseolus lunatus ) ) + 10 g cholesterol / kg ."
51697,g,O,1772.0,") , butter beans ( Phaseolus lunatus ) ) + 10 g cholesterol / kg ."
51698,cholesterol,O,1772.0,") , butter beans ( Phaseolus lunatus ) ) + 10 g cholesterol / kg ."
51699,/,O,1772.0,") , butter beans ( Phaseolus lunatus ) ) + 10 g cholesterol / kg ."
51700,kg,O,1772.0,") , butter beans ( Phaseolus lunatus ) ) + 10 g cholesterol / kg ."
51701,.,O,1772.0,") , butter beans ( Phaseolus lunatus ) ) + 10 g cholesterol / kg ."
51837,The,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51838,results,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51839,suggest,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51840,that,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51841,the,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51842,mechanism,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51843,for,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51844,the,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51845,hypocholesterolaemic,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51846,effect,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51847,does,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51848,not,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51849,involve,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51850,increased,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51851,hepatic,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51852,bile,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51853,acid,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51854,synthesis,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51855,and,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51856,thereby,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51857,increased,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51858,cholesterol,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51859,clearance,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51860,via,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51861,the,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51862,intestinal,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51863,route,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51864,.,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51972,The,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51973,folate,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51974,content,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51975,of,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51976,100,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51977,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51978,samples,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51979,bought,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51980,at,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51981,retail,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51982,bakeries,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51983,was,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51984,measured,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51985,",",O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51986,average,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51987,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51988,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51989,consumption,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51990,was,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51991,estimated,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51992,and,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51993,postfortification,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51994,FA,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51995,dietary,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51996,intake,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51997,was,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51998,calculated,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
51999,.,O,1782.0,"The folate content of 100 bread samples bought at retail bakeries was measured , average wheat flour consumption was estimated and postfortification FA dietary intake was calculated ."
52574,An,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52575,increase,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52576,of,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52577,5,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52578,U,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52579,in,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52580,the,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52581,dietary,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52582,score,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52583,was,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52584,associated,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52585,with,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52586,a,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52587,change,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52588,in,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52589,the,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52590,BMI,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52591,of,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52592,0.43,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52593,(,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52594,P,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52595,=,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52596,0.030,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52597,),O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52598,and,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52599,0.68,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52600,(,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52601,P,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52602,=,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52603,0.007,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52604,),O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52605,",",O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52606,after,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52607,controlling,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52608,for,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52609,potential,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52610,confounders,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52611,",",O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52612,in,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52613,men,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52614,and,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52615,women,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52616,",",O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52617,respectively,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52618,.,O,1804.0,"An increase of 5 U in the dietary score was associated with a change in the BMI of 0.43 ( P = 0.030 ) and 0.68 ( P = 0.007 ) , after controlling for potential confounders , in men and women , respectively ."
52843,A,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52844,total,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52845,of,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52846,14,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52847,phenolic,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52848,compounds,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52849,",",O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52850,a,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52851,piperine,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52852,",",O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52853,cinnamic,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52854,acid,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52855,",",O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52856,and,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52857,cinnamaldehyde,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52858,were,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52859,identified,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52860,and,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52861,quantitated,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52862,.,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52936,Some,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52937,spices,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52938,displayed,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52939,prebiotic,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52940,-,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52941,like,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52942,activity,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52943,by,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52944,promoting,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52945,the,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52946,growth,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52947,of,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52948,beneficial,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52949,bacteria,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52950,and,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52951,suppressing,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52952,the,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52953,growth,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52954,of,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52955,pathogenic,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52956,bacteria,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52957,",",O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52958,suggesting,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52959,their,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52960,potential,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52961,role,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52962,in,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52963,the,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52964,regulation,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52965,of,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52966,intestinal,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52967,microbiota,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52968,and,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52969,the,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52970,enhancement,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52971,of,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52972,gastrointestinal,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52973,health,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52974,.,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
53171,The,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53172,glycaemic,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53173,index,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53174,(,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53175,GI,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53176,),O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53177,of,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53178,pure,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53179,mashed,B-http://purl.bioontology.org/ontology/SNOMEDCT/227294002;http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53180,potato,I-http://purl.bioontology.org/ontology/SNOMEDCT/227294002;http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53181,was,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53182,108,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53183,",",O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53184,whereas,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53185,combined,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53186,with,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53187,chicken,B-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53188,breast,I-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53189,",",O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53190,rapeseed,B-http://purl.bioontology.org/ontology/SNOMEDCT/226908006,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53191,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/226908006,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53192,and,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53193,salad,B-http://purl.bioontology.org/ontology/SNOMEDCT/227927005,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53194,",",O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53195,it,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53196,was,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53197,only,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53198,54,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53199,.,O,1828.0,"The glycaemic index ( GI ) of pure mashed potato was 108 , whereas combined with chicken breast , rapeseed oil and salad , it was only 54 ."
53259,However,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53260,",",O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53261,the,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53262,insulinaemic,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53263,response,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53264,to,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53265,mashed,B-http://purl.bioontology.org/ontology/SNOMEDCT/227294002;http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53266,potato,I-http://purl.bioontology.org/ontology/SNOMEDCT/227294002;http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53267,with,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53268,chicken,B-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53269,breast,I-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53270,and,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53271,rapeseed,B-http://purl.bioontology.org/ontology/SNOMEDCT/226908006,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53272,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/226908006,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53273,was,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53274,lower,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53275,than,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53276,that,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53277,to,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53278,mashed,B-http://purl.bioontology.org/ontology/SNOMEDCT/227294002;http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53279,potato,I-http://purl.bioontology.org/ontology/SNOMEDCT/227294002;http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53280,alone,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53281,.,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53389,A,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53390,cross,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53391,-,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53392,sectional,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53393,case,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53394,-,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53395,control,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53396,observational,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53397,study,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53398,was,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53399,conducted,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53400,enrolling,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53401,83,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53402,patients,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53403,with,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53404,well,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53405,-,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53406,differentiated,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53407,G1,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53408,/,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53409,G2,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53410,GEP,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53411,-,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53412,NETs,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53413,after,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53414,resection,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53415,",",O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53416,as,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53417,well,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53418,as,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53419,83,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53420,healthy,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53421,subjects,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53422,",",O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53423,age,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53424,",",O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53425,sex,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53426,and,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53427,body,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53428,mass,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53429,index,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53430,-,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53431,matched,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53432,.,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53539,A,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53540,smaller,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53541,PhA,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53542,value,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53543,and,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53544,a,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53545,lower,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53546,PREDIMED,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53547,score,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53548,were,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53549,significantly,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53550,correlated,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53551,with,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53552,G2,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53553,tumor,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53554,",",O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53555,metastases,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53556,",",O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53557,and,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53558,progressive,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53559,disease,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53560,.,O,1842.0,"A smaller PhA value and a lower PREDIMED score were significantly correlated with G2 tumor , metastases , and progressive disease ."
53561,To,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53562,the,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53563,best,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53564,of,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53565,our,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53566,knowledge,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53567,",",O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53568,this,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53569,is,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53570,the,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53571,first,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53572,study,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53573,reporting,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53574,an,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53575,association,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53576,between,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53577,nutritional,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53578,status,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53579,and,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53580,tumor,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53581,aggressiveness,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53582,in,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53583,a,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53584,selected,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53585,group,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53586,of,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53587,GEP,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53588,-,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53589,NETs,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
53590,.,O,1843.0,"To the best of our knowledge , this is the first study reporting an association between nutritional status and tumor aggressiveness in a selected group of GEP - NETs ."
54371,Food,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54372,hypersensitivity,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54373,was,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54374,reported,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54375,by,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54376,23,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54377,patients,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54378,(,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54379,27.3,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54380,%,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54381,),O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54382,allergic,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54383,to,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54384,Artemisia,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54385,.,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54617,For,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54618,colon,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54619,cancer,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54620,",",O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54621,no,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54622,statistically,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54623,significant,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54624,associations,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54625,with,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54626,total,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54627,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54628,intake,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54629,or,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54630,total,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54631,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54632,intake,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54633,were,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54634,found,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54635,.,O,1886.0,"For colon cancer , no statistically significant associations with total vegetable intake or total fruit intake were found ."
54677,Brassica,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54678,vegetables,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54679,and,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54680,cooked,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54681,leafy,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54682,vegetables,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54683,showed,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54684,inverse,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54685,associations,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54686,for,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54687,both,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54688,men,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54689,and,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54690,women,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54691,.,O,1888.0,Brassica vegetables and cooked leafy vegetables showed inverse associations for both men and women .
54692,Among,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54693,women,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54694,and,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54695,",",O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54696,to,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54697,a,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54698,lesser,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54699,extent,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54700,",",O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54701,among,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54702,men,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54703,",",O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54704,inverse,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54705,associations,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54706,were,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54707,stronger,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54708,for,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54709,distal,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54710,colonic,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54711,tumors,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54712,than,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54713,for,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54714,proximal,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54715,colonic,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54716,tumors,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54717,.,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
55206,However,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55207,",",O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55208,individual,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55209,flavonoid,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55210,or,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55211,isoflavonoid,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55212,compounds,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55213,appear,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55214,to,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55215,have,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55216,no,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55217,therapeutic,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55218,effect,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55219,on,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55220,diabetes,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55221,",",O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55222,based,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55223,on,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55224,the,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55225,limited,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55226,clinical,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55227,data,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55228,.,O,1908.0,"However , individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes , based on the limited clinical data ."
55514,The,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55515,amount,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55516,of,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55517,spread,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55518,consumed,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55519,was,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55520,not,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55521,associated,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55522,with,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55523,body,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55524,mass,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55525,index,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55526,",",O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55527,a,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55528,past,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55529,history,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55530,or,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55531,family,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55532,history,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55533,of,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55534,heart,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55535,disease,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55536,or,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55537,previously,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55538,diagnosed,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55539,hypertension,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55540,.,O,1921.0,"The amount of spread consumed was not associated with body mass index , a past history or family history of heart disease or previously diagnosed hypertension ."
55541,These,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55542,findings,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55543,suggest,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55544,that,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55545,current,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55546,recommendations,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55547,to,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55548,reduce,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55549,total,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55550,fat,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55551,intake,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55552,and,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55553,to,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55554,reduce,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55555,the,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55556,proportion,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55557,of,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55558,saturated,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55559,fats,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55560,used,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55561,are,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55562,not,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55563,being,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55564,followed,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55565,",",O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55566,at,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55567,least,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55568,in,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55569,respect,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55570,of,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55571,spread,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55572,",",O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55573,by,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55574,those,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55575,at,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55576,greatest,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55577,risk,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55578,of,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55579,coronary,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55580,heart,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55581,disease,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55582,.,O,1922.0,"These findings suggest that current recommendations to reduce total fat intake and to reduce the proportion of saturated fats used are not being followed , at least in respect of spread , by those at greatest risk of coronary heart disease ."
55583,Our,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55584,preliminary,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55585,clinical,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55586,trial,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55587,showed,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55588,that,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55589,consumption,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55590,of,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55591,cooked,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55592,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55593,of,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55594,a,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55595,Japanese,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55596,common,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55597,cultivar,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55598,Yukihikari,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55599,improved,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55600,atopic,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55601,dermatitis,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55602,associated,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55603,with,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55604,a,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55605,suspected,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55606,rice,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55607,allergy,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55608,",",O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55609,although,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55610,the,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55611,underlying,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55612,mechanisms,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55613,remain,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55614,unclear,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55615,.,O,1923.0,"Our preliminary clinical trial showed that consumption of cooked rice of a Japanese common cultivar Yukihikari improved atopic dermatitis associated with a suspected rice allergy , although the underlying mechanisms remain unclear ."
55616,We,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55617,hypothesised,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55618,that,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55619,the,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55620,ameliorating,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55621,effect,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55622,of,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55623,Yukihikari,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55624,on,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55625,atopic,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55626,dermatitis,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55627,is,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55628,associated,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55629,with,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55630,the,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55631,gut,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55632,microbiota,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55633,.,O,1924.0,We hypothesised that the ameliorating effect of Yukihikari on atopic dermatitis is associated with the gut microbiota .
55896,This,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55897,review,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55898,aims,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55899,to,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55900,characterize,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55901,and,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55902,assess,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55903,food,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55904,consumption,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55905,patterns,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55906,and,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55907,nutrient,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55908,intakes,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55909,amongst,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55910,school,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55911,-,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55912,aged,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55913,children,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55914,(,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55915,5,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55916,-,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55917,10,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55918,years,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55919,),O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55920,and,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55921,adolescents,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55922,(,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55923,10,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55924,-,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55925,19,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55926,years,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55927,),O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55928,in,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55929,countries,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55930,of,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55931,the,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55932,EMR,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55933,.,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
56127,The,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56128,aim,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56129,of,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56130,this,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56131,study,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56132,was,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56133,to,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56134,determine,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56135,the,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56136,effect,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56137,of,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56138,pomegranate,B-http://purl.bioontology.org/ontology/SNOMEDCT/227441008;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56139,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/227441008;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56140,consumption,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56141,on,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56142,serum,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56143,levels,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56144,of,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56145,estradiol,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56146,",",O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56147,estrone,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56148,",",O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56149,testosterone,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56150,",",O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56151,androstenedione,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56152,",",O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56153,and,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56154,sex,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56155,hormone,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56156,binding,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56157,globulin,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56158,(,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56159,SHBG,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56160,),O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56161,.,O,1939.0,"The aim of this study was to determine the effect of pomegranate juice consumption on serum levels of estradiol , estrone , testosterone , androstenedione , and sex hormone binding globulin ( SHBG ) ."
56162,Sixty,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56163,-,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56164,four,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56165,healthy,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56166,postmenopausal,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56167,women,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56168,were,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56169,randomly,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56170,assigned,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56171,to,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56172,drink,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56173,8,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56174,ounces,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56175,of,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56176,either,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56177,100,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56178,%,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56179,commercial,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56180,pomegranate,B-http://purl.bioontology.org/ontology/SNOMEDCT/227441008;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56181,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/227441008;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56182,(,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56183,intervention,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56184,),O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56185,or,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56186,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/226491003;http://purl.bioontology.org/ontology/SNOMEDCT/735215001;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56187,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/226491003;http://purl.bioontology.org/ontology/SNOMEDCT/735215001;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56188,(,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56189,control,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56190,),O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56191,for,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56192,3,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56193,weeks,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56194,.,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56338,Additional,O,1944.0,Additional larger trials would be needed to determine effects in normal versus overweight / obese women .
56339,larger,O,1944.0,Additional larger trials would be needed to determine effects in normal versus overweight / obese women .
56340,trials,O,1944.0,Additional larger trials would be needed to determine effects in normal versus overweight / obese women .
56341,would,O,1944.0,Additional larger trials would be needed to determine effects in normal versus overweight / obese women .
56342,be,O,1944.0,Additional larger trials would be needed to determine effects in normal versus overweight / obese women .
56343,needed,O,1944.0,Additional larger trials would be needed to determine effects in normal versus overweight / obese women .
56344,to,O,1944.0,Additional larger trials would be needed to determine effects in normal versus overweight / obese women .
56345,determine,O,1944.0,Additional larger trials would be needed to determine effects in normal versus overweight / obese women .
56346,effects,O,1944.0,Additional larger trials would be needed to determine effects in normal versus overweight / obese women .
56347,in,O,1944.0,Additional larger trials would be needed to determine effects in normal versus overweight / obese women .
56348,normal,O,1944.0,Additional larger trials would be needed to determine effects in normal versus overweight / obese women .
56349,versus,O,1944.0,Additional larger trials would be needed to determine effects in normal versus overweight / obese women .
56350,overweight,O,1944.0,Additional larger trials would be needed to determine effects in normal versus overweight / obese women .
56351,/,O,1944.0,Additional larger trials would be needed to determine effects in normal versus overweight / obese women .
56352,obese,O,1944.0,Additional larger trials would be needed to determine effects in normal versus overweight / obese women .
56353,women,O,1944.0,Additional larger trials would be needed to determine effects in normal versus overweight / obese women .
56354,.,O,1944.0,Additional larger trials would be needed to determine effects in normal versus overweight / obese women .
56435,Chicken,B-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56436,nuggets,I-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56437,were,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56438,prepared,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56439,using,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56440,batter,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56441,containing,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56442,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56443,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56444,",",O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56445,oxidized,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56446,starch,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56447,",",O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56448,salt,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56449,",",O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56450,and,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56451,leavening,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56452,agents,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56453,prior,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56454,to,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56455,steaming,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56456,",",O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56457,oven,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56458,baking,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56459,",",O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56460,freezing,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56461,",",O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56462,and,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56463,final,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56464,oven,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56465,baking,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56466,for,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56467,sensory,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56468,evaluation,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56469,.,O,1950.0,"Chicken nuggets were prepared using batter containing wheat flour , oxidized starch , salt , and leavening agents prior to steaming , oven baking , freezing , and final oven baking for sensory evaluation ."
56675,Conversely,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56676,",",O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56677,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56678,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56679,are,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56680,less,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56681,known,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56682,for,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56683,their,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56684,contribution,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56685,of,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56686,key,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56687,micronutrients,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56688,(,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56689,vitamin,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56690,C,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56691,",",O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56692,potassium,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56693,",",O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56694,magnesium,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56695,),O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56696,",",O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56697,fiber,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56698,",",O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56699,and,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56700,phytochemicals,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56701,(,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56702,phenolics,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56703,and,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56704,carotenoids,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56705,),O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56706,.,O,1957.0,"Conversely , potato products are less known for their contribution of key micronutrients ( vitamin C , potassium , magnesium ) , fiber , and phytochemicals ( phenolics and carotenoids ) ."
56858,Dietary,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56859,modification,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56860,is,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56861,one,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56862,of,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56863,the,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56864,most,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56865,important,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56866,lifestyle,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56867,changes,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56868,that,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56869,has,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56870,been,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56871,shown,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56872,to,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56873,significantly,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56874,decrease,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56875,the,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56876,risk,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56877,of,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56878,cardiovascular,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56879,(,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56880,CV,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56881,),O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56882,disease,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56883,(,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56884,CVD,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56885,),O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56886,by,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56887,attenuating,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56888,related,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56889,risk,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56890,factors,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
56891,.,O,1962.0,Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular ( CV ) disease ( CVD ) by attenuating related risk factors .
57018,The,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57019,aim,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57020,of,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57021,this,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57022,expert,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57023,opinion,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57024,recommendation,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57025,was,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57026,to,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57027,elucidate,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57028,the,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57029,different,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57030,impact,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57031,of,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57032,animal,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57033,vs,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57034,vegetable,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57035,protein,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57036,on,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57037,modifying,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57038,cardiometabolic,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57039,risk,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57040,factors,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57041,.,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
58385,We,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58386,used,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58387,data,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58388,from,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58389,the,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58390,Mexican,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58391,Teachers,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58392,',O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58393,Cohort,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58394,including,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58395,64,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58396,934,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58397,disease,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58398,-,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58399,free,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58400,women,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58401,aged,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58402,≥25,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58403,years,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58404,at,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58405,baseline,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58406,.,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
59020,Beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59021,consumption,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59022,contributed,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59023,to,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59024,9·6,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59025,and,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59026,5·3,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59027,%,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59028,inter,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59029,-,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59030,individual,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59031,variation,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59032,in,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59033,GI,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59034,and,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59035,GL,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59036,",",O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59037,respectively,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59038,.,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59297,Estimated,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59298,daily,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59299,intake,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59300,of,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59301,protein,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59302,",",O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59303,plant,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59304,fat,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59305,",",O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59306,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59307,",",O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59308,onion,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59309,",",O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59310,allicin,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59311,",",O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59312,and,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59313,quercetin,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59314,was,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59315,greater,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59316,in,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59317,the,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59318,TD,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59319,compared,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59320,to,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59321,the,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59322,RD,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59323,.,O,2052.0,"Estimated daily intake of protein , plant fat , garlic , onion , allicin , and quercetin was greater in the TD compared to the RD ."
59677,Nitrite,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59678,curing,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59679,of,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59680,all,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59681,meats,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59682,lowered,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59683,lipid,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59684,and,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59685,protein,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59686,oxidation,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59687,to,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59688,the,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59689,level,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59690,of,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59691,oxidation,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59692,in,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59693,uncured,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59694,chicken,B-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59695,.,O,2065.0,Nitrite curing of all meats lowered lipid and protein oxidation to the level of oxidation in uncured chicken .
59841,Demographic,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59842,and,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59843,history,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59844,data,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59845,were,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59846,collected,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59847,from,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59848,"128,934",O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59849,adults,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59850,undergoing,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59851,health,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59852,evaluations,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59853,in,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59854,1978,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59855,-,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59856,1985,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59857,",",O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59858,with,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59859,subsequent,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59860,death,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59861,ascertained,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59862,by,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59863,an,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59864,automated,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59865,linkage,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59866,system,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59867,.,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
60162,However,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60163,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60164,a,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60165,diet,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60166,based,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60167,on,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60168,vegetables,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60169,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60170,fruits,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60171,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60172,whole,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60173,grains,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60174,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60175,and,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60176,legumes,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60177,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60178,supplemented,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60179,with,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60180,vitamin,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60181,B-12,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60182,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60183,is,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60184,nutritionally,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60185,superior,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60186,to,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60187,diets,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60188,including,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60189,animal,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60190,products,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60191,and,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60192,is,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60193,healthful,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60194,for,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60195,children,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60196,and,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60197,adults,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60198,.,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60718,Consumers,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60719,who,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60720,are,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60721,predominately,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60722,beer,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60723,drinkers,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60724,were,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60725,more,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60726,heavily,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60727,influenced,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60728,by,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60729,nutritional,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60730,information,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60731,than,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60732,consumers,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60733,who,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60734,were,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60735,predominately,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60736,wine,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60737,drinkers,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
60738,.,O,2107.0,Consumers who are predominately beer drinkers were more heavily influenced by nutritional information than consumers who were predominately wine drinkers .
61045,Blood,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61046,and,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61047,milk,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61048,parameters,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61049,do,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61050,not,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61051,indicate,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61052,any,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61053,adverse,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61054,effects,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61055,of,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61056,feeding,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61057,this,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61058,natural,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61059,compound,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61060,.,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61122,Thus,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61123,",",O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61124,in,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61125,this,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61126,study,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61127,",",O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61128,the,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61129,potential,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61130,anti,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61131,-,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61132,diabetic,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61133,properties,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61134,of,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61135,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61136,on,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61137,glucose,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61138,homeostasis,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61139,and,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61140,insulin,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61141,signaling,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61142,were,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61143,evaluated,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61144,in,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61145,type,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61146,2,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61147,diabetic,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61148,Zucker,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61149,diabetic,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61150,fatty,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61151,(,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61152,ZDF,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61153,),O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61154,rats,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61155,.,O,2122.0,"Thus , in this study , the potential anti - diabetic properties of cocoa on glucose homeostasis and insulin signaling were evaluated in type 2 diabetic Zucker diabetic fatty ( ZDF ) rats ."
61326,These,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61327,findings,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61328,suggest,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61329,that,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61330,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61331,has,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61332,the,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61333,potential,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61334,to,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61335,alleviate,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61336,both,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61337,hyperglycemia,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61338,and,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61339,hepatic,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61340,insulin,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61341,resistance,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61342,in,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61343,type,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61344,2,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61345,diabetic,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61346,ZDF,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61347,rats,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61348,.,O,2128.0,These findings suggest that cocoa has the potential to alleviate both hyperglycemia and hepatic insulin resistance in type 2 diabetic ZDF rats .
61438,Some,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61439,studies,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61440,",",O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61441,specifically,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61442,on,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61443,sweetened,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61444,beverages,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61445,",",O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61446,highlighted,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61447,a,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61448,potential,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61449,concern,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61450,in,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61451,relation,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61452,to,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61453,obesity,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61454,risk,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61455,",",O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61456,although,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61457,these,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61458,were,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61459,limited,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61460,by,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61461,important,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61462,methodological,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61463,issues,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61464,.,O,2132.0,"Some studies , specifically on sweetened beverages , highlighted a potential concern in relation to obesity risk , although these were limited by important methodological issues ."
61512,The,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61513,evidence,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61514,for,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61515,colorectal,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61516,cancer,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61517,suggested,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61518,an,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61519,association,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61520,with,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61521,sugar,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61522,",",O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61523,but,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61524,this,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61525,appeared,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61526,to,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61527,have,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61528,been,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61529,confounded,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61530,by,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61531,energy,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61532,intake,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61533,and,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61534,glycemic,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61535,load,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61536,.,O,2135.0,"The evidence for colorectal cancer suggested an association with sugar , but this appeared to have been confounded by energy intake and glycemic load ."
61748,The,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61749,main,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61750,pharmacological,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61751,actions,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61752,of,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61753,ginger,B-http://purl.bioontology.org/ontology/SNOMEDCT/227400003,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61754,and,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61755,compounds,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61756,isolated,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61757,therefrom,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61758,include,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61759,immuno,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61760,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61761,modulatory,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61762,",",O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61763,anti,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61764,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61765,tumorigenic,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61766,",",O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61767,anti,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61768,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61769,inflammatory,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61770,",",O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61771,anti,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61772,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61773,apoptotic,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61774,",",O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61775,anti,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61776,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61777,hyperglycemic,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61778,",",O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61779,anti,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61780,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61781,lipidemic,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61782,and,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61783,anti,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61784,-,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61785,emetic,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61786,actions,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61787,.,O,2142.0,"The main pharmacological actions of ginger and compounds isolated therefrom include immuno - modulatory , anti - tumorigenic , anti - inflammatory , anti - apoptotic , anti - hyperglycemic , anti - lipidemic and anti - emetic actions ."
61886,Substantial,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61887,experimental,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61888,studies,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61889,indicated,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61890,that,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61891,many,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61892,dietary,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61893,natural,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61894,products,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61895,could,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61896,affect,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61897,the,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61898,development,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61899,and,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61900,progression,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61901,of,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61902,breast,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61903,cancer,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61904,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61905,such,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61906,as,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61907,soy,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61908,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61909,pomegranate,B-http://purl.bioontology.org/ontology/SNOMEDCT/227441008,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61910,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61911,mangosteen,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61912,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61913,citrus,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61914,fruits,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61915,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61916,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61917,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61918,grape,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61919,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61920,mango,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61921,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61922,cruciferous,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61923,vegetables,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61924,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61925,ginger,B-http://purl.bioontology.org/ontology/SNOMEDCT/227400003,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61926,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61927,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61928,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61929,black,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61930,cumin,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61931,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61932,edible,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61933,macro,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61934,-,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61935,fungi,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61936,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61937,and,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61938,cereals,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61939,.,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
62500,This,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62501,was,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62502,confirmed,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62503,by,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62504,bronchial,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62505,challenge,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62506,testing,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62507,",",O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62508,but,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62509,the,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62510,comparison,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62511,was,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62512,not,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62513,obviously,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62514,consistent,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62515,with,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62516,the,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62517,results,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62518,of,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62519,prick,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62520,testing,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62521,or,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62522,estimation,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62523,of,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62524,histamine,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62525,released,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62526,from,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62527,his,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62528,leucocytes,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62529,.,O,2168.0,"This was confirmed by bronchial challenge testing , but the comparison was not obviously consistent with the results of prick testing or estimation of histamine released from his leucocytes ."
62551,Food,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62552,extracts,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62553,for,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62554,diagnostic,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62555,purposes,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62556,often,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62557,lack,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62558,sufficient,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62559,activity,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62560,and,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62561,consistency,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62562,.,O,2170.0,Food extracts for diagnostic purposes often lack sufficient activity and consistency .
62716,Variation,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62717,of,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62718,extraction,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62719,conditions,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62720,had,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62721,little,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62722,effect,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62723,on,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62724,the,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62725,composition,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62726,and,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62727,activity,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62728,of,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62729,extracts,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62730,from,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62731,hazelnut,B-http://purl.bioontology.org/ontology/SNOMEDCT/256353000,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62732,.,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
63832,Food,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63833,intake,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63834,",",O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63835,assessed,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63836,by,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63837,a,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63838,FFQ,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63839,",",O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63840,was,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63841,aggregated,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63842,into,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63843,thirty,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63844,-,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63845,four,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63846,separate,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63847,food,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63848,groups,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
63849,.,O,2216.0,"Food intake , assessed by a FFQ , was aggregated into thirty - four separate food groups ."
64112,The,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64113,strength,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64114,of,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64115,this,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64116,scientific,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64117,base,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64118,guides,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64119,US,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64120,national,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64121,policymaking,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64122,in,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64123,diet,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64124,and,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64125,health,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64126,issues,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64127,and,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64128,facilitates,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64129,community,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64130,and,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64131,local,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64132,programs,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64133,that,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64134,address,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64135,national,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64136,dietary,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64137,goals,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64138,to,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64139,increase,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64140,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64141,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64142,vegetable,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64143,consumption,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64144,.,O,2230.0,The strength of this scientific base guides US national policymaking in diet and health issues and facilitates community and local programs that address national dietary goals to increase fruit and vegetable consumption .
64592,The,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64593,minimum,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64594,milk,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64595,temperature,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64596,was,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64597,estimated,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64598,to,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64599,be,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64600,8,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64601,°,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64602,C,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64603,.,O,2246.0,The minimum milk temperature was estimated to be 8 ° C .
64740,It,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64741,was,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64742,observed,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64743,that,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64744,the,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64745,addition,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64746,of,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64747,ISWs,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64748,in,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64749,soil,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64750,increased,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64751,heavy,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64752,metal,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64753,contents,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64754,in,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64755,all,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64756,fractions,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64757,.,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
65271,In,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65272,multivariate,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65273,analyses,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65274,",",O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65275,animal,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65276,fat,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65277,tended,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65278,to,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65279,be,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65280,positively,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65281,correlated,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65282,",",O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65283,and,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65284,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65285,consumption,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65286,inversely,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65287,correlated,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65288,",",O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65289,with,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65290,CHD,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65291,.,O,2274.0,"In multivariate analyses , animal fat tended to be positively correlated , and fruit consumption inversely correlated , with CHD ."
65377,Thus,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65378,",",O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65379,while,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65380,the,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65381,risk,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65382,/,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65383,benefit,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65384,ratio,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65385,varies,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65386,for,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65387,individuals,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65388,",",O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65389,the,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65390,use,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65391,of,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65392,alcohol,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65393,for,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65394,cardioprotective,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65395,purposes,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65396,should,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65397,not,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65398,be,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65399,encouraged,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65400,as,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65401,a,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65402,public,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65403,health,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65404,measure,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65405,.,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65474,One,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65475,of,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65476,these,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65477,",",O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65478,corresponding,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65479,to,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65480,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/412357001,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65481,Lipid,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65482,Transfer,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65483,Protein,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65484,(,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65485,LTP,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65486,),O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65487,",",O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65488,appeared,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65489,to,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65490,be,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65491,the,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65492,major,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65493,one,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65494,.,O,2284.0,"One of these , corresponding to corn Lipid Transfer Protein ( LTP ) , appeared to be the major one ."
65616,This,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65617,relationship,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65618,was,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65619,examined,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65620,in,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65621,a,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65622,case,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65623,-,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65624,control,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65625,study,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65626,conducted,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65627,in,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65628,3,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65629,geographical,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65630,areas,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65631,of,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65632,Canada,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65633,[,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65634,Metropolitan,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65635,Toronto,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65636,(,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65637,Ontario,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65638,),O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65639,",",O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65640,Montreal,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65641,(,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65642,Quebec,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65643,),O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65644,",",O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65645,and,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65646,Vancouver,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65647,(,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65648,British,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65649,Columbia,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65650,),O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65651,],O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65652,with,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65653,617,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65654,incident,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65655,cases,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65656,and,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65657,637,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65658,population,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65659,controls,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65660,.,O,2288.0,"This relationship was examined in a case - control study conducted in 3 geographical areas of Canada [ Metropolitan Toronto ( Ontario ) , Montreal ( Quebec ) , and Vancouver ( British Columbia ) ] with 617 incident cases and 637 population controls ."
65738,The,O,2292.0,The decreasing trend was significant for beer intake .
65739,decreasing,O,2292.0,The decreasing trend was significant for beer intake .
65740,trend,O,2292.0,The decreasing trend was significant for beer intake .
65741,was,O,2292.0,The decreasing trend was significant for beer intake .
65742,significant,O,2292.0,The decreasing trend was significant for beer intake .
65743,for,O,2292.0,The decreasing trend was significant for beer intake .
65744,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,2292.0,The decreasing trend was significant for beer intake .
65745,intake,O,2292.0,The decreasing trend was significant for beer intake .
65746,.,O,2292.0,The decreasing trend was significant for beer intake .
65860,Here,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65861,",",O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65862,we,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65863,show,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65864,that,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65865,the,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65866,genetically,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65867,modified,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65868,soybean,B-http://purl.bioontology.org/ontology/SNOMEDCT/226911007,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65869,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/226911007,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65870,Plenish,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65871,",",O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65872,which,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65873,came,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65874,on,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65875,the,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65876,U.S.,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65877,market,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65878,in,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65879,2014,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65880,and,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65881,is,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65882,low,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65883,in,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65884,linoleic,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65885,acid,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65886,",",O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65887,induces,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65888,less,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65889,obesity,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65890,than,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65891,conventional,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65892,soybean,B-http://purl.bioontology.org/ontology/SNOMEDCT/226911007,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65893,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/226911007,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65894,in,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65895,C57BL/6,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65896,male,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65897,mice,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
65898,.,O,2298.0,"Here , we show that the genetically modified soybean oil Plenish , which came on the U.S. market in 2014 and is low in linoleic acid , induces less obesity than conventional soybean oil in C57BL/6 male mice ."
66268,Furthermore,O,2312.0,"Furthermore , red wine significantly reduced post - ischemic neutrophil infiltration ."
66269,",",O,2312.0,"Furthermore , red wine significantly reduced post - ischemic neutrophil infiltration ."
66270,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2312.0,"Furthermore , red wine significantly reduced post - ischemic neutrophil infiltration ."
66271,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2312.0,"Furthermore , red wine significantly reduced post - ischemic neutrophil infiltration ."
66272,significantly,O,2312.0,"Furthermore , red wine significantly reduced post - ischemic neutrophil infiltration ."
66273,reduced,O,2312.0,"Furthermore , red wine significantly reduced post - ischemic neutrophil infiltration ."
66274,post,O,2312.0,"Furthermore , red wine significantly reduced post - ischemic neutrophil infiltration ."
66275,-,O,2312.0,"Furthermore , red wine significantly reduced post - ischemic neutrophil infiltration ."
66276,ischemic,O,2312.0,"Furthermore , red wine significantly reduced post - ischemic neutrophil infiltration ."
66277,neutrophil,O,2312.0,"Furthermore , red wine significantly reduced post - ischemic neutrophil infiltration ."
66278,infiltration,O,2312.0,"Furthermore , red wine significantly reduced post - ischemic neutrophil infiltration ."
66279,.,O,2312.0,"Furthermore , red wine significantly reduced post - ischemic neutrophil infiltration ."
66611,In,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66612,this,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66613,review,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66614,(,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66615,Part,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66616,2,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66617,),O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66618,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66619,we,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66620,present,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66621,a,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66622,research,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66623,overview,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66624,conducted,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66625,on,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66626,some,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66627,plants,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66628,and,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66629,vegetables,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66630,(,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66631,spirulina,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66632,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66633,broccoli,B-http://purl.bioontology.org/ontology/SNOMEDCT/735123009,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66634,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66635,chamomile,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66636,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66637,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66638,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66639,ginger,B-http://purl.bioontology.org/ontology/SNOMEDCT/227400003,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66640,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66641,laurel,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66642,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66643,marigold,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66644,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66645,roselle,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66646,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66647,and,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66648,rosemary,B-http://purl.bioontology.org/ontology/SNOMEDCT/227410007,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66649,),O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66650,",",O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66651,which,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66652,are,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66653,frequently,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66654,consumed,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66655,by,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66656,humans,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66657,.,O,2327.0,"In this review ( Part 2 ) , we present a research overview conducted on some plants and vegetables ( spirulina , broccoli , chamomile , cocoa , ginger , laurel , marigold , roselle , and rosemary ) , which are frequently consumed by humans ."
66783,Alcohol,O,2332.0,Alcohol consumption was ascertained by baseline questionnaire between October 2000 and December 2002 .
66784,consumption,O,2332.0,Alcohol consumption was ascertained by baseline questionnaire between October 2000 and December 2002 .
66785,was,O,2332.0,Alcohol consumption was ascertained by baseline questionnaire between October 2000 and December 2002 .
66786,ascertained,O,2332.0,Alcohol consumption was ascertained by baseline questionnaire between October 2000 and December 2002 .
66787,by,O,2332.0,Alcohol consumption was ascertained by baseline questionnaire between October 2000 and December 2002 .
66788,baseline,O,2332.0,Alcohol consumption was ascertained by baseline questionnaire between October 2000 and December 2002 .
66789,questionnaire,O,2332.0,Alcohol consumption was ascertained by baseline questionnaire between October 2000 and December 2002 .
66790,between,O,2332.0,Alcohol consumption was ascertained by baseline questionnaire between October 2000 and December 2002 .
66791,October,O,2332.0,Alcohol consumption was ascertained by baseline questionnaire between October 2000 and December 2002 .
66792,2000,O,2332.0,Alcohol consumption was ascertained by baseline questionnaire between October 2000 and December 2002 .
66793,and,O,2332.0,Alcohol consumption was ascertained by baseline questionnaire between October 2000 and December 2002 .
66794,December,O,2332.0,Alcohol consumption was ascertained by baseline questionnaire between October 2000 and December 2002 .
66795,2002,O,2332.0,Alcohol consumption was ascertained by baseline questionnaire between October 2000 and December 2002 .
66796,.,O,2332.0,Alcohol consumption was ascertained by baseline questionnaire between October 2000 and December 2002 .
67206,Boiling,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67207,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226757003;http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67208,rice,I-http://purl.bioontology.org/ontology/SNOMEDCT/226757003;http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67209,with,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67210,ghee,B-http://purl.bioontology.org/ontology/SNOMEDCT/226901000,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67211,or,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67212,cooking,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67213,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226757003;http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67214,rice,I-http://purl.bioontology.org/ontology/SNOMEDCT/226757003;http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67215,with,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67216,ghee,B-http://purl.bioontology.org/ontology/SNOMEDCT/226901000,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67217,pilaf,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67218,-,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67219,style,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67220,may,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67221,provide,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67222,beneficial,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67223,effects,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67224,on,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67225,postprandial,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67226,blood,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67227,glucose,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67228,and,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67229,insulin,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67230,concentrations,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67231,",",O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67232,and,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67233,improve,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67234,colonic,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67235,health,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67236,.,O,2348.0,"Boiling red rice with ghee or cooking red rice with ghee pilaf - style may provide beneficial effects on postprandial blood glucose and insulin concentrations , and improve colonic health ."
67710,Due,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67711,to,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67712,the,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67713,frequency,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67714,and,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67715,the,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67716,extent,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67717,of,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67718,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67719,consumption,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67720,",",O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67721,the,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67722,supporting,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67723,epidemiological,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67724,and,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67725,animal,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67726,data,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67727,",",O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67728,which,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67729,connect,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67730,increased,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67731,intakes,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67732,with,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67733,decreased,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67734,cancer,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67735,and,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67736,cardiovascular,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67737,disease,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67738,risk,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67739,",",O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67740,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67741,'s,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67742,role,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67743,in,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67744,the,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67745,American,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67746,diet,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67747,is,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67748,of,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67749,undeniable,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67750,importance,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67751,as,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67752,part,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67753,of,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67754,a,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67755,healthy,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67756,diet,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67757,.,O,2366.0,"Due to the frequency and the extent of tomato consumption , the supporting epidemiological and animal data , which connect increased intakes with decreased cancer and cardiovascular disease risk , tomato 's role in the American diet is of undeniable importance as part of a healthy diet ."
67987,The,O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
67988,nutritional,O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
67989,and,O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
67990,functional,O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
67991,quality,O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
67992,of,O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
67993,pseudocereals,O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
67994,can,O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
67995,be,O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
67996,improved,O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
67997,by,O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
67998,fermentation,O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
67999,using,O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
68000,Lactic,O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
68001,Acid,O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
68002,Bacteria,O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
68003,(,O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
68004,LAB,O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
68005,),O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
68006,.,O,2375.0,The nutritional and functional quality of pseudocereals can be improved by fermentation using Lactic Acid Bacteria ( LAB ) .
68125,However,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68126,",",O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68127,there,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68128,has,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68129,been,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68130,increasing,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68131,interest,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68132,in,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68133,wheat,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68134,gluten,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68135,over,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68136,the,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68137,past,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68138,two,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68139,decades,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68140,because,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68141,of,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68142,its,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68143,well,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68144,-,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68145,established,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68146,role,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68147,in,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68148,triggering,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68149,coeliac,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68150,disease,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68151,",",O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68152,and,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68153,its,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68154,perceived,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68155,role,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68156,in,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68157,other,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68158,adverse,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68159,reactions,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68160,to,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68161,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68162,.,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68383,Over,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68384,14,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68385,years,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68386,of,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68387,follow,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68388,-,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68389,up,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68390,",",O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68391,1803,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68392,incident,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68393,diabetes,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68394,cases,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68395,were,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68396,identified,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68397,through,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68398,self,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68399,-,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68400,reports,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68401,",",O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68402,supplementary,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68403,questionnaires,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68404,and,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68405,drug,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68406,reimbursement,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68407,information,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68408,.,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68592,In,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68593,this,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68594,large,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68595,prospective,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68596,cohort,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68597,",",O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68598,we,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68599,observed,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68600,an,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68601,association,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68602,between,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68603,dietary,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68604,cholesterol,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68605,and,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68606,type,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68607,2,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68608,diabetes,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68609,",",O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68610,but,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68611,no,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68612,association,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68613,with,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68614,egg,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68615,consumption,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68616,.,O,2393.0,"In this large prospective cohort , we observed an association between dietary cholesterol and type 2 diabetes , but no association with egg consumption ."
68736,Reductions,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68737,in,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68738,the,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68739,different,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68740,types,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68741,of,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68742,discretionary,B-http://purl.bioontology.org/ontology/SNOMEDCT/255620007,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68743,food,I-http://purl.bioontology.org/ontology/SNOMEDCT/255620007,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68744,were,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68745,modelled,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68746,individually,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68747,to,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68748,estimate,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68749,the,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68750,impact,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68751,on,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68752,energy,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68753,consumption,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68754,and,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68755,population,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68756,body,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68757,weight,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68758,by,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68759,5,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68760,-,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68761,year,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68762,age,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68763,and,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68764,sex,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68765,groups,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68766,.,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68997,Moreover,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
68998,",",O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
68999,the,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69000,study,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69001,highlights,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69002,that,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69003,policy,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69004,responses,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69005,to,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69006,improve,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69007,population,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69008,diets,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69009,may,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69010,need,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69011,to,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69012,be,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69013,tailored,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69014,to,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69015,target,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69016,different,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69017,types,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69018,of,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69019,foods,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69020,for,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69021,different,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69022,population,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69023,groups,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69024,.,O,2404.0,"Moreover , the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups ."
69352,Mixing,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69353,the,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69354,meals,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69355,significantly,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69356,increased,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69357,the,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69358,insulinemic,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69359,indexes,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69360,(,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69361,p,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69362,less,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69363,than,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69364,0.05,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69365,),O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69366,and,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69367,introduced,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69368,a,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69369,positive,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69370,correlation,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69371,between,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69372,glycemic,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69373,and,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69374,insulinemic,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69375,indexes,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69376,(,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69377,n,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69378,=,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69379,6,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69380,",",O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69381,r,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69382,=,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69383,0.903,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69384,;,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69385,p,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69386,less,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69387,than,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69388,0.05,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69389,),O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69390,.,O,2417.0,"Mixing the meals significantly increased the insulinemic indexes ( p less than 0.05 ) and introduced a positive correlation between glycemic and insulinemic indexes ( n = 6 , r = 0.903 ; p less than 0.05 ) ."
69575,Various,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69576,types,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69577,of,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69578,malnutrition,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69579,prevalent,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69580,in,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69581,developing,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69582,countries,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69583,such,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69584,as,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69585,Nigeria,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69586,are,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69587,iron,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69588,deficiency,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69589,anemia,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69590,(,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69591,ID,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69592,/,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69593,A,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69594,),O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69595,",",O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69596,protein,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69597,-,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69598,energy,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69599,malnutrition,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69600,(,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69601,PEM,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69602,),O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69603,",",O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69604,Vitamin,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69605,A,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69606,deficiency,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69607,(,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69608,VAD,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69609,),O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69610,",",O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69611,iodine,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69612,deficiency,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69613,disorder,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69614,(,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69615,IDD,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69616,),O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
69617,.,O,2426.0,"Various types of malnutrition prevalent in developing countries such as Nigeria are iron deficiency anemia ( ID / A ) , protein - energy malnutrition ( PEM ) , Vitamin A deficiency ( VAD ) , iodine deficiency disorder ( IDD ) ."
70360,Age,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70361,",",O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70362,duration,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70363,of,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70364,diabetes,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70365,",",O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70366,or,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70367,insulin,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70368,regimen,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70369,did,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70370,not,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70371,correlate,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70372,with,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70373,subjects,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70374,',O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70375,responses,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70376,to,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70377,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70378,.,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70580,Milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70581,is,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70582,also,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70583,a,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70584,source,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70585,of,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70586,animal,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70587,fats,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70588,in,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70589,the,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70590,diet,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70591,",",O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70592,and,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70593,animal,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70594,fat,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70595,intake,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70596,is,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70597,associated,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70598,with,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70599,ovarian,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70600,cancer,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70601,risk,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70602,.,O,2460.0,"Milk is also a source of animal fats in the diet , and animal fat intake is associated with ovarian cancer risk ."
70662,Total,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70663,frequency,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70664,of,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70665,usual,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70666,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70667,intake,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70668,was,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70669,not,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70670,associated,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70671,with,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70672,increased,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70673,risk,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70674,.,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70725,Among,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70726,persons,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70727,who,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70728,reported,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70729,drinking,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70730,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70731,regularly,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70732,",",O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70733,persons,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70734,reporting,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70735,drinking,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70736,only,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70737,whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70738,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70739,were,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70740,at,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70741,increased,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70742,risk,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70743,(,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70744,relative,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70745,risk,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70746,=,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70747,2.6,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70748,",",O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70749,95,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70750,%,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70751,CI,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70752,1.7,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70753,-,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70754,4.0,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70755,),O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70756,relative,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70757,to,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70758,persons,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70759,who,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70760,drank,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70761,only,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70762,skim,B-http://purl.bioontology.org/ontology/SNOMEDCT/25743006;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70763,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/25743006;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70764,or,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70765,2,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70766,%,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70767,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70768,.,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70826,We,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70827,computed,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70828,flavonol,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70829,intakes,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70830,from,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70831,dietary,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70832,data,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70833,collected,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70834,by,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70835,validated,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70836,food,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70837,frequency,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70838,questionnaires,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70839,in,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70840,1991,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70841,and,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70842,1995,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70843,from,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70844,"90,630",O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70845,women,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70846,in,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70847,the,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70848,Nurses,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70849,Health,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70850,Study,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70851,II,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70852,.,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70899,During,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70900,8,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70901,years,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70902,of,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70903,follow,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70904,-,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70905,up,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70906,",",O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70907,we,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70908,documented,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70909,710,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70910,cases,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70911,of,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70912,invasive,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70913,breast,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70914,cancer,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70915,.,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
71018,Among,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71019,the,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71020,major,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71021,food,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71022,sources,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71023,of,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71024,flavonols,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71025,",",O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71026,we,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71027,found,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71028,a,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71029,significant,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71030,inverse,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71031,association,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71032,with,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71033,intake,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71034,of,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71035,beans,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71036,or,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71037,lentils,B-http://purl.bioontology.org/ontology/SNOMEDCT/227350006,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71038,but,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71039,not,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71040,with,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71041,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71042,",",O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71043,onions,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71044,",",O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71045,apples,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71046,",",O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71047,string,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71048,beans,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71049,",",O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71050,broccoli,B-http://purl.bioontology.org/ontology/SNOMEDCT/735123009,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71051,",",O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71052,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/227563001,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71053,pepper,I-http://purl.bioontology.org/ontology/SNOMEDCT/227563001,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71054,and,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71055,blueberries,B-http://purl.bioontology.org/ontology/SNOMEDCT/412061001,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71056,.,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71862,The,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71863,replacement,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71864,of,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71865,soybean,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71866,hulls,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71867,with,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71868,50,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71869,and,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71870,100,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71871,g,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71872,of,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71873,CH,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71874,/,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71875,d,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71876,did,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71877,not,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71878,affect,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71879,dry,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71880,matter,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71881,intake,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71882,",",O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71883,milk,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71884,production,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71885,",",O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71886,and,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71887,milk,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71888,coagulation,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71889,properties,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
71890,.,O,2500.0,"The replacement of soybean hulls with 50 and 100 g of CH / d did not affect dry matter intake , milk production , and milk coagulation properties ."
72289,Principal,O,2514.0,Principal component analysis was used to identify dietary patterns .
72290,component,O,2514.0,Principal component analysis was used to identify dietary patterns .
72291,analysis,O,2514.0,Principal component analysis was used to identify dietary patterns .
72292,was,O,2514.0,Principal component analysis was used to identify dietary patterns .
72293,used,O,2514.0,Principal component analysis was used to identify dietary patterns .
72294,to,O,2514.0,Principal component analysis was used to identify dietary patterns .
72295,identify,O,2514.0,Principal component analysis was used to identify dietary patterns .
72296,dietary,O,2514.0,Principal component analysis was used to identify dietary patterns .
72297,patterns,O,2514.0,Principal component analysis was used to identify dietary patterns .
72298,.,O,2514.0,Principal component analysis was used to identify dietary patterns .
72551,Potassium,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72552,was,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72553,the,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72554,most,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72555,abundant,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72556,mineral,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72557,at,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72558,27.05,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72559,g,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72560,/,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72561,kg,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72562,",",O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72563,followed,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72564,by,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72565,magnesium,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72566,(,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72567,3.82,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72568,g,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72569,/,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72570,kg,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72571,),O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72572,",",O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72573,phosphorus,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72574,(,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72575,3.24,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72576,g,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72577,/,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72578,kg,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72579,),O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72580,",",O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72581,calcium,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72582,(,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72583,2.22,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72584,g,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72585,/,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72586,kg,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72587,),O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72588,and,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72589,sodium,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72590,(,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72591,0.06,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72592,g,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72593,/,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72594,kg,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72595,),O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
72596,.,O,2522.0,"Potassium was the most abundant mineral at 27.05 g / kg , followed by magnesium ( 3.82 g / kg ) , phosphorus ( 3.24 g / kg ) , calcium ( 2.22 g / kg ) and sodium ( 0.06 g / kg ) ."
73092,Based,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73093,on,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73094,some,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73095,double,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73096,-,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73097,blind,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73098,",",O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73099,randomized,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73100,",",O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73101,placebo,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73102,-,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73103,controlled,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73104,clinical,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73105,trials,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73106,which,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73107,denied,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73108,the,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73109,hypolipidemic,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73110,effects,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73111,of,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73112,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73113,",",O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73114,some,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73115,meta,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73116,-,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73117,analysis,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73118,concluded,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73119,that,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73120,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73121,did,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73122,not,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73123,possess,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73124,beneficial,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73125,effects,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73126,for,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73127,hyperlipidemia,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73128,.,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73395,We,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73396,estimated,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73397,regression,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73398,coefficients,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73399,(,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73400,or,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73401,percentage,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73402,differences,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73403,),O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73404,and,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73405,their,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73406,95,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73407,%,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73408,CI,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73409,using,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73410,multiple,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73411,linear,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73412,regression,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73413,models,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73414,.,O,2550.0,We estimated regression coefficients ( or percentage differences ) and their 95 % CI using multiple linear regression models .
73722,Bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73723,",",O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73724,oatmeal,B-http://purl.bioontology.org/ontology/SNOMEDCT/226725004,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73725,",",O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73726,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73727,",",O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73728,lentils,B-http://purl.bioontology.org/ontology/SNOMEDCT/227350006,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73729,",",O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73730,kidney,B-http://purl.bioontology.org/ontology/SNOMEDCT/227362005,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73731,beans,I-http://purl.bioontology.org/ontology/SNOMEDCT/227362005,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73732,",",O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73733,and,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73734,high,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73735,-,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73736,amylose,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73737,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/412357001,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73738,muffins,I-http://purl.bioontology.org/ontology/SNOMEDCT/412357001,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73739,resulted,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73740,in,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73741,a,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73742,significantly,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73743,lower,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73744,glucose,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73745,area,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73746,than,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73747,50,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73748,g,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73749,glucose,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73750,",",O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73751,and,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73752,the,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73753,glucose,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73754,response,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73755,generally,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73756,could,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73757,be,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73758,predicted,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73759,by,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73760,the,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73761,physical,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73762,structure,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73763,and,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73764,the,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73765,known,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73766,digestibility,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73767,of,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73768,the,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73769,ingested,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73770,carbohydrate,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73771,.,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73849,Maternal,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73850,nutrition,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73851,can,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73852,have,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73853,a,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73854,profound,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73855,effect,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73856,on,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73857,fetal,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73858,growth,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73859,",",O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73860,development,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73861,",",O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73862,and,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73863,subsequent,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73864,infant,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73865,birth,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73866,weight,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73867,.,O,2565.0,"Maternal nutrition can have a profound effect on fetal growth , development , and subsequent infant birth weight ."
73907,Preconception,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73908,food,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73909,frequency,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73910,data,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73911,were,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73912,collected,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73913,retrospectively,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73914,in,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73915,309,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73916,women,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
73917,.,O,2568.0,Preconception food frequency data were collected retrospectively in 309 women .
74445,Of,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74446,326,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74447,atopic,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74448,children,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74449,",",O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74450,10,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74451,(,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74452,3,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74453,%,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74454,),O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74455,presented,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74456,positive,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74457,skin,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74458,test,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74459,to,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74460,latex,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74461,",",O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74462,but,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74463,only,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74464,five,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74465,(,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74466,1.5,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74467,%,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74468,),O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74469,also,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74470,had,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74471,a,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74472,positive,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74473,clinical,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74474,history,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74475,to,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74476,latex,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74477,exposure,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74478,.,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74586,Apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74587,",",O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74588,kiwi,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74589,",",O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74590,and,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74591,chestnut,B-http://purl.bioontology.org/ontology/SNOMEDCT/260188004,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74592,were,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74593,the,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74594,most,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74595,common,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74596,SPT,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74597,-,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74598,positive,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74599,foods,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74600,.,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74672,PAs,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74673,have,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74674,been,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74675,reported,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74676,to,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74677,be,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74678,hepatotoxic,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74679,",",O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74680,mutagenic,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74681,",",O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74682,and,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74683,carcinogenic,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74684,;,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74685,they,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74686,are,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74687,a,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74688,significant,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74689,group,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74690,of,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74691,natural,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74692,toxins,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74693,affecting,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74694,livestock,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74695,",",O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74696,wildlife,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74697,",",O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74698,and,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74699,humans,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74700,.,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74886,A,O,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
74887,modification,O,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
74888,to,O,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
74889,the,O,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
74890,triple,O,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
74891,enzyme,O,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
74892,microbiological,O,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
74893,method,O,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
74894,was,O,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
74895,used,O,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
74896,to,O,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
74897,measure,O,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
74898,folic,O,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
74899,acid,O,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
74900,in,O,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
74901,the,O,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
74902,individual,O,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
74903,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
74904,samples,O,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
74905,.,O,2602.0,A modification to the triple enzyme microbiological method was used to measure folic acid in the individual bread samples .
75537,Since,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75538,1982,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75539,",",O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75540,13,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75541,further,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75542,publications,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75543,reported,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75544,additional,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75545,cases,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75546,of,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75547,dietary,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75548,chloride,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75549,depletion,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75550,.,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75881,The,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75882,diet,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75883,is,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75884,characterized,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75885,by,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75886,abundant,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75887,plant,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75888,foods,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75889,(,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75890,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75891,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75892,vegetables,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75893,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75894,breads,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75895,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75896,other,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75897,forms,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75898,of,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75899,cereals,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75900,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75901,potatoes,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75902,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75903,beans,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75904,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75905,nuts,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75906,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75907,and,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75908,seeds,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75909,),O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75910,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75911,fresh,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75912,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75913,as,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75914,the,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75915,typical,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75916,daily,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75917,dessert,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75918,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75919,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75920,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75921,as,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75922,the,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75923,principal,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75924,source,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75925,of,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75926,fat,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75927,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75928,dairy,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75929,products,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75930,(,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75931,principally,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75932,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75933,and,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75934,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75935,),O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75936,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75937,and,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75938,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75939,and,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75940,poultry,B-http://purl.bioontology.org/ontology/SNOMEDCT/28230009,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75941,consumed,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75942,in,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75943,low,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75944,to,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75945,moderate,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75946,amounts,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75947,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75948,zero,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75949,to,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75950,four,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75951,eggs,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75952,consumed,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75953,weekly,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75954,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75955,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75956,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75957,consumed,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75958,in,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75959,low,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75960,amounts,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75961,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75962,and,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75963,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75964,consumed,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75965,in,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75966,low,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75967,to,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75968,moderate,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75969,amounts,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75970,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75971,normally,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75972,with,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75973,meals,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75974,.,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
76370,Pirlimycin,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76371,milk,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76372,pharmacokinetics,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76373,were,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76374,adequately,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76375,described,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76376,by,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76377,the,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76378,model,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76379,across,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76380,the,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76381,range,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76382,of,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76383,observed,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76384,concentrations,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76385,.,O,2652.0,Pirlimycin milk pharmacokinetics were adequately described by the model across the range of observed concentrations .
76397,Udder,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76398,residual,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76399,volume,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76400,was,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76401,larger,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76402,in,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76403,cows,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76404,with,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76405,1,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76406,",",O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76407,or,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76408,2,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76409,or,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76410,greater,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76411,diseased,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76412,mammary,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76413,glands,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76414,than,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76415,in,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76416,the,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76417,healthy,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76418,cows,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76419,.,O,2654.0,"Udder residual volume was larger in cows with 1 , or 2 or greater diseased mammary glands than in the healthy cows ."
76554,Studies,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76555,investigating,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76556,the,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76557,relation,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76558,of,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76559,diet,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76560,to,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76561,breast,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76562,cancer,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76563,have,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76564,produced,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76565,conflicting,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76566,results,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
76567,.,O,2660.0,Studies investigating the relation of diet to breast cancer have produced conflicting results .
77097,Also,O,2676.0,"Also , the inhabitants of the high - risk region drink more tea at a much higher temperature ."
77098,",",O,2676.0,"Also , the inhabitants of the high - risk region drink more tea at a much higher temperature ."
77099,the,O,2676.0,"Also , the inhabitants of the high - risk region drink more tea at a much higher temperature ."
77100,inhabitants,O,2676.0,"Also , the inhabitants of the high - risk region drink more tea at a much higher temperature ."
77101,of,O,2676.0,"Also , the inhabitants of the high - risk region drink more tea at a much higher temperature ."
77102,the,O,2676.0,"Also , the inhabitants of the high - risk region drink more tea at a much higher temperature ."
77103,high,O,2676.0,"Also , the inhabitants of the high - risk region drink more tea at a much higher temperature ."
77104,-,O,2676.0,"Also , the inhabitants of the high - risk region drink more tea at a much higher temperature ."
77105,risk,O,2676.0,"Also , the inhabitants of the high - risk region drink more tea at a much higher temperature ."
77106,region,O,2676.0,"Also , the inhabitants of the high - risk region drink more tea at a much higher temperature ."
77107,drink,O,2676.0,"Also , the inhabitants of the high - risk region drink more tea at a much higher temperature ."
77108,more,O,2676.0,"Also , the inhabitants of the high - risk region drink more tea at a much higher temperature ."
77109,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,2676.0,"Also , the inhabitants of the high - risk region drink more tea at a much higher temperature ."
77110,at,O,2676.0,"Also , the inhabitants of the high - risk region drink more tea at a much higher temperature ."
77111,a,O,2676.0,"Also , the inhabitants of the high - risk region drink more tea at a much higher temperature ."
77112,much,O,2676.0,"Also , the inhabitants of the high - risk region drink more tea at a much higher temperature ."
77113,higher,O,2676.0,"Also , the inhabitants of the high - risk region drink more tea at a much higher temperature ."
77114,temperature,O,2676.0,"Also , the inhabitants of the high - risk region drink more tea at a much higher temperature ."
77115,.,O,2676.0,"Also , the inhabitants of the high - risk region drink more tea at a much higher temperature ."
77381,The,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77382,purpose,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77383,of,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77384,this,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77385,review,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77386,article,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77387,is,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77388,to,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77389,provide,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77390,a,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77391,comprehensive,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77392,analysis,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77393,of,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77394,various,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77395,research,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77396,and,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77397,review,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77398,reports,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77399,on,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77400,different,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77401,contraceptive,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77402,and,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77403,fertility,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77404,drugs,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77405,used,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77406,in,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77407,human,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77408,and,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77409,animals,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77410,",",O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77411,their,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77412,occurrence,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77413,in,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77414,the,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77415,environment,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77416,and,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77417,their,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77418,ill,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77419,-,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77420,effects,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77421,on,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77422,living,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77423,systems,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77424,.,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
78517,Although,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78518,the,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78519,inverse,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78520,association,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78521,between,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78522,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78523,consumption,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78524,and,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78525,risk,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78526,of,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78527,diabetes,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78528,has,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78529,been,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78530,reported,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78531,numerous,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78532,times,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78533,",",O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78534,the,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78535,role,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78536,of,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78537,caffeine,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78538,intake,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78539,in,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78540,this,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78541,association,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78542,has,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78543,remained,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78544,unclear,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78545,.,O,2723.0,"Although the inverse association between coffee consumption and risk of diabetes has been reported numerous times , the role of caffeine intake in this association has remained unclear ."
78670,Among,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78671,men,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78672,who,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78673,consumed,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78674,one,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78675,cup,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78676,per,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78677,month,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78678,to,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78679,six,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78680,cups,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78681,per,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78682,week,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78683,and,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78684,among,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78685,those,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78686,who,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78687,consumed,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78688,one,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78689,cup,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78690,per,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78691,d,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78692,or,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78693,more,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78694,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78695,the,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78696,associated,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78697,hazard,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78698,ratios,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78699,were,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78700,0.69,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78701,(,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78702,95,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78703,%,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78704,CI,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78705,0.50,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78706,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78707,0.97,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78708,),O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78709,and,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78710,0.69,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78711,(,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78712,95,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78713,%,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78714,CI,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78715,0.49,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78716,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78717,0.98,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78718,),O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78719,compared,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78720,with,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78721,those,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78722,who,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78723,drank,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78724,little,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78725,to,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78726,no,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78727,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78728,",",O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78729,with,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78730,a,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78731,P,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78732,value,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78733,for,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78734,trend,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78735,of,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78736,0.32,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
78737,.,O,2729.0,"Among men who consumed one cup per month to six cups per week and among those who consumed one cup per d or more , the associated hazard ratios were 0.69 ( 95 % CI 0.50 , 0.97 ) and 0.69 ( 95 % CI 0.49 , 0.98 ) compared with those who drank little to no coffee , with a P value for trend of 0.32 ."
79160,They,O,2742.0,They seem to contribute to a better diet quality and may reduce appetite .
79161,seem,O,2742.0,They seem to contribute to a better diet quality and may reduce appetite .
79162,to,O,2742.0,They seem to contribute to a better diet quality and may reduce appetite .
79163,contribute,O,2742.0,They seem to contribute to a better diet quality and may reduce appetite .
79164,to,O,2742.0,They seem to contribute to a better diet quality and may reduce appetite .
79165,a,O,2742.0,They seem to contribute to a better diet quality and may reduce appetite .
79166,better,O,2742.0,They seem to contribute to a better diet quality and may reduce appetite .
79167,diet,O,2742.0,They seem to contribute to a better diet quality and may reduce appetite .
79168,quality,O,2742.0,They seem to contribute to a better diet quality and may reduce appetite .
79169,and,O,2742.0,They seem to contribute to a better diet quality and may reduce appetite .
79170,may,O,2742.0,They seem to contribute to a better diet quality and may reduce appetite .
79171,reduce,O,2742.0,They seem to contribute to a better diet quality and may reduce appetite .
79172,appetite,O,2742.0,They seem to contribute to a better diet quality and may reduce appetite .
79173,.,O,2742.0,They seem to contribute to a better diet quality and may reduce appetite .
79546,Fermented,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2756.0,Fermented milk intake was not associated with PD .
79547,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2756.0,Fermented milk intake was not associated with PD .
79548,intake,O,2756.0,Fermented milk intake was not associated with PD .
79549,was,O,2756.0,Fermented milk intake was not associated with PD .
79550,not,O,2756.0,Fermented milk intake was not associated with PD .
79551,associated,O,2756.0,Fermented milk intake was not associated with PD .
79552,with,O,2756.0,Fermented milk intake was not associated with PD .
79553,PD,O,2756.0,Fermented milk intake was not associated with PD .
79554,.,O,2756.0,Fermented milk intake was not associated with PD .
92925,Its,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92926,proper,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92927,functionality,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92928,is,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92929,essential,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92930,to,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92931,maintain,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92932,the,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92933,body,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92934,homeostasis,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
92935,.,O,3224.0,Its proper functionality is essential to maintain the body homeostasis .
93562,The,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93563,results,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93564,for,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93565,all,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93566,20,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93567,patients,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93568,show,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93569,that,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93570,uric,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93571,acid,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93572,crystallization,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93573,was,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93574,significantly,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93575,lower,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93576,following,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93577,the,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93578,consumption,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93579,of,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93580,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93581,powder,I-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93582,or,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93583,dark,B-http://purl.bioontology.org/ontology/SNOMEDCT/443931000124105;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93584,chocolate,I-http://purl.bioontology.org/ontology/SNOMEDCT/443931000124105;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93585,relative,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93586,to,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93587,baseline,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93588,or,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93589,following,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93590,the,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93591,consumption,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93592,of,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93593,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/227610000;http://purl.bioontology.org/ontology/SNOMEDCT/70813002;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93594,chocolate,I-http://purl.bioontology.org/ontology/SNOMEDCT/227610000;http://purl.bioontology.org/ontology/SNOMEDCT/70813002;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93595,.,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93932,Although,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93933,most,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93934,of,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93935,the,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93936,popular,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93937,botanicals,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93938,have,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93939,a,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93940,long,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93941,history,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93942,in,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93943,folk,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93944,medicine,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93945,",",O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93946,there,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93947,is,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93948,paucity,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93949,of,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93950,data,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93951,regarding,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93952,their,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93953,efficacy,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93954,and,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93955,safety,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93956,",",O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93957,particularly,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93958,as,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93959,it,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93960,relates,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93961,to,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93962,human,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93963,studies,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93964,.,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
94096,Thus,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94097,",",O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94098,well,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94099,defined,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94100,randomized,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94101,clinical,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94102,trials,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94103,are,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94104,warranted,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94105,in,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94106,this,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94107,area,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94108,.,O,3267.0,"Thus , well defined randomized clinical trials are warranted in this area ."
94154,In,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94155,the,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94156,first,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94157,study,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94158,",",O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94159,hamsters,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94160,fed,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94161,on,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94162,coconut,B-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94163,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94164,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94165,150,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94166,g,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94167,/,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94168,kg,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94169,diet,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94170,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94171,and,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94172,cholesterol,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94173,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94174,30,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94175,g,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94176,/,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94177,kg,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94178,diet,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94179,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94180,developed,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94181,lipid,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94182,-,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94183,rich,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94184,lesions,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94185,in,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94186,the,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94187,ascending,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94188,aorta,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94189,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94190,0.28,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94191,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94192,SD,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94193,0.14,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94194,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94195,mm2,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94196,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94197,and,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94198,aortic,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94199,arch,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94200,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94201,0.01,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94202,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94203,SD,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94204,0.01,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94205,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94206,mm2,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94207,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94208,after,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94209,4,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94210,weeks,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94211,that,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94212,continued,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94213,to,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94214,progress,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94215,over,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94216,the,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94217,next,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94218,8,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94219,weeks,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94220,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94221,0.75,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94222,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94223,SD,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94224,0.41,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94225,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94226,mm2,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94227,and,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94228,0.12,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94229,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94230,SD,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94231,0.11,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94232,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94233,mm2,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94234,for,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94235,the,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94236,ascending,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94237,aorta,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94238,and,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94239,aortic,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94240,arch,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94241,respectively,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94242,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94243,.,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94774,In,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94775,conclusion,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94776,",",O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94777,this,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94778,study,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94779,shows,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94780,that,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94781,the,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94782,2-,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94783,and,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94784,3,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94785,-,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94786,hour,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94787,TG,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94788,responses,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94789,to,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94790,fat,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94791,are,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94792,higher,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94793,compared,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94794,with,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94795,that,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94796,induced,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94797,by,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94798,carbohydrate,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94799,.,O,3287.0,"In conclusion , this study shows that the 2- and 3 - hour TG responses to fat are higher compared with that induced by carbohydrate ."
94944,Substances,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94945,present,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94946,in,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94947,vegetables,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94948,and,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94949,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94950,that,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94951,may,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94952,help,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94953,protect,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94954,against,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94955,cancer,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94956,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94957,and,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94958,their,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94959,mechanisms,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94960,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94961,are,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94962,also,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94963,briefly,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94964,reviewed,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94965,;,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94966,these,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94967,include,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94968,dithiolthiones,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94969,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94970,isothiocyanates,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94971,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94972,indole-3,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94973,-,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94974,carbinol,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94975,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94976,allium,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94977,compounds,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94978,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94979,isoflavones,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94980,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94981,protease,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94982,inhibitors,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94983,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94984,saponins,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94985,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94986,phytosterols,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94987,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94988,inositol,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94989,hexaphosphate,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94990,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94991,vitamin,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94992,C,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94993,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94994,D,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94995,-,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94996,limonene,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94997,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94998,lutein,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
94999,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95000,folic,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95001,acid,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95002,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95003,beta,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95004,carotene,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95005,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95006,lycopene,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95007,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95008,selenium,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95009,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95010,vitamin,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95011,E,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95012,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95013,flavonoids,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95014,",",O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95015,and,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95016,dietary,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95017,fiber,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95018,.,O,3292.0,"Substances present in vegetables and fruit that may help protect against cancer , and their mechanisms , are also briefly reviewed ; these include dithiolthiones , isothiocyanates , indole-3 - carbinol , allium compounds , isoflavones , protease inhibitors , saponins , phytosterols , inositol hexaphosphate , vitamin C , D - limonene , lutein , folic acid , beta carotene , lycopene , selenium , vitamin E , flavonoids , and dietary fiber ."
95100,Many,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95101,people,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95102,erroneously,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95103,believe,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95104,they,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95105,are,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95106,lactose,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95107,intolerant,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95108,or,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95109,develop,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95110,gastrointestinal,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95111,symptoms,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95112,after,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95113,intake,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95114,of,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95115,lactose,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95116,.,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95157,This,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95158,",",O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95159,in,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95160,turn,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95161,",",O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95162,can,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95163,increase,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95164,the,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95165,risk,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95166,of,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95167,major,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95168,chronic,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95169,diseases,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95170,such,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95171,as,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95172,osteoporosis,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95173,(,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95174,porous,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95175,bones,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95176,),O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95177,and,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95178,hypertension,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95179,.,O,3299.0,"This , in turn , can increase the risk of major chronic diseases such as osteoporosis ( porous bones ) and hypertension ."
95205,Scientific,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95206,findings,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95207,indicate,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95208,that,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95209,the,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95210,prevalence,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95211,of,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95212,lactose,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95213,intolerance,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95214,is,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95215,grossly,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95216,overestimated,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95217,.,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95375,94,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95376,%,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95377,of,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95378,the,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95379,patients,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95380,showed,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95381,positive,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95382,prick,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95383,tests,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95384,to,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95385,raw,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95386,celeriac,B-http://purl.bioontology.org/ontology/SNOMEDCT/227235004,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95387,",",O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95388,36,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95389,%,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95390,to,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95391,cooked,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95392,celeriac,B-http://purl.bioontology.org/ontology/SNOMEDCT/227235004,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95393,and,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95394,8/13,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95395,to,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95396,cooking,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95397,water,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95398,.,O,3306.0,"94 % of the patients showed positive prick tests to raw celeriac , 36 % to cooked celeriac and 8/13 to cooking water ."
95868,Since,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95869,avoidance,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95870,of,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95871,dietary,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95872,gluten,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95873,is,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95874,the,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95875,only,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95876,option,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95877,for,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95878,celiac,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95879,patients,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95880,",",O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95881,a,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95882,sensitive,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95883,gluten,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95884,detection,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95885,and,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95886,quantitation,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95887,method,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95888,is,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95889,warranted,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95890,.,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
96646,Researchers,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96647,are,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96648,working,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96649,to,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96650,explain,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96651,this,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96652,observation,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96653,in,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96654,molecular,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96655,and,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96656,nutritional,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96657,terms,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96658,.,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
97058,Moreover,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97059,",",O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97060,the,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97061,association,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97062,of,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97063,FD,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97064,",",O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97065,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97066,and,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97067,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97068,with,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97069,hypertension,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97070,needs,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97071,further,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97072,evidence,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97073,.,O,3362.0,"Moreover , the association of FD , cheese and yogurt with hypertension needs further evidence ."
97188,Several,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97189,lectins,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97190,have,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97191,been,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97192,found,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97193,to,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97194,possess,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97195,anticancer,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97196,properties,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97197,in,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97198,vitro,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97199,",",O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97200,in,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97201,vivo,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97202,",",O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97203,and,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97204,in,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97205,human,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97206,case,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97207,studies,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97208,;,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97209,they,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97210,are,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97211,used,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97212,as,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97213,therapeutic,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97214,agents,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97215,",",O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97216,preferentially,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97217,binding,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97218,to,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97219,cancer,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97220,cell,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97221,membranes,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97222,or,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97223,their,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97224,receptors,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97225,",",O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97226,causing,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97227,cytotoxicity,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97228,",",O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97229,apoptosis,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97230,",",O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97231,and,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97232,inhibition,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97233,of,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97234,tumor,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97235,growth,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97236,.,O,3367.0,"Several lectins have been found to possess anticancer properties in vitro , in vivo , and in human case studies ; they are used as therapeutic agents , preferentially binding to cancer cell membranes or their receptors , causing cytotoxicity , apoptosis , and inhibition of tumor growth ."
97661,Associations,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97662,have,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97663,been,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97664,established,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97665,between,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97666,the,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97667,metabolic,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97668,syndrome,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97669,",",O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97670,its,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97671,constituents,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97672,and,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97673,dementia,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
97674,.,O,3384.0,"Associations have been established between the metabolic syndrome , its constituents and dementia ."
98400,The,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98401,study,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98402,enrolled,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98403,961,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98404,patients,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98405,with,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98406,UADT,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98407,cancer,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98408,and,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98409,"2,883",O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98410,noncancer,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98411,outpatients,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98412,who,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98413,visited,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98414,Aichi,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98415,Cancer,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98416,Center,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98417,between,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98418,2001,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98419,and,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98420,2005,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98421,.,O,3410.0,"The study enrolled 961 patients with UADT cancer and 2,883 noncancer outpatients who visited Aichi Cancer Center between 2001 and 2005 ."
98567,No,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98568,change,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98569,in,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98570,these,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98571,associations,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98572,was,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98573,seen,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98574,on,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98575,stratification,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98576,by,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98577,each,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98578,confounding,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98579,factors,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98580,.,O,3417.0,No change in these associations was seen on stratification by each confounding factors .
98581,These,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98582,findings,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98583,suggest,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98584,that,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98585,consumption,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98586,of,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98587,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98588,might,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98589,be,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98590,associated,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98591,with,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98592,a,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98593,decreased,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98594,risk,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98595,of,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98596,UADT,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98597,cancer,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98598,",",O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98599,whereas,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98600,that,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98601,of,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98602,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98603,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98604,might,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98605,be,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98606,associated,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98607,with,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98608,an,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98609,increased,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98610,risk,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98611,.,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
99023,After,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99024,at,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99025,least,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99026,7,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99027,wk,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99028,of,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99029,adaptation,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99030,",",O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99031,whole,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99032,-,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99033,body,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99034,insulin,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99035,sensitivity,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99036,and,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99037,insulin,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99038,secretion,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99039,were,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99040,assessed,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99041,by,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99042,euglycemic,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99043,-,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99044,hyperinsulinemic,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99045,and,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99046,hyperglycemic,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99047,clamps,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99048,",",O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99049,respectively,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99050,.,O,3434.0,"After at least 7 wk of adaptation , whole - body insulin sensitivity and insulin secretion were assessed by euglycemic - hyperinsulinemic and hyperglycemic clamps , respectively ."
99379,Overall,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99380,",",O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99381,this,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99382,study,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99383,shows,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99384,that,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99385,supplementation,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99386,of,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99387,GSGME,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99388,did,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99389,not,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99390,influence,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99391,inflammation,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99392,or,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99393,ER,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99394,stress,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99395,in,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99396,the,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99397,liver,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99398,but,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99399,increased,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99400,milk,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99401,yield,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99402,",",O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99403,an,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99404,effect,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99405,that,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99406,could,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99407,be,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99408,due,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99409,to,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99410,effects,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99411,on,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99412,ruminal,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99413,metabolism,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99414,.,O,3444.0,"Overall , this study shows that supplementation of GSGME did not influence inflammation or ER stress in the liver but increased milk yield , an effect that could be due to effects on ruminal metabolism ."
99672,Dietary,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99673,vitamin,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99674,C,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99675,reduced,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99676,the,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99677,milk,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99678,somatic,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99679,cell,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99680,count,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99681,but,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99682,did,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99683,not,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99684,affect,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99685,the,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99686,febrile,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99687,response,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99688,or,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99689,milk,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99690,production,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99691,following,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99692,LPS,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99693,infusion,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99694,.,O,3453.0,Dietary vitamin C reduced the milk somatic cell count but did not affect the febrile response or milk production following LPS infusion .
99939,Consumption,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99940,of,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99941,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99942,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99943,within,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99944,the,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99945,Mediterranean,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99946,diet,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99947,has,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99948,been,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99949,long,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99950,known,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99951,to,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99952,have,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99953,many,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99954,health,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99955,benefits,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99956,.,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
100320,Literature,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100321,evidence,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100322,from,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100323,animal,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100324,and,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100325,cell,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100326,culture,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100327,studies,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100328,demonstrates,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100329,the,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100330,anticancer,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100331,potential,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100332,of,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100333,rosemary,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100334,extract,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100335,",",O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100336,carnosol,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100337,",",O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100338,carnosic,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100339,acid,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100340,",",O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100341,ursolic,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100342,acid,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100343,",",O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100344,and,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100345,rosmarinic,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100346,acid,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100347,.,O,3475.0,"Literature evidence from animal and cell culture studies demonstrates the anticancer potential of rosemary extract , carnosol , carnosic acid , ursolic acid , and rosmarinic acid ."
100348,No,O,3476.0,No evidence for other rosemary constituents was found .
100349,evidence,O,3476.0,No evidence for other rosemary constituents was found .
100350,for,O,3476.0,No evidence for other rosemary constituents was found .
100351,other,O,3476.0,No evidence for other rosemary constituents was found .
100352,rosemary,B-http://purl.bioontology.org/ontology/SNOMEDCT/227410007,3476.0,No evidence for other rosemary constituents was found .
100353,constituents,O,3476.0,No evidence for other rosemary constituents was found .
100354,was,O,3476.0,No evidence for other rosemary constituents was found .
100355,found,O,3476.0,No evidence for other rosemary constituents was found .
100356,.,O,3476.0,No evidence for other rosemary constituents was found .
100518,Systematic,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100519,data,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100520,collection,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100521,has,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100522,continued,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100523,(,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100524,2011,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100525,-,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100526,2018,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100527,),O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100528,and,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100529,the,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100530,dataset,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100531,now,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100532,contains,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100533,over,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100534,3400,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100535,data,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100536,points,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100537,.,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100640,Updated,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100641,ED01,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100642,estimates,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100643,ranged,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100644,between,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100645,0.03,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100646, ,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100647,mg,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100648,for,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100649,walnut,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100650,protein,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100651,and,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100652,26.2,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100653, ,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100654,mg,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100655,for,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100656,shrimp,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100657,protein,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100658,.,O,3487.0,Updated ED01 estimates ranged between 0.03   mg for walnut protein and 26.2   mg for shrimp protein .
100747,Dairy,O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100748,products,O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100749,were,O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100750,grouped,O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100751,as,O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100752,low,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100753,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100754,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100755,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100756,",",O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100757,whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100758,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100759,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100760,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100761,",",O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100762,buttermilk,B-http://purl.bioontology.org/ontology/SNOMEDCT/226769006,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100763,",",O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100764,low,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100765,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100766,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100767,yogurt,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100768,",",O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100769,whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100770,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100771,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100772,yogurt,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100773,",",O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100774,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100775,and,O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100776,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100777,.,O,3494.0,"Dairy products were grouped as low - fat milk , whole - fat milk , buttermilk , low - fat yogurt , whole - fat yogurt , cheese and butter ."
100829,Median,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100830,intake,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100831,of,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100832,total,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100833,dairy,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100834,products,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100835,was,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100836,four,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100837,servings,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100838,/,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100839,d.,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100840,Low,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100841,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100842,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100843,yogurt,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100844,substituted,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100845,for,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100846,whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100847,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100848,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100849,yogurt,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100850,was,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100851,associated,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100852,with,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100853,a,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100854,higher,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100855,rate,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100856,of,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100857,ischaemic,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100858,stroke,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100859,(,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100860,hazard,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100861,ratio,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100862,(,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100863,HR,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100864,),O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100865,=,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100866,2·58,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100867,(,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100868,95,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100869,%,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100870,CI,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100871,1·11,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100872,",",O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100873,5·97)/serving,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100874,per,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100875,d,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100876,),O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100877,.,O,3498.0,"Median intake of total dairy products was four servings / d. Low - fat yogurt substituted for whole - fat yogurt was associated with a higher rate of ischaemic stroke ( hazard ratio ( HR ) = 2·58 ( 95 % CI 1·11 , 5·97)/serving per d ) ."
100910,We,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100911,did,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100912,not,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100913,observe,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100914,any,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100915,associations,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100916,for,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100917,haemorrhagic,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100918,stroke,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100919,.,O,3500.0,We did not observe any associations for haemorrhagic stroke .
101323,The,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101324,present,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101325,review,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101326,illustrates,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101327,the,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101328,main,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101329,foods,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101330,and,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101331,their,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101332,active,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101333,components,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101334,",",O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101335,including,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101336,their,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101337,antioxidant,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101338,",",O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101339,cytotoxic,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101340,",",O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101341,and,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101342,pro,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101343,-,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101344,apoptotic,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101345,properties,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101346,",",O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101347,with,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101348,a,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101349,particular,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101350,focus,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101351,on,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101352,the,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101353,evidence,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101354,related,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101355,to,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101356,cancers,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101357,of,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101358,the,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101359,digestive,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101360,system,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101361,.,O,3515.0,"The present review illustrates the main foods and their active components , including their antioxidant , cytotoxic , and pro - apoptotic properties , with a particular focus on the evidence related to cancers of the digestive system ."
101452,Red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101453,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101454,",",O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101455,salted,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101456,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101457,",",O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101458,and,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101459,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101460,were,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101461,positively,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101462,associated,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101463,with,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101464,risk,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101465,of,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101466,lymphoid,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101467,cancers,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101468,[,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101469,odds,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101470,ratios,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101471,(,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101472,OR,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101473,),O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101474,for,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101475,the,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101476,highest,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101477,tertile,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101478,vs.,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101479,the,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101480,lowest,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101481,one,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101482,of,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101483,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101484,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101485,=,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101486,1.68,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101487,",",O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101488,95,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101489,%,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101490,confidence,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101491,interval,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101492,(,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101493,CI,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101494,),O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101495,1.37,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101496,-,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101497,2.08,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101498,",",O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101499,OR,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101500,for,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101501,whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101502,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101503,=,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101504,2.92,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101505,",",O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101506,95,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101507,%,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101508,CI,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101509,2.63,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101510,-,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101511,3.63,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101512,),O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101513,.,O,3519.0,"Red meat , salted meat , and milk were positively associated with risk of lymphoid cancers [ odds ratios ( OR ) for the highest tertile vs. the lowest one of red meat = 1.68 , 95 % confidence interval ( CI ) 1.37 - 2.08 , OR for whole milk = 2.92 , 95 % CI 2.63 - 3.63 ) ."
101732,Chocolate,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101733,elicits,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101734,unique,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101735,brain,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101736,activity,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101737,compared,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101738,to,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101739,other,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101740,foods,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101741,",",O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101742,activating,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101743,similar,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101744,brain,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101745,regions,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101746,and,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101747,neurobiological,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101748,substrates,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101749,with,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101750,potentially,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101751,similar,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101752,psychoactive,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101753,effects,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101754,as,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101755,substances,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101756,of,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101757,abuse,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
101758,.,O,3530.0,"Chocolate elicits unique brain activity compared to other foods , activating similar brain regions and neurobiological substrates with potentially similar psychoactive effects as substances of abuse ."
102385,Dietary,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102386,advice,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102387,aims,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102388,to,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102389,reduce,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102390,the,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102391,majority,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102392,of,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102393,lithogenic,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102394,risk,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102395,factors,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102396,",",O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102397,reducing,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102398,the,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102399,supersaturation,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102400,of,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102401,urine,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102402,",",O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102403,mainly,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102404,for,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102405,calcium,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102406,oxalate,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102407,",",O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102408,calcium,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102409,phosphate,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102410,",",O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102411,and,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102412,uric,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102413,acid,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102414,.,O,3553.0,"Dietary advice aims to reduce the majority of lithogenic risk factors , reducing the supersaturation of urine , mainly for calcium oxalate , calcium phosphate , and uric acid ."
102927,As,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102928,compared,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102929,to,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102930,controls,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102931,",",O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102932,patients,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102933,showed,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102934,an,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102935,impaired,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102936,fat,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102937,",",O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102938,but,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102939,not,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102940,sugar,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102941,perception,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102942,.,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
103162,Odds,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103163,ratios,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103164,(,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103165,ORs,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103166,),O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103167,and,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103168,95,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103169,%,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103170,confidence,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103171,intervals,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103172,were,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103173,estimated,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103174,using,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103175,conditional,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103176,logistic,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103177,regression,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103178,models,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103179,adjusting,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103180,for,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103181,Helicobacter,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103182,pylori,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103183,infection,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103184,",",O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103185,and,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103186,other,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103187,potential,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103188,confounders,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103189,.,O,3581.0,"Odds ratios ( ORs ) and 95 % confidence intervals were estimated using conditional logistic regression models adjusting for Helicobacter pylori infection , and other potential confounders ."
103332,Relative,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103333,risks,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103334,of,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103335,different,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103336,patterns,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103337,of,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103338,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103339,consumption,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103340,for,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103341,specific,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103342,cancer,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103343,diagnoses,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103344,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103345,adjusted,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103346,for,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103347,sex,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103348,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103349,age,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103350,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103351,smoking,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103352,history,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103353,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103354,education,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103355,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103356,and,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103357,county,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103358,of,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103359,residence,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103360,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103361,were,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103362,calculated,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103363,with,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103364,multiple,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103365,logistic,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103366,regression,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103367,analysis,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103368,.,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
104173,The,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104174,mechanisms,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104175,underlying,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104176,the,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104177,effects,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104178,of,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104179,CLA,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104180,are,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104181,still,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104182,moot,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104183,.,O,3621.0,The mechanisms underlying the effects of CLA are still moot .
104264,For,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104265,this,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104266,purpose,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104267,",",O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104268,while,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104269,lockdown,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104270,restrictions,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104271,were,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104272,in,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104273,place,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104274,(,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104275,February,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104276,-,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104277,April,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104278,2020,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104279,),O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104280,",",O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104281,359,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104282,subjects,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104283,from,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104284,the,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104285,Brisighella,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104286,Heart,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104287,Study,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104288,cohort,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104289,underwent,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104290,a,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104291,phone,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104292,interview,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104293,about,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104294,their,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104295,lifestyle,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104296,habit,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104297,changes,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104298,during,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104299,COVID-19,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104300,-,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104301,related,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104302,quarantine,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104303,.,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104304,Quarantine,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104305,did,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104306,not,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104307,significantly,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104308,modify,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104309,smoking,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104310,habit,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104311,nor,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104312,body,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104313,mass,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104314,index,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104315,.,O,3626.0,Quarantine did not significantly modify smoking habit nor body mass index .
104415,This,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104416,study,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104417,determined,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104418,the,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104419,feasibility,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104420,of,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104421,using,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104422,okra,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104423,gum,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104424,as,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104425,a,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104426,fat,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104427,replacer,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104428,in,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104429,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104430,bar,I-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104431,cookies,I-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104432,.,O,3630.0,This study determined the feasibility of using okra gum as a fat replacer in chocolate bar cookies .
104433,Fat,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104434,-,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104435,free,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104436,cookies,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104437,were,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104438,prepared,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104439,with,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104440,okra,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104441,gum,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104442,(,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104443,OK,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104444,),O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104445,or,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104446,applesauce,B-http://purl.bioontology.org/ontology/SNOMEDCT/420823005,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104447,(,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104448,AP,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104449,),O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104450,",",O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104451,replacing,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104452,margarine,B-http://purl.bioontology.org/ontology/SNOMEDCT/226890008,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104453,and,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104454,egg,B-http://purl.bioontology.org/ontology/SNOMEDCT/256442007,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104455,yolk,I-http://purl.bioontology.org/ontology/SNOMEDCT/256442007,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104456,in,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104457,high,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104458,-,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104459,fat,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104460,cookies,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104461,(,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104462,CTL,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104463,),O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104464,.,O,3631.0,"Fat - free cookies were prepared with okra gum ( OK ) or applesauce ( AP ) , replacing margarine and egg yolk in high - fat cookies ( CTL ) ."
104663,Skin,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104664,prick,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104665,test,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104666,(,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104667,SPT,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104668,),O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104669,with,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104670,fresh,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104671,avocado,B-http://purl.bioontology.org/ontology/SNOMEDCT/735249009,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104672,was,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104673,positive,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104674,in,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104675,all,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104676,patients,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104677,with,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104678,the,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104679,Strong,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104680,avocado,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104681,variety,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104682,(,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104683,SAv,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104684,),O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104685,and,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104686,in,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104687,14,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104688,patients,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104689,with,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104690,the,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104691,Hass,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104692,avocado,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104693,variety,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104694,(,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104695,HAv,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104696,),O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104697,.,O,3641.0,Skin prick test ( SPT ) with fresh avocado was positive in all patients with the Strong avocado variety ( SAv ) and in 14 patients with the Hass avocado variety ( HAv ) .
104857,Milk,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104858,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104859,is,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104860,rich,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104861,in,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104862,both,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104863,sucrose,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104864,and,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104865,fat,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104866,",",O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104867,and,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104868,is,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104869,therefore,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104870,considered,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104871,unsuitable,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104872,for,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104873,diabetics,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
104874,.,O,3648.0,"Milk chocolate is rich in both sucrose and fat , and is therefore considered unsuitable for diabetics ."
105584,The,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105585,purpose,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105586,of,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105587,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105588,present,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105589,review,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105590,is,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105591,to,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105592,summarize,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105593,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105594,current,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105595,literature,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105596,concerning,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105597,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105598,beneficial,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105599,effects,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105600,of,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105601,honey,B-http://purl.bioontology.org/ontology/SNOMEDCT/227598003,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105602,in,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105603,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105604,management,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105605,of,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105606,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105607,obesity,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105608,-,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105609,related,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105610,dysfunctions,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105611,",",O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105612,including,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105613,neurodegeneration,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105614,.,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105719,Many,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105720,non,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105721,-,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105722,gluten,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105723,cereals,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105724,and,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105725,starches,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105726,(,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105727,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105728,",",O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105729,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/412357001,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105730,",",O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105731,sorghum,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105732,",",O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105733,millets,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105734,",",O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105735,and,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105736,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105737,/,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105738,pea,B-http://purl.bioontology.org/ontology/SNOMEDCT/260184002,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105739,starch,I-http://purl.bioontology.org/ontology/SNOMEDCT/260184002,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105740,),O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105741,and,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105742,various,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105743,gluten,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105744,replacers,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105745,(,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105746,xanthan,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105747,and,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105748,guar,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105749,gum,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105750,),O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105751,have,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105752,been,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105753,used,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105754,for,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105755,retaining,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105756,the,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105757,physical,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105758,-,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105759,sensorial,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105760,properties,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105761,of,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105762,gluten,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105763,-,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105764,free,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105765,",",O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105766,cereal,B-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105767,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105768,based,I-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105769,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105770,.,O,3677.0,"Many non - gluten cereals and starches ( rice , corn , sorghum , millets , and potato / pea starch ) and various gluten replacers ( xanthan and guar gum ) have been used for retaining the physical - sensorial properties of gluten - free , cereal - based products ."
105771,This,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105772,paper,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105773,reviews,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105774,the,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105775,recent,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105776,advances,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105777,in,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105778,the,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105779,formulation,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105780,of,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105781,cereal,B-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105782,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105783,based,I-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105784,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105785,gluten,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105786,-,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105787,free,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105788,products,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105789,by,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105790,utilizing,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105791,alternate,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105792,flours,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105793,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105794,starches,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105795,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105796,gums,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105797,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105798,hydrocolloids,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105799,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105800,enzymes,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105801,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105802,novel,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105803,ingredients,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105804,",",O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105805,and,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105806,processing,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105807,techniques,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105808,.,O,3678.0,"This paper reviews the recent advances in the formulation of cereal - based , gluten - free products by utilizing alternate flours , starches , gums , hydrocolloids , enzymes , novel ingredients , and processing techniques ."
105809,The,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105810,pseudo,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105811,cereals,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105812,amaranth,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105813,",",O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105814,quinoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/227515004,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105815,",",O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105816,and,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105817,buckwheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/226723006,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105818,",",O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105819,are,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105820,promising,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105821,in,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105822,gluten,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105823,-,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105824,free,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105825,diet,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105826,formulation,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
105827,.,O,3679.0,"The pseudo cereals amaranth , quinoa , and buckwheat , are promising in gluten - free diet formulation ."
106138,The,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106139,purpose,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106140,of,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106141,this,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106142,study,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106143,was,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106144,to,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106145,provide,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106146,a,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106147,multifaceted,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106148,nutritional,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106149,analysis,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106150,of,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106151,the,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106152,modern,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106153,Mongolian,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106154,diet,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106155,.,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106363,Dairy,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106364,and,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106365,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106366,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106367,were,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106368,more,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106369,consumed,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106370,in,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106371,summer,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106372,and,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106373,winter,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106374,",",O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106375,respectively,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106376,.,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106887,Consumption,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106888,of,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106889,a,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106890,diet,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106891,rich,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106892,in,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106893,fruits,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106894,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106895,vegetables,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106896,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106897,folate,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106898,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106899,K,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106900,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106901,Ca,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106902,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106903,Mg,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106904,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106905,dietary,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106906,fibre,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106907,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106908,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106909,and,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106910,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106911,may,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106912,protect,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106913,against,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106914,stroke,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106915,.,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
107049,Healthy,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107050,lifestyle,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107051,choices,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107052,reduce,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107053,the,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107054,risk,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107055,of,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107056,stroke,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107057,by,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107058,~80,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107059,%,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107060,",",O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107061,and,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107062,of,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107063,the,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107064,factors,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107065,that,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107066,increase,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107067,the,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107068,risk,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107069,of,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107070,stroke,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107071,",",O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107072,the,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107073,worst,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107074,is,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107075,diet,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107076,:,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107077,only,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107078,~0.1,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107079,%,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107080,of,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107081,Americans,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107082,consume,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107083,a,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107084,healthy,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107085,diet,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107086,",",O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107087,and,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107088,only,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107089,8.3,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107090,%,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107091,consume,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107092,a,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107093,somewhat,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107094,healthy,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107095,diet,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107096,.,O,3722.0,"Healthy lifestyle choices reduce the risk of stroke by ~80 % , and of the factors that increase the risk of stroke , the worst is diet : only ~0.1 % of Americans consume a healthy diet , and only 8.3 % consume a somewhat healthy diet ."
107514,The,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107515,approach,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107516,by,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107517,which,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107518,the,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107519,insulinemia,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107520,was,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107521,kept,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107522,constant,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107523,by,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107524,the,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107525,artificial,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107526,pancreas,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107527,seems,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107528,to,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107529,be,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107530,a,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107531,valuable,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107532,tool,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107533,for,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107534,studying,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107535,glycemic,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107536,responses,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107537,to,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107538,different,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107539,meals,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107540,in,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107541,IDDM,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107542,patients,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107543,who,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107544,otherwise,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107545,show,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107546,great,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107547,variations,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107548,in,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107549,circulating,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107550,insulin,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107551,and,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107552,glucose,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107553,levels,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107554,when,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107555,treated,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107556,by,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107557,subcutaneously,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107558,administered,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107559,insulin,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107560,.,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107561,Ochratoxin,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107562,A,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107563,(,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107564,OTA,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107565,),O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107566,is,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107567,a,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107568,mycotoxin,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107569,",",O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107570,or,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107571,fungal,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107572,toxin,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107573,",",O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107574,that,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107575,contaminates,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107576,multiple,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107577,foodstuffs,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107578,worldwide,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107579,.,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
108504,Animal,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108505,data,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108506,for,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108507,the,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108508,effects,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108509,of,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108510,individual,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108511,fatty,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108512,acids,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108513,on,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108514,plasma,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108515,LDL,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108516,-,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108517,C,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108518,concentrations,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108519,and,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108520,metabolism,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108521,are,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108522,sparse,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108523,.,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108904,Among,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108905,men,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108906,",",O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108907,the,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108908,pattern,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108909,of,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108910,associations,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108911,was,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108912,overall,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108913,found,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108914,to,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108915,be,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108916,similar,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108917,to,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108918,that,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108919,for,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108920,women,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
108921,.,O,3787.0,"Among men , the pattern of associations was overall found to be similar to that for women ."
109127,©,O,3799.0,© 2018 Society of Chemical Industry .
109128,2018,O,3799.0,© 2018 Society of Chemical Industry .
109129,Society,O,3799.0,© 2018 Society of Chemical Industry .
109130,of,O,3799.0,© 2018 Society of Chemical Industry .
109131,Chemical,O,3799.0,© 2018 Society of Chemical Industry .
109132,Industry,O,3799.0,© 2018 Society of Chemical Industry .
109133,.,O,3799.0,© 2018 Society of Chemical Industry .
109336,Suppression,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109337,of,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109338,ovarian,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109339,steroids,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109340,by,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109341,ovariectomy,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109342,resulted,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109343,in,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109344,a,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109345,greater,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109346,persistency,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109347,of,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109348,lactation,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109349,and,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109350,a,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109351,decrease,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109352,in,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109353,MEC,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109354,exfoliation,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109355,.,O,3808.0,Suppression of ovarian steroids by ovariectomy resulted in a greater persistency of lactation and a decrease in MEC exfoliation .
109895,These,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109896,results,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109897,warrant,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109898,further,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109899,investigations,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109900,and,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109901,",",O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109902,if,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109903,confirmed,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109904,",",O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109905,they,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109906,might,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109907,have,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109908,important,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109909,public,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109910,health,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109911,implications,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109912,for,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109913,the,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109914,reduction,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109915,of,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109916,thyroid,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109917,cancer,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109918,through,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109919,the,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109920,improvement,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109921,of,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109922,dietary,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109923,habits,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
109924,.,O,3826.0,"These results warrant further investigations and , if confirmed , they might have important public health implications for the reduction of thyroid cancer through the improvement of dietary habits ."
110042,The,O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110043,method,O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110044,was,O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110045,tested,O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110046,using,O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110047,different,O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110048,foods,O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110049,spiked,O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110050,with,O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110051,mustard,B-http://purl.bioontology.org/ontology/SNOMEDCT/51905005,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110052,",",O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110053,celery,B-http://purl.bioontology.org/ontology/SNOMEDCT/256326004,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110054,",",O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110055,soy,O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110056,",",O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110057,or,O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110058,lupine,B-http://purl.bioontology.org/ontology/SNOMEDCT/719108000;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110059,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/719108000;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110060,in,O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110061,the,O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110062,1,O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110063,-,O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110064,0.001,O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110065,%,O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110066,range,O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110067,.,O,3832.0,"The method was tested using different foods spiked with mustard , celery , soy , or lupine flour in the 1 - 0.001 % range ."
110103,The,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110104,DNA,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110105,-,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110106,based,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110107,allergen,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110108,-,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110109,MLPA,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110110,method,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110111,will,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110112,constitute,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110113,a,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110114,complementary,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110115,method,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110116,to,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110117,the,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110118,traditional,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110119,protein,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110120,-,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110121,based,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110122,methods,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110123,.,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110474,After,O,3850.0,"After a mean follow - up of 8.7 years , 1015 participants were newly diagnosed with bladder cancer ."
110475,a,O,3850.0,"After a mean follow - up of 8.7 years , 1015 participants were newly diagnosed with bladder cancer ."
110476,mean,O,3850.0,"After a mean follow - up of 8.7 years , 1015 participants were newly diagnosed with bladder cancer ."
110477,follow,O,3850.0,"After a mean follow - up of 8.7 years , 1015 participants were newly diagnosed with bladder cancer ."
110478,-,O,3850.0,"After a mean follow - up of 8.7 years , 1015 participants were newly diagnosed with bladder cancer ."
110479,up,O,3850.0,"After a mean follow - up of 8.7 years , 1015 participants were newly diagnosed with bladder cancer ."
110480,of,O,3850.0,"After a mean follow - up of 8.7 years , 1015 participants were newly diagnosed with bladder cancer ."
110481,8.7,O,3850.0,"After a mean follow - up of 8.7 years , 1015 participants were newly diagnosed with bladder cancer ."
110482,years,O,3850.0,"After a mean follow - up of 8.7 years , 1015 participants were newly diagnosed with bladder cancer ."
110483,",",O,3850.0,"After a mean follow - up of 8.7 years , 1015 participants were newly diagnosed with bladder cancer ."
110484,1015,O,3850.0,"After a mean follow - up of 8.7 years , 1015 participants were newly diagnosed with bladder cancer ."
110485,participants,O,3850.0,"After a mean follow - up of 8.7 years , 1015 participants were newly diagnosed with bladder cancer ."
110486,were,O,3850.0,"After a mean follow - up of 8.7 years , 1015 participants were newly diagnosed with bladder cancer ."
110487,newly,O,3850.0,"After a mean follow - up of 8.7 years , 1015 participants were newly diagnosed with bladder cancer ."
110488,diagnosed,O,3850.0,"After a mean follow - up of 8.7 years , 1015 participants were newly diagnosed with bladder cancer ."
110489,with,O,3850.0,"After a mean follow - up of 8.7 years , 1015 participants were newly diagnosed with bladder cancer ."
110490,bladder,O,3850.0,"After a mean follow - up of 8.7 years , 1015 participants were newly diagnosed with bladder cancer ."
110491,cancer,O,3850.0,"After a mean follow - up of 8.7 years , 1015 participants were newly diagnosed with bladder cancer ."
110492,.,O,3850.0,"After a mean follow - up of 8.7 years , 1015 participants were newly diagnosed with bladder cancer ."
110908,A,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110909,low,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110910,incidence,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110911,for,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110912,both,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110913,cancers,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110914,has,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110915,been,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110916,recorded,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110917,in,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110918,Mongolia,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110919,and,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110920,Bolivia,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110921,.,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
111544,The,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111545,ORs,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111546,of,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111547,the,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111548,highest,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111549,quartile,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111550,relative,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111551,to,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111552,the,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111553,lowest,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111554,quartile,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111555,of,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111556,total,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111557,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111558,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111559,fruit,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111560,intake,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111561,were,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111562,0.28,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111563,(,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111564,95,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111565,%,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111566,CI,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111567,0.18,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111568,-,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111569,0.43,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111570,),O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111571,and,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111572,0.53,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111573,(,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111574,95,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111575,%,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111576,CI,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111577,0.34,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111578,-,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111579,0.82,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111580,),O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111581,",",O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111582,respectively,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111583,.,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111623,An,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111624,inverse,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111625,association,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111626,was,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111627,also,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111628,observed,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111629,for,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111630,vitamin,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111631,A,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111632,",",O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111633,carotene,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111634,",",O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111635,vitamin,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111636,C,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111637,",",O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111638,vitamin,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111639,E,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111640,",",O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111641,and,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111642,fiber,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111643,intake,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111644,.,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111696,For,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111697,this,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111698,purpose,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111699,",",O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111700,histopathological,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111701,analysis,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111702,and,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111703,immunohistochemistry,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111704,for,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111705,RUNX-2,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111706,and,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111707,RANK,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111708,-,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111709,L,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111710,were,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111711,investigated,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111712,in,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111713,this,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111714,setting,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111715,.,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
112210,After,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112211,41,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112212,wk,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112213,the,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112214,cumulative,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112215,survival,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112216,of,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112217,the,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112218,mice,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112219,given,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112220,20,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112221,mg,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112222,ethyl,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112223,carbamate,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112224,/,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112225,kg,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112226,in,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112227,water,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112228,was,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112229,depressed,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112230,compared,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112231,with,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112232,the,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112233,mice,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112234,drinking,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112235,wines,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112236,or,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112237,ethanol,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112238,solution,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112239,with,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112240,this,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112241,ethyl,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112242,carbamate,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112243,level,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112244,.,O,3919.0,After 41 wk the cumulative survival of the mice given 20 mg ethyl carbamate / kg in water was depressed compared with the mice drinking wines or ethanol solution with this ethyl carbamate level .
112314,Wine,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112315,treatments,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112316,also,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112317,reduced,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112318,the,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112319,frequency,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112320,of,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112321,hepatocellular,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112322,adenomas,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112323,compared,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112324,with,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112325,those,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112326,of,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112327,other,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112328,treatment,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112329,groups,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112330,",",O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112331,and,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112332,no,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112333,hepatocellular,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112334,carcinomas,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112335,developed,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112336,in,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112337,any,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112338,of,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112339,the,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112340,groups,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112341,given,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112342,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112343,",",O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112344,even,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112345,with,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112346,the,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112347,20,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112348,-,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112349,mg,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112350,/,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112351,kg,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112352,ethyl,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112353,carbamate,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112354,dose,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112355,.,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112704,From,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112705,1984,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112706,to,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112707,1988,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112708,a,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112709,population,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112710,-,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112711,based,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112712,case,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112713,-,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112714,control,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112715,study,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112716,was,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112717,carried,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112718,out,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112719,in,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112720,the,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112721,Netherlands,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112722,",",O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112723,in,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112724,collaboration,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112725,with,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112726,the,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112727,International,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112728,Agency,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112729,for,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112730,Research,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112731,on,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112732,Cancer,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112733,",",O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112734,to,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112735,examine,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112736,the,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112737,possible,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112738,relationship,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112739,between,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112740,the,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112741,habitual,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112742,lifetime,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112743,consumption,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112744,of,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112745,alcohol,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112746,",",O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112747,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112748,and,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112749,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112750,and,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112751,exocrine,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112752,pancreatic,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112753,carcinoma,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112754,in,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112755,176,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112756,cases,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112757,and,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112758,487,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112759,controls,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
112760,.,O,3933.0,"From 1984 to 1988 a population - based case - control study was carried out in the Netherlands , in collaboration with the International Agency for Research on Cancer , to examine the possible relationship between the habitual lifetime consumption of alcohol , coffee and tea and exocrine pancreatic carcinoma in 176 cases and 487 controls ."
113221,About,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113222,once,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113223,a,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113224,day,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113225,consumers,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113226,of,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113227,HFCS,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113228,-,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113229,sweetened,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113230,soda,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113231,had,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113232,a,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113233,49,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113234,%,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113235,higher,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113236,risk,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113237,(,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113238,P<0·011,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113239,),O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113240,",",O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113241,moderate,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113242,apple,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113243,juice,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113244,consumers,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113245,(,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113246,2,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113247,-,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113248,4,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113249,times,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113250,/,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113251,week,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113252,),O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113253,had,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113254,a,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113255,61,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113256,%,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113257,higher,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113258,risk,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113259,(,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113260,P<0·007,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113261,),O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113262,and,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113263,moderate,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113264,fruit,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113265,drink,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113266,consumers,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113267,had,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113268,a,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113269,58,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113270,%,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113271,higher,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113272,risk,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113273,(,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113274,P<0·009,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113275,),O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113276,",",O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113277,as,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113278,compared,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113279,with,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113280,never,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113281,/,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113282,seldom,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113283,consumers,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113284,.,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113296,These,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113297,associations,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113298,are,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113299,possibly,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113300,because,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113301,of,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113302,the,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113303,high,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113304,fructose,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113305,:,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113306,glucose,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113307,ratios,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113308,",",O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113309,and,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113310,fructose,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113311,malabsorption,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113312,.,O,3948.0,"These associations are possibly because of the high fructose : glucose ratios , and fructose malabsorption ."
113463,It,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113464,should,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113465,however,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113466,be,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113467,noted,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113468,that,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113469,these,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113470,bioactive,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113471,factors,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113472,can,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113473,be,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113474,significantly,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113475,affected,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113476,by,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113477,differences,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113478,in,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113479,strawberry,B-http://purl.bioontology.org/ontology/SNOMEDCT/102261002,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113480,cultivars,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113481,",",O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113482,agricultural,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113483,practices,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113484,",",O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113485,storage,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113486,",",O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113487,and,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113488,processing,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113489,methods,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113490,:,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113491,freezing,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113492,versus,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113493,dry,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113494,heat,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113495,has,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113496,been,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113497,associated,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113498,with,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113499,maximum,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113500,retention,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113501,of,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113502,strawberry,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113503,bioactives,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113504,in,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113505,several,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113506,studies,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113507,.,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113508,Nutritional,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113509,epidemiology,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113510,shows,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113511,inverse,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113512,association,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113513,between,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113514,strawberry,B-http://purl.bioontology.org/ontology/SNOMEDCT/102261002,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113515,consumption,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113516,and,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113517,incidence,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113518,of,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113519,hypertension,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113520,or,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113521,serum,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113522,C,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113523,-,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113524,reactive,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113525,protein,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113526,;,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113527,controlled,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113528,feeding,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113529,studies,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113530,have,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113531,identified,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113532,the,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113533,ability,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113534,of,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113535,strawberries,B-http://purl.bioontology.org/ontology/SNOMEDCT/102261002,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113536,to,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113537,attenuate,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113538,high,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113539,-,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113540,fat,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113541,diet,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113542,induced,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113543,postprandial,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113544,oxidative,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113545,stress,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113546,and,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113547,inflammation,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113548,",",O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113549,or,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113550,postprandial,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113551,hyperglycemia,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113552,",",O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113553,or,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113554,hyperlipidemia,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113555,in,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113556,subjects,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113557,with,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113558,cardiovascular,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113559,risk,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113560,factors,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113561,.,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113562,Mechanistic,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113563,studies,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113564,have,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113565,elucidated,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113566,specific,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113567,biochemical,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113568,pathways,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113569,that,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113570,might,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113571,confer,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113572,these,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113573,protective,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113574,effects,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113575,of,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113576,strawberries,B-http://purl.bioontology.org/ontology/SNOMEDCT/102261002,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113577,:,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113578,upregulation,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113579,of,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113580,endothelial,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113581,nitric,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113582,oxide,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113583,synthase,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113584,(,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113585,eNOS,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113586,),O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113587,activity,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113588,",",O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113589,downregulation,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113590,of,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113591,NF,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113592,-,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113593,kB,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113594,activity,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113595,and,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113596,subsequent,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113597,inflammation,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113598,",",O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113599,or,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113600,inhibitions,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113601,of,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113602,carbohydrate,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113603,digestive,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113604,enzymes,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113605,.,O,3956.0,"Mechanistic studies have elucidated specific biochemical pathways that might confer these protective effects of strawberries : upregulation of endothelial nitric oxide synthase ( eNOS ) activity , downregulation of NF - kB activity and subsequent inflammation , or inhibitions of carbohydrate digestive enzymes ."
113957,Individuals,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113958,with,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113959,celiac,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113960,disease,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113961,generally,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113962,are,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113963,advised,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113964,to,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113965,follow,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113966,a,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113967,lifelong,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113968,gluten,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113969,-,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113970,free,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113971,diet,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113972,and,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113973,avoid,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113974,consumption,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113975,of,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113976,the,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113977,prolamins,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113978,gliadin,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113979,(,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113980,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113981,),O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113982,",",O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113983,secalin,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113984,(,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113985,rye,B-http://purl.bioontology.org/ontology/SNOMEDCT/412068007,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113986,),O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113987,",",O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113988,and,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113989,hordein,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113990,(,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113991,barley,B-http://purl.bioontology.org/ontology/SNOMEDCT/735124003,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113992,),O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113993,.,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
114055,In,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114056,others,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114057,(,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114058,eg,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114059,",",O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114060,Scandinavia,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114061,",",O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114062,United,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114063,Kingdom,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114064,),O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114065,",",O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114066,the,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114067,gluten,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114068,-,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114069,free,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114070,diet,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114071,may,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114072,include,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114073,foods,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114074,such,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114075,as,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114076,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114077,starch,I-http://purl.bioontology.org/ontology/SNOMEDCT/412071004,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114078,that,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114079,have,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114080,been,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114081,rendered,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114082,gluten,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114083,free,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114084,but,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114085,nonetheless,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114086,contain,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114087,small,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114088,amounts,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114089,of,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114090,toxic,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114091,prolamins,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114092,.,O,3973.0,"In others ( eg , Scandinavia , United Kingdom ) , the gluten - free diet may include foods such as wheat starch that have been rendered gluten free but nonetheless contain small amounts of toxic prolamins ."
114661,There,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114662,were,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114663,1109,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114664,(,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114665,5·2,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114666,%,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114667,),O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114668,first,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114669,sepsis,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114670,events,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114671,.,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114742,Dietary,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114743,modification,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114744,may,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114745,potentially,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114746,provide,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114747,an,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114748,option,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114749,for,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114750,reducing,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114751,sepsis,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114752,risk,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
114753,.,O,3997.0,Dietary modification may potentially provide an option for reducing sepsis risk .
115121,Recently,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115122,there,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115123,has,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115124,been,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115125,a,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115126,surge,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115127,in,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115128,the,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115129,number,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115130,of,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115131,publications,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115132,that,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115133,has,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115134,investigated,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115135,their,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115136,biological,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115137,properties,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
115138,.,O,4010.0,Recently there has been a surge in the number of publications that has investigated their biological properties .
116217,Mechanisms,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116218,of,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116219,action,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116220,are,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116221,being,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116222,elucidated,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116223,by,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116224,modern,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116225,technology,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116226,.,O,4050.0,Mechanisms of action are being elucidated by modern technology .
116375,When,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116376,the,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116377,rats,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116378,were,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116379,treated,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116380,with,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116381,a,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116382,low,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116383,dose,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116384,(,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116385,50,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116386,mg,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116387,/,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116388,kg,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116389,),O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116390,of,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116391,raw,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116392,aqueous,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116393,extract,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116394,of,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116395,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116396,",",O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116397,no,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116398,significant,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116399,changes,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116400,in,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116401,the,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116402,serum,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116403,glucose,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116404,levels,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116405,were,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116406,observed,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116407,compared,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116408,with,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116409,the,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116410,control,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116411,group,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116412,.,O,4058.0,"When the rats were treated with a low dose ( 50 mg / kg ) of raw aqueous extract of garlic , no significant changes in the serum glucose levels were observed compared with the control group ."
116619,The,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116620,development,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116621,of,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116622,this,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116623,disease,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116624,is,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116625,influenced,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116626,by,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116627,genetic,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116628,and,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116629,environmental,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116630,factors,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116631,.,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116830,Calcium,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116831,",",O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116832,bioactive,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116833,peptides,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116834,and,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116835,as,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116836,yet,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116837,unidentified,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116838,components,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116839,in,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116840,whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116841,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116842,may,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116843,protect,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116844,from,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116845,hypertension,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116846,",",O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116847,and,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116848,folic,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116849,acid,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116850,",",O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116851,vitamin,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116852,B6,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116853,(,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116854,pyridoxine,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116855,),O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116856,and,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116857,B12,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116858,(,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116859,cyanocobalamin,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116860,),O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116861,or,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116862,other,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116863,unidentified,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116864,components,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116865,of,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116866,skim,B-http://purl.bioontology.org/ontology/SNOMEDCT/25743006;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116867,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/25743006;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116868,may,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116869,contribute,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116870,to,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116871,low,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116872,homocysteine,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116873,levels,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
116874,.,O,4076.0,"Calcium , bioactive peptides and as yet unidentified components in whole milk may protect from hypertension , and folic acid , vitamin B6 ( pyridoxine ) and B12 ( cyanocobalamin ) or other unidentified components of skim milk may contribute to low homocysteine levels ."
117355,When,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117356,a,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117357,single,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117358,logistic,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117359,model,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117360,was,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117361,fitted,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117362,including,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117363,all,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117364,food,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117365,items,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117366,significant,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117367,in,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117368,univariate,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117369,analysis,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117370,",",O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117371,the,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117372,3,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117373,items,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117374,remaining,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117375,statistically,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117376,significant,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117377,were,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117378,green,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117379,vegetables,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117380,(,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117381,relative,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117382,risk,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117383,",",O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117384,RR,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117385,=,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117386,0.27,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117387,for,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117388,upper,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117389,vs.,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117390,lower,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117391,tertile,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117392,),O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117393,",",O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117394,polenta,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117395,(,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117396,RR,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117397,=,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117398,2.32,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117399,),O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117400,and,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117401,ham,B-http://purl.bioontology.org/ontology/SNOMEDCT/442861000124104,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117402,(,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117403,RR,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117404,=,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117405,1.60,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117406,),O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117407,.,O,4093.0,"When a single logistic model was fitted including all food items significant in univariate analysis , the 3 items remaining statistically significant were green vegetables ( relative risk , RR = 0.27 for upper vs. lower tertile ) , polenta ( RR = 2.32 ) and ham ( RR = 1.60 ) ."
117774,Dose,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117775,-,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117776,dependent,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117777,HR,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117778,(,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117779,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117780,peel,I-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117781,=,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117782,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117783,pulp,I-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117784,>,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117785,peach,B-http://purl.bioontology.org/ontology/SNOMEDCT/735049002,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117786,=,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117787,cherry,B-http://purl.bioontology.org/ontology/SNOMEDCT/735248001,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117788,),O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117789,was,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117790,demonstrated,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117791,in,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117792,both,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117793,allergic,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117794,groups,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117795,",",O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117796,but,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117797,to,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117798,a,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117799,higher,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117800,extent,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117801,in,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117802,patients,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117803,with,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117804,fruit,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117805,allergy,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117806,(,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117807,P,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117808,<,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117809,0.01,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117810,),O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117811,.,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117812,Increased,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117813,basophil,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117814,sensitivity,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117815,to,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117816,birch,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117817,pollen,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117818,was,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117819,found,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117820,in,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117821,the,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117822,group,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117823,with,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117824,fruit,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117825,allergy,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117826,(,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117827,P,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117828,<,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117829,0.001,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117830,),O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
117831,.,O,4108.0,Increased basophil sensitivity to birch pollen was found in the group with fruit allergy ( P < 0.001 ) .
118058,Most,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118059,Cd,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118060,is,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118061,accumulated,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118062,in,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118063,the,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118064,vacuoles,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118065,of,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118066,plant,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118067,cells,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118068,",",O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118069,except,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118070,what,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118071,is,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118072,absorbed,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118073,by,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118074,the,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118075,cell,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118076,wall,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118077,",",O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118078,allowing,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118079,Cd,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118080,to,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118081,be,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118082,released,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118083,from,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118084,plant,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118085,tissues,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118086,under,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118087,moderate,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118088,conditions,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118089,.,O,4118.0,"Most Cd is accumulated in the vacuoles of plant cells , except what is absorbed by the cell wall , allowing Cd to be released from plant tissues under moderate conditions ."
118154,Extensive,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118155,research,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118156,within,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118157,the,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118158,past,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118159,two,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118160,decades,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118161,has,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118162,revealed,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118163,that,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118164,obesity,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118165,",",O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118166,a,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118167,major,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118168,risk,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118169,factor,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118170,for,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118171,type,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118172,2,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118173,diabetes,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118174,",",O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118175,atherosclerosis,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118176,",",O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118177,cancer,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118178,",",O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118179,and,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118180,other,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118181,chronic,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118182,diseases,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118183,",",O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118184,is,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118185,a,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118186,proinflammatory,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118187,disease,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118188,.,O,4122.0,"Extensive research within the past two decades has revealed that obesity , a major risk factor for type 2 diabetes , atherosclerosis , cancer , and other chronic diseases , is a proinflammatory disease ."
118189,Several,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118190,spices,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118191,have,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118192,been,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118193,shown,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118194,to,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118195,exhibit,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118196,activity,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118197,against,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118198,obesity,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118199,through,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118200,antioxidant,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118201,and,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118202,anti,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118203,-,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118204,inflammatory,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118205,mechanisms,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118206,.,O,4123.0,Several spices have been shown to exhibit activity against obesity through antioxidant and anti - inflammatory mechanisms .
118246,Curcumin,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118247,directly,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118248,interacts,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118249,with,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118250,adipocytes,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118251,",",O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118252,pancreatic,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118253,cells,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118254,",",O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118255,hepatic,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118256,stellate,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118257,cells,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118258,",",O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118259,macrophages,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118260,",",O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118261,and,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118262,muscle,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118263,cells,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118264,.,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118265,There,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118266,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118267,it,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118268,suppresses,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118269,the,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118270,proinflammatory,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118271,transcription,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118272,factors,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118273,nuclear,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118274,factor,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118275,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118276,kappa,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118277,B,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118278,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118279,signal,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118280,transducer,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118281,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118282,activators,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118283,of,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118284,transcription-3,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118285,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118286,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118287,Wnt,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118288,/,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118289,beta,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118290,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118291,catenin,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118292,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118293,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118294,it,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118295,activates,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118296,peroxisome,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118297,proliferator,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118298,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118299,activated,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118300,receptor,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118301,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118302,gamma,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118303,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118304,Nrf2,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118305,cell,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118306,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118307,signaling,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118308,pathways,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118309,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118310,thus,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118311,leading,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118312,to,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118313,the,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118314,downregulation,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118315,of,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118316,adipokines,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118317,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118318,including,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118319,tumor,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118320,necrosis,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118321,factor,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118322,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118323,interleukin-6,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118324,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118325,resistin,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118326,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118327,leptin,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118328,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118329,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118330,monocyte,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118331,chemotactic,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118332,protein-1,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118333,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118334,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118335,the,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118336,upregulation,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118337,of,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118338,adiponectin,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118339,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118340,other,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118341,gene,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118342,products,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118343,.,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118364,Other,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118365,structurally,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118366,homologous,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118367,nutraceuticals,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118368,",",O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118369,derived,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118370,from,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118371,red,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118372,chili,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118373,",",O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118374,cinnamon,B-http://purl.bioontology.org/ontology/SNOMEDCT/227388008,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118375,",",O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118376,cloves,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118377,",",O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118378,black,B-http://purl.bioontology.org/ontology/SNOMEDCT/412060000;http://purl.bioontology.org/ontology/SNOMEDCT/227563001,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118379,pepper,I-http://purl.bioontology.org/ontology/SNOMEDCT/412060000;http://purl.bioontology.org/ontology/SNOMEDCT/227563001,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118380,",",O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118381,and,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118382,ginger,B-http://purl.bioontology.org/ontology/SNOMEDCT/227400003,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118383,",",O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118384,also,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118385,exhibit,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118386,effects,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118387,against,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118388,obesity,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118389,and,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118390,insulin,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118391,resistance,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118392,.,O,4128.0,"Other structurally homologous nutraceuticals , derived from red chili , cinnamon , cloves , black pepper , and ginger , also exhibit effects against obesity and insulin resistance ."
118504,The,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118505,findings,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118506,demonstrated,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118507,that,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118508,shellfish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735029006,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118509,consumption,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118510,may,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118511,increase,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118512,the,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118513,risk,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118514,of,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118515,hyperuricemia,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118516,and,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118517,gout,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118518,but,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118519,may,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118520,not,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118521,increase,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118522,the,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118523,risk,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118524,of,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118525,type,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118526,2,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118527,diabetes,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118528,",",O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118529,cardiovascular,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118530,diseases,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118531,",",O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118532,and,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118533,thyroid,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118534,cancer,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118535,.,O,4133.0,"The findings demonstrated that shellfish consumption may increase the risk of hyperuricemia and gout but may not increase the risk of type 2 diabetes , cardiovascular diseases , and thyroid cancer ."
118536,Adequate,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118537,evidence,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118538,is,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118539,lacking,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118540,on,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118541,the,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118542,association,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118543,between,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118544,shellfish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735029006,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118545,consumption,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118546,and,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118547,the,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118548,risk,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118549,of,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118550,colorectal,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118551,cancer,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118552,",",O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118553,pancreatic,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118554,cancer,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118555,",",O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118556,oral,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118557,cancer,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118558,",",O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118559,endometriosis,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118560,",",O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118561,hip,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118562,fracture,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118563,",",O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118564,cognitive,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118565,function,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118566,",",O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118567,wheeze,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118568,",",O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118569,eczema,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118570,and,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118571,food,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118572,allergy,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
118573,.,O,4134.0,"Adequate evidence is lacking on the association between shellfish consumption and the risk of colorectal cancer , pancreatic cancer , oral cancer , endometriosis , hip fracture , cognitive function , wheeze , eczema and food allergy ."
119131,Higher,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119132,dietary,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119133,energy,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119134,density,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119135,(,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119136,DED,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119137,),O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119138,has,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119139,been,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119140,reported,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119141,to,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119142,be,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119143,associated,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119144,with,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119145,weight,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119146,gain,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119147,",",O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119148,obesity,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119149,and,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119150,poorer,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119151,dietary,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119152,quality,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119153,",",O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119154,yet,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119155,nationally,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119156,representative,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119157,estimates,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119158,that,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119159,would,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119160,allow,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119161,tracking,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119162,of,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119163,secular,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119164,trends,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119165,and,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119166,inter,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119167,-,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119168,country,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119169,comparisons,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119170,are,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119171,limited,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119172,.,O,4155.0,"Higher dietary energy density ( DED ) has been reported to be associated with weight gain , obesity and poorer dietary quality , yet nationally representative estimates that would allow tracking of secular trends and inter - country comparisons are limited ."
119319,Variation,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119320,in,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119321,the,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119322,intakes,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119323,of,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119324,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119325,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119326,vegetables,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119327,and,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119328,sugar,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119329,-,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119330,sweetened,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119331,beverages,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119332,(,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119333,SSB,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119334,),O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119335,across,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119336,consumer,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119337,groups,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119338,contributed,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119339,to,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119340,the,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119341,largest,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119342,variance,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119343,in,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119344,DED,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119345,estimates,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119346,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119347,followed,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119348,by,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119349,variation,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119350,in,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119351,the,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119352,intakes,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119353,of,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119354,potatoes,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119355,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119356,fresh,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119357,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119358,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119359,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119360,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119361,chips,B-http://purl.bioontology.org/ontology/SNOMEDCT/227282006,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119362,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119363,ready,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119364,-,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119365,to,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119366,-,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119367,eat,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119368,breakfast,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119369,cereals,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119370,",",O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119371,and,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119372,confectionery,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119373,.,O,4160.0,"Variation in the intakes of fruit , vegetables and sugar - sweetened beverages ( SSB ) across consumer groups contributed to the largest variance in DED estimates , followed by variation in the intakes of potatoes , fresh meat , bread , chips , ready - to - eat breakfast cereals , and confectionery ."
119442,Females,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119443,consumed,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119444,",",O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119445,on,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119446,average,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119447,",",O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119448,1·5,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119449,times,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119450,more,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119451,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119452,and,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119453,vegetables,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119454,combined,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119455,when,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119456,compared,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119457,with,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119458,males,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119459,",",O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119460,largely,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119461,explaining,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119462,the,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119463,sex,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119464,differences,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119465,in,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119466,DED,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119467,estimates,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119468,.,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
120091,Cinnamon,B-http://purl.bioontology.org/ontology/SNOMEDCT/227388008,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120092,was,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120093,the,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120094,most,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120095,bioactive,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120096,product,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120097,followed,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120098,by,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120099,witch,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120100,hazel,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120101,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120102,green,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120103,and,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120104,black,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120105,teas,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120106,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120107,allspice,B-http://purl.bioontology.org/ontology/SNOMEDCT/227375005,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120108,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120109,bay,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120110,leaves,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120111,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120112,nutmeg,B-http://purl.bioontology.org/ontology/SNOMEDCT/735046009,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120113,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120114,cloves,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120115,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120116,mushrooms,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120117,",",O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120118,and,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120119,brewer,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120120,'s,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120121,yeast,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120122,.,O,4184.0,"Cinnamon was the most bioactive product followed by witch hazel , green and black teas , allspice , bay leaves , nutmeg , cloves , mushrooms , and brewer 's yeast ."
120288,Dairy,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120289,products,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120290,have,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120291,an,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120292,important,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120293,role,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120294,in,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120295,a,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120296,healthy,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120297,diet,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120298,due,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120299,to,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120300,their,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120301,high,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120302,-,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120303,quality,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120304,protein,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120305,and,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120306,rich,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120307,micronutrients,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120308,.,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120365,In,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120366,recent,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120367,years,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120368,",",O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120369,the,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120370,prevalence,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120371,of,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120372,metabolic,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120373,syndrome,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120374,",",O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120375,which,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120376,threatens,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120377,public,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120378,health,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120379,",",O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120380,is,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120381,increasing,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120382,rapidly,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120383,.,O,4193.0,"In recent years , the prevalence of metabolic syndrome , which threatens public health , is increasing rapidly ."
120796,These,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120797,findings,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120798,were,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120799,in,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120800,accordance,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120801,with,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120802,the,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120803,generally,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120804,held,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120805,view,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120806,in,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120807,Japan,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120808,that,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120809,moderate,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120810,intake,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120811,of,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120812,animal,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120813,protein,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120814,was,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120815,protective,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120816,against,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120817,stroke,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120818,.,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120940,In,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120941,addition,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120942,",",O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120943,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120944,",",O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120945,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120946,and,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120947,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120948,had,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120949,a,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120950,protective,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120951,effect,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120952,during,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120953,adolescence,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
120954,.,O,4215.0,"In addition , cheese , fish and tea had a protective effect during adolescence ."
121197,Proteomic,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121198,analysis,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121199,revealed,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121200,a,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121201,total,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121202,of,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121203,1330,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121204,common,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121205,proteins,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121206,in,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121207,milk,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121208,sEV,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121209,among,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121210,BLV,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121211,-,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121212,infected,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121213,cattle,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121214,",",O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121215,whereas,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121216,118,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121217,proteins,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121218,were,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121219,uniquely,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121220,expressed,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121221,compared,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121222,with,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121223,those,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121224,from,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121225,uninfected,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121226,cattle,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121227,.,O,4225.0,"Proteomic analysis revealed a total of 1330 common proteins in milk sEV among BLV - infected cattle , whereas 118 proteins were uniquely expressed compared with those from uninfected cattle ."
121355,A,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121356,random,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121357,sample,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121358,of,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121359,1153,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121360,individuals,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121361,",",O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121362,aged,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121363,18,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121364,-,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121365,69,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121366,years,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121367,",",O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121368,was,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121369,recruited,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121370,to,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121371,participate,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121372,in,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121373,the,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121374,cross,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121375,-,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121376,sectional,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121377,Observation,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121378,of,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121379,Cardiovascular,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121380,Risk,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121381,Factors,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121382,in,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121383,Luxembourg,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121384,study,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121385,.,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121402,Blood,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121403,glucose,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121404,and,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121405,insulin,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121406,levels,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121407,were,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121408,used,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121409,for,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121410,the,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121411,homoeostasis,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121412,model,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121413,assessment,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121414,of,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121415,insulin,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121416,resistance,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121417,(,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121418,HOMA,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121419,-,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121420,IR,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121421,),O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121422,.,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121974,They,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121975,received,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121976,by,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121977,force-,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121978,feeding,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121979,7.14,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121980,mL/(kg,O,4249.0,They received by force- feeding 7.14 mL/(kg .
121981,.,O,4249.0,They received by force- feeding 7.14 mL/(kg .
122023,d,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122024,),O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122025,],O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122026,",",O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122027,or,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122028,2.6,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122029,mol,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122030,/,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122031,L,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122032,ethanol,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122033,(,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122034,E,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122035,-,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122036,PE,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122037,),O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122038,or,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122039,water,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122040,(,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122041,W,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122042,-,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122043,PE,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122044,),O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122045,as,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122046,their,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122047,respective,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122048,controls,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122049,.,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122114,Apo,O,4254.0,Apo - A1 was not affected .
122115,-,O,4254.0,Apo - A1 was not affected .
122116,A1,O,4254.0,Apo - A1 was not affected .
122117,was,O,4254.0,Apo - A1 was not affected .
122118,not,O,4254.0,Apo - A1 was not affected .
122119,affected,O,4254.0,Apo - A1 was not affected .
122120,.,O,4254.0,Apo - A1 was not affected .
122350,Cancer,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122351,cases,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122352,(,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122353,n,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122354,=,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122355,419,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122356,),O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122357,were,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122358,identified,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122359,through,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122360,the,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122361,Utah,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122362,Cancer,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122363,Registry,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122364,",",O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122365,and,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122366,controls,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122367,(,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122368,n,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122369,=,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122370,889,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122371,),O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122372,were,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122373,obtained,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122374,through,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122375,random,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122376,digit,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122377,dialing,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122378,and,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122379,the,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122380,Health,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122381,Care,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122382,Financing,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122383,Administration,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122384,.,O,4263.0,"Cancer cases ( n = 419 ) were identified through the Utah Cancer Registry , and controls ( n = 889 ) were obtained through random digit dialing and the Health Care Financing Administration ."
122895,Using,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122896,22,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122897,pre,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122898,-,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122899,defined,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122900,food,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122901,groups,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122902,",",O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122903,three,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122904,DP,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122905,were,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122906,extracted,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
122907,.,O,4282.0,"Using 22 pre - defined food groups , three DP were extracted ."
123015,The,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123016,"""",O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123017,traditional,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123018,"""",O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123019,DP,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123020,(,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123021,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123022,",",O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123023,potatoes,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123024,",",O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123025,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123026,",",O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123027,vegetables,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123028,",",O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123029,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123030,",",O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123031,stock,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123032,),O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123033,was,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123034,positively,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123035,associated,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123036,with,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123037,age,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123038,and,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123039,negatively,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123040,associated,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123041,with,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123042,being,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123043,a,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123044,former,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123045,/,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123046,current,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123047,smoker,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123048,",",O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123049,education,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123050,(,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123051,men,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123052,),O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123053,",",O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123054,and,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123055,residing,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123056,in,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123057,an,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123058,urban,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123059,/,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123060,semi,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123061,-,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123062,urban,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123063,area,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123064,.,O,4285.0,"The "" traditional "" DP ( bread , potatoes , milk , vegetables , butter , stock ) was positively associated with age and negatively associated with being a former / current smoker , education ( men ) , and residing in an urban / semi - urban area ."
123236,MDA,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123237,levels,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123238,were,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123239,increased,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123240,by,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123241,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123242,diets,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123243,relative,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123244,to,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123245,the,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123246,chicken,B-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123247,diets,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123248,.,O,4292.0,MDA levels were increased by beef diets relative to the chicken diets .
123275,Higher,O,4294.0,Higher dietary chicken ( but not beef ) increased IGF - I irrespective of HAMS feeding .
123276,dietary,O,4294.0,Higher dietary chicken ( but not beef ) increased IGF - I irrespective of HAMS feeding .
123277,chicken,B-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,4294.0,Higher dietary chicken ( but not beef ) increased IGF - I irrespective of HAMS feeding .
123278,(,O,4294.0,Higher dietary chicken ( but not beef ) increased IGF - I irrespective of HAMS feeding .
123279,but,O,4294.0,Higher dietary chicken ( but not beef ) increased IGF - I irrespective of HAMS feeding .
123280,not,O,4294.0,Higher dietary chicken ( but not beef ) increased IGF - I irrespective of HAMS feeding .
123281,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,4294.0,Higher dietary chicken ( but not beef ) increased IGF - I irrespective of HAMS feeding .
123282,),O,4294.0,Higher dietary chicken ( but not beef ) increased IGF - I irrespective of HAMS feeding .
123283,increased,O,4294.0,Higher dietary chicken ( but not beef ) increased IGF - I irrespective of HAMS feeding .
123284,IGF,O,4294.0,Higher dietary chicken ( but not beef ) increased IGF - I irrespective of HAMS feeding .
123285,-,O,4294.0,Higher dietary chicken ( but not beef ) increased IGF - I irrespective of HAMS feeding .
123286,I,O,4294.0,Higher dietary chicken ( but not beef ) increased IGF - I irrespective of HAMS feeding .
123287,irrespective,O,4294.0,Higher dietary chicken ( but not beef ) increased IGF - I irrespective of HAMS feeding .
123288,of,O,4294.0,Higher dietary chicken ( but not beef ) increased IGF - I irrespective of HAMS feeding .
123289,HAMS,O,4294.0,Higher dietary chicken ( but not beef ) increased IGF - I irrespective of HAMS feeding .
123290,feeding,O,4294.0,Higher dietary chicken ( but not beef ) increased IGF - I irrespective of HAMS feeding .
123291,.,O,4294.0,Higher dietary chicken ( but not beef ) increased IGF - I irrespective of HAMS feeding .
123870,There,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123871,was,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123872,also,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123873,a,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123874,clue,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123875,that,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123876,the,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123877,unfavorable,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123878,influence,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123879,of,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123880,frequent,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123881,intake,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123882,of,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123883,a,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123884,few,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123885,food,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123886,items,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123887,(,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123888,i.e.,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123889,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123890,",",O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123891,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123892,",",O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123893,liver,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123894,",",O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123895,ham,B-http://purl.bioontology.org/ontology/SNOMEDCT/442861000124104;http://purl.bioontology.org/ontology/SNOMEDCT/227018006,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123896,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/442861000124104;http://purl.bioontology.org/ontology/SNOMEDCT/227018006,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123897,salami,I-http://purl.bioontology.org/ontology/SNOMEDCT/442861000124104;http://purl.bioontology.org/ontology/SNOMEDCT/227018006,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123898,",",O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123899,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123900,and,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123901,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123902,",",O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123903,and,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123904,retinol,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123905,),O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123906,may,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123907,be,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123908,greater,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123909,or,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123910,restricted,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123911,to,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123912,older,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123913,individuals,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123914,(,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123915,i.e.,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123916,",",O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123917,>,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123918,or,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123919,=,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123920,70,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123921,yrs,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123922,of,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123923,age,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123924,),O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123925,.,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
124249,Significant,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124250,differences,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124251,were,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124252,detected,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124253,in,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124254,the,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124255,protein,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124256,compositions,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124257,of,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124258,the,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124259,analyzed,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124260,wine,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124261,varieties,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124262,",",O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124263,and,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124264,the,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124265,major,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124266,protein,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124267,bands,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124268,were,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124269,identified,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124270,by,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124271,mass,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124272,spectrometry,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124273,after,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124274,in,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124275,-,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124276,gel,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124277,digestion,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124278,with,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124279,trypsin,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124280,.,O,4332.0,"Significant differences were detected in the protein compositions of the analyzed wine varieties , and the major protein bands were identified by mass spectrometry after in - gel digestion with trypsin ."
124281,In,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124282,German,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124283,Portugieser,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124284,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124285,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124286,",",O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124287,a,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124288,total,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124289,of,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124290,121,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124291,tryptic,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124292,peptides,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124293,were,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124294,identified,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124295,",",O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124296,which,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124297,were,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124298,attributed,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124299,to,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124300,12,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124301,grape,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124302,proteins,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124303,and,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124304,6,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124305,proteins,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124306,derived,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124307,from,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124308,yeast,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124309,.,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124402,Olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,4338.0,Olive oil reportedly has cardioprotective effects .
124403,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,4338.0,Olive oil reportedly has cardioprotective effects .
124404,reportedly,O,4338.0,Olive oil reportedly has cardioprotective effects .
124405,has,O,4338.0,Olive oil reportedly has cardioprotective effects .
124406,cardioprotective,O,4338.0,Olive oil reportedly has cardioprotective effects .
124407,effects,O,4338.0,Olive oil reportedly has cardioprotective effects .
124408,.,O,4338.0,Olive oil reportedly has cardioprotective effects .
124672,When,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124673,a,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124674,logistic,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124675,model,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124676,was,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124677,fitted,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124678,that,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124679,included,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124680,the,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124681,aforementioned,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124682,food,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124683,items,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124684,in,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124685,addition,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124686,to,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124687,major,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124688,nondietary,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124689,covariates,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124690,",",O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124691,all,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124692,of,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124693,the,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124694,foods,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124695,",",O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124696,except,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124697,liver,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124698,and,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124699,beverages,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124700,that,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124701,contain,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124702,methylxanthine,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124703,",",O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124704,remained,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124705,significant,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124706,.,O,4348.0,"When a logistic model was fitted that included the aforementioned food items in addition to major nondietary covariates , all of the foods , except liver and beverages that contain methylxanthine , remained significant ."
124707,Interestingly,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124708,",",O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124709,these,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124710,associations,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124711,are,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124712,in,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124713,agreement,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124714,with,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124715,the,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124716,positive,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124717,correlation,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124718,that,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124719,is,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124720,emerging,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124721,internationally,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124722,between,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124723,the,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124724,consumption,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124725,of,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124726,fat,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124727,and,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124728,proteins,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124729,and,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124730,non,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124731,-,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124732,Hodgkin,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124733,'s,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124734,lymphoma,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
124735,.,O,4349.0,"Interestingly , these associations are in agreement with the positive correlation that is emerging internationally between the consumption of fat and proteins and non - Hodgkin 's lymphoma ."
125041,Red,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125042,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125043,has,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125044,been,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125045,suggested,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125046,to,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125047,be,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125048,adversely,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125049,associated,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125050,with,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125051,risk,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125052,of,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125053,myocardial,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125054,infarction,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125055,(,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125056,MI,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125057,),O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125058,",",O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125059,whereas,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125060,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125061,consumption,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125062,has,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125063,been,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125064,found,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125065,to,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125066,be,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125067,protective,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125068,.,O,4362.0,"Red meat has been suggested to be adversely associated with risk of myocardial infarction ( MI ) , whereas vegetable consumption has been found to be protective ."
125093,We,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125094,followed,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125095,up,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125096,29,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125097,142,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125098,women,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125099,and,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125100,26,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125101,029,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125102,men,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125103,in,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125104,the,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125105,Danish,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125106,Diet,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125107,",",O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125108,Cancer,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125109,and,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125110,Health,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125111,study,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125112,aged,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125113,50,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125114,-,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125115,64,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125116,years,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125117,with,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125118,no,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125119,known,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125120,history,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125121,of,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125122,MI,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125123,at,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125124,baseline,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125125,.,O,4364.0,"We followed up 29 142 women and 26 029 men in the Danish Diet , Cancer and Health study aged 50 - 64 years with no known history of MI at baseline ."
125299,Among,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125300,men,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125301,",",O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125302,a,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125303,similar,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125304,pattern,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125305,was,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125306,observed,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125307,",",O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125308,but,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125309,the,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125310,associations,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125311,were,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125312,weak,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125313,and,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125314,mostly,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125315,statistically,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125316,non,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125317,-,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125318,significant,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125319,.,O,4372.0,"Among men , a similar pattern was observed , but the associations were weak and mostly statistically non - significant ."
125692,Women,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125693,consuming,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125694,5,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125695,or,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125696,more,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125697,servings,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125698,of,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125699,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125700,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125701,vegetables,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125702,daily,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125703,had,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125704,a,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125705,relative,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125706,risk,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125707,of,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125708,0.59,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125709,(,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125710,95,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125711,%,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125712,CI,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125713,=,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125714,0.26,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125715,-,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125716,1.34,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125717,),O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125718,in,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125719,comparison,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125720,to,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125721,them,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125722,consuming,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125723,less,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125724,than,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125725,once,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125726,daily,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125727,.,O,4384.0,Women consuming 5 or more servings of fruit and vegetables daily had a relative risk of 0.59 ( 95 % CI = 0.26 - 1.34 ) in comparison to them consuming less than once daily .
125834,Within,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125835,the,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125836,group,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125837,of,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125838,vegetables,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125839,",",O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125840,the,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125841,strongest,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125842,inverse,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125843,association,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125844,was,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125845,observed,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125846,for,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125847,root,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125848,vegetables,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125849,(,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125850,p,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125851,=,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125852,0.03,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125853,by,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125854,Wald,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125855,test,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125856,),O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
125857,.,O,4388.0,"Within the group of vegetables , the strongest inverse association was observed for root vegetables ( p = 0.03 by Wald test ) ."
126105,Risk,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126106,of,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126107,rectal,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126108,cancer,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126109,increased,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126110,nonsignificantly,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126111,among,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126112,men,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126113,with,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126114,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126115,consumption,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126116,",",O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126117,among,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126118,women,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126119,with,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126120,high,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126121,white,B-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126122,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126123,use,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126124,",",O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126125,and,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126126,among,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126127,men,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126128,and,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126129,women,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126130,with,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126131,high,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126132,long,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126133,-,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126134,term,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126135,alcohol,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126136,use,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126137,.,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126389,Change,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126390,in,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126391,frequency,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126392,of,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126393,consumption,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126394,during,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126395,adulthood,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126396,was,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126397,calculated,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126398,by,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126399,subtracting,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126400,frequency,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126401,of,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126402,consumption,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126403,of,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126404,specific,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126405,foods,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126406,or,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126407,food,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126408,groups,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126409,at,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126410,age,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126411,30,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126412,yr,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126413,from,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126414,frequency,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126415,of,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126416,consumption,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126417,during,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126418,the,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126419,previous,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126420,year,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126421,(,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126422,recent,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126423,consumption,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126424,),O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126425,.,O,4404.0,Change in frequency of consumption during adulthood was calculated by subtracting frequency of consumption of specific foods or food groups at age 30 yr from frequency of consumption during the previous year ( recent consumption ) .
126505,Compared,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126506,with,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126507,individuals,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126508,with,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126509,the,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126510,highest,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126511,reduction,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126512,in,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126513,consumption,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126514,since,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126515,age,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126516,30,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126517,yr,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126518,",",O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126519,risks,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126520,were,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126521,higher,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126522,for,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126523,those,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126524,with,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126525,smallest,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126526,reduction,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126527,in,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126528,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126529,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126530,intake,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126531,(,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126532,OR,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126533,=,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126534,2.8,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126535,;,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126536,CI,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126537,=,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126538,1.1,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126539,-,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126540,7.3,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126541,),O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126542,",",O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126543,particularly,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126544,for,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126545,hamburgers,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126546,/,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126547,cheeseburgers,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126548,(,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126549,OR,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126550,=,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126551,2.8,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126552,;,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126553,CI,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126554,=,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126555,1.2,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126556,-,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126557,6.8,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126558,),O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126559,and,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126560,pork,B-http://purl.bioontology.org/ontology/SNOMEDCT/226934003,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126561,chops,I-http://purl.bioontology.org/ontology/SNOMEDCT/226934003,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126562,/,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126563,ham,B-http://purl.bioontology.org/ontology/SNOMEDCT/442861000124104,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126564,steaks,I-http://purl.bioontology.org/ontology/SNOMEDCT/442861000124104,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126565,(,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126566,OR,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126567,=,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126568,3.7,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126569,;,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126570,CI,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126571,=,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126572,1.6,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126573,-,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126574,8.7,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126575,),O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
126576,.,O,4408.0,"Compared with individuals with the highest reduction in consumption since age 30 yr , risks were higher for those with smallest reduction in red meat intake ( OR = 2.8 ; CI = 1.1 - 7.3 ) , particularly for hamburgers / cheeseburgers ( OR = 2.8 ; CI = 1.2 - 6.8 ) and pork chops / ham steaks ( OR = 3.7 ; CI = 1.6 - 8.7 ) ."
127135,The,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127136,cMetS,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127137,was,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127138,calculated,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127139,based,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127140,on,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127141,waist,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127142,circumference,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127143,",",O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127144,triglycerides,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127145,",",O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127146,high,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127147,-,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127148,density,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127149,lipoprotein,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127150,cholesterol,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127151,",",O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127152,glucose,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127153,",",O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127154,and,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127155,mean,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127156,arterial,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127157,blood,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127158,pressure,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127159,.,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127436,Samples,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127437,from,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127438,each,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127439,step,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127440,of,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127441,bread,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127442,preparation,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127443,were,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127444,analyzed,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127445,for,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127446,folic,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127447,acid,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127448,concentration,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127449,.,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127464,Rats,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127465,were,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127466,divided,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127467,into,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127468,five,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127469,groups,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127470,",",O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127471,four,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127472,of,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127473,them,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127474,were,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127475,injected,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127476,subcutaneously,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127477,with,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127478,dimethylhydrazine,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127479,(,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127480,DMH,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127481,),O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127482,.,O,4436.0,"Rats were divided into five groups , four of them were injected subcutaneously with dimethylhydrazine ( DMH ) ."
127729,Given,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127730,the,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127731,potential,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127732,of,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127733,NHPs,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127734,to,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127735,additively,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127736,cause,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127737,hypoglycemia,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127738,when,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127739,used,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127740,concurrently,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127741,with,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127742,conventional,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127743,medications,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127744,",",O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127745,pharmacists,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127746,should,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127747,be,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127748,up,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127749,to,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127750,date,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127751,with,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127752,current,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127753,evidence,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127754,around,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127755,NHPs,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127756,that,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127757,may,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127758,affect,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127759,diabetes,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127760,care,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127761,to,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127762,prevent,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127763,adverse,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127764,reactions,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127765,and,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127766,interactions,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127767,.,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127796,Forty,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127797,-,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127798,eight,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127799,Holstein,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127800,cows,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127801,were,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127802,used,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127803,to,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127804,determine,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127805,the,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127806,effects,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127807,of,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127808,short,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127809,-,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127810,term,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127811,oral,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127812,drenches,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127813,of,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127814,propylene,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127815,glycol,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127816,(,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127817,PG,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127818,),O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127819,and,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127820,Ca,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127821,-,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127822,soaps,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127823,of,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127824,palm,B-http://purl.bioontology.org/ontology/SNOMEDCT/226907001,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127825,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/226907001,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127826,fatty,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127827,acids,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127828,(,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127829,fat,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127830,),O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127831,on,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127832,plasma,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127833,concentrations,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127834,of,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127835,key,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127836,metabolites,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127837,",",O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127838,liver,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127839,composition,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127840,",",O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127841,and,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127842,milk,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127843,production,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127844,during,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127845,the,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127846,first,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127847,3,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127848,wk,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127849,of,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127850,lactation,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127851,.,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
128741,This,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128742,paper,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128743,demonstrates,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128744,that,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128745,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128746,makes,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128747,a,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128748,significant,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128749,contribution,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128750,to,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128751,U.S.,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128752,per,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128753,capita,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128754,dietary,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128755,antioxidants,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128756,and,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128757,by,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128758,inference,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128759,the,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128760,European,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128761,Community,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128762,'s,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128763,.,O,4477.0,This paper demonstrates that chocolate makes a significant contribution to U.S. per capita dietary antioxidants and by inference the European Community 's .
128816,Conversely,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128817,",",O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128818,the,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128819,fat,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128820,from,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128821,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128822,alone,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128823,is,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128824,a,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128825,pro,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128826,-,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128827,oxidant,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128828,in,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128829,this,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128830,model,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128831,.,O,4480.0,"Conversely , the fat from chocolate alone is a pro - oxidant in this model ."
128832,This,O,4481.0,This is also demonstrated in an in vivo human study .
128833,is,O,4481.0,This is also demonstrated in an in vivo human study .
128834,also,O,4481.0,This is also demonstrated in an in vivo human study .
128835,demonstrated,O,4481.0,This is also demonstrated in an in vivo human study .
128836,in,O,4481.0,This is also demonstrated in an in vivo human study .
128837,an,O,4481.0,This is also demonstrated in an in vivo human study .
128838,in,O,4481.0,This is also demonstrated in an in vivo human study .
128839,vivo,O,4481.0,This is also demonstrated in an in vivo human study .
128840,human,O,4481.0,This is also demonstrated in an in vivo human study .
128841,study,O,4481.0,This is also demonstrated in an in vivo human study .
128842,.,O,4481.0,This is also demonstrated in an in vivo human study .
129031,However,O,4488.0,"However , plant - based diets are not necessarily low - fat ."
129032,",",O,4488.0,"However , plant - based diets are not necessarily low - fat ."
129033,plant,O,4488.0,"However , plant - based diets are not necessarily low - fat ."
129034,-,O,4488.0,"However , plant - based diets are not necessarily low - fat ."
129035,based,O,4488.0,"However , plant - based diets are not necessarily low - fat ."
129036,diets,O,4488.0,"However , plant - based diets are not necessarily low - fat ."
129037,are,O,4488.0,"However , plant - based diets are not necessarily low - fat ."
129038,not,O,4488.0,"However , plant - based diets are not necessarily low - fat ."
129039,necessarily,O,4488.0,"However , plant - based diets are not necessarily low - fat ."
129040,low,O,4488.0,"However , plant - based diets are not necessarily low - fat ."
129041,-,O,4488.0,"However , plant - based diets are not necessarily low - fat ."
129042,fat,O,4488.0,"However , plant - based diets are not necessarily low - fat ."
129043,.,O,4488.0,"However , plant - based diets are not necessarily low - fat ."
129398,The,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129399,lifetime,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129400,risk,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129401,of,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129402,IHD,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129403,was,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129404,reduced,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129405,by,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129406,approximately,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129407,31,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129408,%,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129409,in,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129410,those,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129411,who,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129412,consumed,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129413,nuts,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129414,frequently,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129415,and,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129416,by,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129417,37,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129418,%,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129419,in,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129420,male,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129421,vegetarians,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129422,compared,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129423,with,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129424,nonvegetarians,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129425,.,O,4499.0,The lifetime risk of IHD was reduced by approximately 31 % in those who consumed nuts frequently and by 37 % in male vegetarians compared with nonvegetarians .
129460,Intake,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129461,of,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129462,legumes,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129463,was,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129464,negatively,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129465,associated,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129466,with,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129467,risk,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129468,of,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129469,colon,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129470,cancer,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129471,in,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129472,nonvegetarians,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129473,and,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129474,risk,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129475,of,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129476,pancreatic,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129477,cancer,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129478,.,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129479,Higher,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129480,consumption,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129481,of,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129482,all,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129483,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129484,or,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129485,dried,B-http://purl.bioontology.org/ontology/SNOMEDCT/227449005;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129486,fruit,I-http://purl.bioontology.org/ontology/SNOMEDCT/227449005;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129487,was,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129488,associated,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129489,with,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129490,lower,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129491,risks,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129492,of,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129493,lung,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129494,",",O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129495,prostate,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129496,",",O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129497,and,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129498,pancreatic,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129499,cancers,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129500,.,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129741,A,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129742,standard,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129743,serving,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129744,of,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129745,almonds,B-http://purl.bioontology.org/ontology/SNOMEDCT/256350002,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129746,reduced,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129747,postprandial,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129748,glycemia,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129749,significantly,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129750,in,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129751,participants,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129752,with,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129753,diabetes,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129754,(,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129755,-30,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129756,%,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129757,",",O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129758,P,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129759,=,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129760,.043,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129761,),O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129762,but,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129763,did,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129764,not,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129765,influence,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129766,glycemia,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129767,in,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129768,participants,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129769,without,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129770,diabetes,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129771,(,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129772,-7,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129773,%,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129774,",",O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129775,P,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129776,=,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129777,.638,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129778,),O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129779,.,O,4510.0,"A standard serving of almonds reduced postprandial glycemia significantly in participants with diabetes ( -30 % , P = .043 ) but did not influence glycemia in participants without diabetes ( -7 % , P = .638 ) ."
129995,Frequent,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
129996,consumption,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
129997,of,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
129998,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
129999,was,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130000,also,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130001,inversely,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130002,associated,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130003,with,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130004,this,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130005,cancer,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130006,.,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130053,For,O,4523.0,"For nutrient intake , increased calcium and fat intake decreased the risk for this cancer ."
130054,nutrient,O,4523.0,"For nutrient intake , increased calcium and fat intake decreased the risk for this cancer ."
130055,intake,O,4523.0,"For nutrient intake , increased calcium and fat intake decreased the risk for this cancer ."
130056,",",O,4523.0,"For nutrient intake , increased calcium and fat intake decreased the risk for this cancer ."
130057,increased,O,4523.0,"For nutrient intake , increased calcium and fat intake decreased the risk for this cancer ."
130058,calcium,O,4523.0,"For nutrient intake , increased calcium and fat intake decreased the risk for this cancer ."
130059,and,O,4523.0,"For nutrient intake , increased calcium and fat intake decreased the risk for this cancer ."
130060,fat,O,4523.0,"For nutrient intake , increased calcium and fat intake decreased the risk for this cancer ."
130061,intake,O,4523.0,"For nutrient intake , increased calcium and fat intake decreased the risk for this cancer ."
130062,decreased,O,4523.0,"For nutrient intake , increased calcium and fat intake decreased the risk for this cancer ."
130063,the,O,4523.0,"For nutrient intake , increased calcium and fat intake decreased the risk for this cancer ."
130064,risk,O,4523.0,"For nutrient intake , increased calcium and fat intake decreased the risk for this cancer ."
130065,for,O,4523.0,"For nutrient intake , increased calcium and fat intake decreased the risk for this cancer ."
130066,this,O,4523.0,"For nutrient intake , increased calcium and fat intake decreased the risk for this cancer ."
130067,cancer,O,4523.0,"For nutrient intake , increased calcium and fat intake decreased the risk for this cancer ."
130068,.,O,4523.0,"For nutrient intake , increased calcium and fat intake decreased the risk for this cancer ."
130692,Although,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130693,several,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130694,plant,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130695,parts,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130696,have,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130697,potentials,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130698,for,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130699,chemoprevention,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130700,and,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130701,other,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130702,therapeutic,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130703,use,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130704,",",O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130705,their,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130706,molecular,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130707,mechanisms,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130708,of,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130709,action,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130710,are,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130711,not,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130712,always,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130713,well,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130714,understood,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130715,.,O,4547.0,"Although several plant parts have potentials for chemoprevention and other therapeutic use , their molecular mechanisms of action are not always well understood ."
130942,Epidemiological,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130943,studies,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130944,have,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130945,observed,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130946,a,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130947,negative,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130948,association,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130949,between,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130950,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130951,intake,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130952,and,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130953,the,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130954,incidence,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130955,of,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130956,cardiovascular,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130957,disease,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
130958,.,O,4553.0,Epidemiological studies have observed a negative association between tomato intake and the incidence of cardiovascular disease .
131417,Natural,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131418,compounds,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131419,of,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131420,plant,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131421,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131422,fungus,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131423,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131424,and,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131425,actinomycetes,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131426,origin,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131427,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131428,such,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131429,as,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131430,phenolics,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131431,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131432,polyketides,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131433,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131434,tetrapeptide,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131435,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131436,terpenoids,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131437,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131438,alkaloids,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131439,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131440,and,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131441,hydoxamic,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131442,acid,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131443,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131444,have,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131445,been,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131446,reported,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131447,to,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131448,show,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131449,potential,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131450,HDAC,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131451,-,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131452,inhibitory,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131453,activity,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131454,.,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131891,A,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131892,total,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131893,mixed,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131894,ration,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131895,based,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131896,on,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131897,corn,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131898,silage,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131899,",",O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131900,grass,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131901,-,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131902,clover,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131903,silages,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131904,",",O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131905,and,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131906,pelleted,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131907,sugar,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131908,beet,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131909,pulp,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131910,was,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131911,used,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131912,on,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131913,all,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131914,treatments,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
131915,.,O,4585.0,"A total mixed ration based on corn silage , grass - clover silages , and pelleted sugar beet pulp was used on all treatments ."
132057,Treatments,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132058,did,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132059,not,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132060,influence,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132061,milk,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132062,free,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132063,fatty,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132064,acids,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132065,at,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132066,4,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132067,degrees,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132068,C,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132069,at,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132070,0,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132071,or,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132072,28,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132073,h,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132074,after,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132075,milking,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132076,.,O,4590.0,Treatments did not influence milk free fatty acids at 4 degrees C at 0 or 28 h after milking .
132077,The,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132078,average,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132079,diameter,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132080,of,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132081,milk,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132082,fat,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132083,globules,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132084,was,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132085,significantly,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132086,greater,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132087,in,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132088,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132089,from,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132090,cows,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132091,offered,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132092,low,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132093,de,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132094,novo,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132095,diets,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
132096,.,O,4591.0,The average diameter of milk fat globules was significantly greater in milk from cows offered low de novo diets .
